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Abstract
The modern insurgence of antimicrobial resistance prompted the research of new drug
alternatives. In parallel, the problem of their delivery has stimulated the research
of novel biomimietic vehicles. Synthetic materials can be designed to perform both
functions effectively. Recently engineered nanocapsules were shown to promote bac-
terial membrane poration and gene delivery into mammalian cells. Their constitutive
molecule, capzip, is a three branched peptide, which contains sequences inspired from
a naturally occurring antimicrobial peptide (AMP). AMPs act on bacteria disrupting
their membrane, a mechanism which does not strongly promote resistance.
As the atomistic details of the capzip nanocapsule assembly are still unknown, this
project studied its structure in water and its interaction with model membranes, by
means of multiscale Molecular Dynamics simulations. The in silico investigation clar-
ified the preferred structure that capzip adopts in order to form robust capsules. In
particular, the original formulation of capzip included an amphiphilic pattern to pro-
mote antimicrobial activity, but simulations proved that this has a key role in granting
structural stability as well. This provides insight for the development of the next
generation of multi-branched antimicrobial molecules. The multiscale investigation
performed prompted also a comparison between coarse-grained force fields, which will
contribute to inform the choice of the most adapt one for future simulations of large
peptidic assemblies.
The structures found to be stable in solution were selected for further simulations
at the interface with a model bacterial and mammalian membrane. The insertion of
charged residues in the membrane ester region produced a local decrease in lipid mo-
bility and, under the effect of an externally applied electric field in the physiological
range, pore formation with subsequent membrane disruption. Coarse-grained simula-
tions confirmed these findings, clarifying the attraction mechanism between the capsule
and the model bacterial membrane. Moreover, they suggested a lower affinity with the
model mammalian membrane. The exploration of the peptide-membrane interactions
prompted an investigation of the currently used lipid parameters in the GROMOS
atomistic force field. Given the inconsistency between the parametrisation of proteins
and lipids found in the latest versions of the force field, we proposed a new parametrisa-
tion that reconcile these. The new parameters showed a peptide-membrane interaction
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cience has always thrived thanks to human curiosity and to the desire of modify-
ing the environment around us. Out of the many science fields at service of human
wealth, the most challenging and still far away from being mastered is the comprehen-
sion and manipulation of the human body and mind. It is striking how we are finally
scratching the understanding of these two entities in the same historical moment, at
a point where computers start imitating human reasoning [Editor BBC, 2016; Google,
2016; Alom et al., 2019] and biological materials are turned into semi-functional organs
[Rossi et al., 2018].
The process of understanding is intertwined with the process of engineering, and
goes in parallel with the development of technology. As such, in the past two cen-
turies we witnessed a technological evolution that condensed the collective expertise
we accumulated so far into objects belonging, by now, to our daily life.
This boost of technical knowledge allowed for the development of novel instruments,
and in turn for the accumulation of a broader scientific knowledge. Consequently, the
times of all-round scientists left the way to an era in which specialisation is necessary
to master and understand a subject, in the hope and trust that piecewise knowledge
builds an organic body once the effort of many scientists is joined together.
The increasing understanding of how the body works - or fail to do so sometimes
- together with the discovery of bacteria and the symbiotic or disruptive relationship
we have with them, poses novel questions to science: why the body, which is carefully
design to function effectively, is susceptible to pathogenic diseases, malfunctioning of
its organs or failures in controlling its cells growth (tumours)? And why in some cases
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it defends itself also against beneficial drugs? But mostly, what can we do to repair
such faults?
Our biological and emotional push to change the course of nature to improve our
lives lead to the development of “medical technologies” such as drugs and treatments
to aid the body in fighting the agents which attack it. Historically, this proceeded
from a process of trial and error of natural substances, to an informed synthesis of
artificial drugs to repair the body [Wishart et al., 2018], together with disinfectants
[City of Vienna Climate Protection Programme, 2012] and antibiotics [The Johns Hop-
kins University, 2017] to fight pathogens: all together, we are closer and closer to the
magic bullet envisioned a century ago by Nobel Prize Paul Ehrlich, who dreamed of a
“personalised and tailored drug” able to target specific molecular defects, while being
beneficial to other healthy cells [Strebhardt and Ullrich, 2008]. A success of the kind
will be a life saving technology, and condense in a single “bullet” centuries of efforts to
understand nature.
Given the vast amount of knowledge on the topic, every research task focusses on
single, simplified questions to complete the full picture. While new problems arise and
are answered, new experimental techniques are developed to investigate them. However,
the difficulties of studying micrometric systems as cells and bacteria are manifold, as
we often do not possess instruments to look at them with the desired level of detail, or
to do so without perturbing their natural conditions. Therefore, in the last decades a
new investigation approach emerged, proposing to model the systems of interest from
the theoretical knowledge gathered so far, in terms of their structure, behaviour and
properties. Computational Biology is the field that proposes to do that, implementing
those models first and then querying them for properties which are still unknown. At
times, this proves to be the only method possible to answer the question posed, for
example to uncover the atomistic details of protein unfolding, to monitor the dynamics
of transport channels or instead to predict the evolution of a cancer cell population
[Lee et al., 2009; Dror et al., 2012; Wang et al., 2015b].
This thesis aims at employing techniques belonging to Computational Biology to
answer the specific question of how an artificial molecule behaves within selected bi-
ological environments. Thus, while studying a structural biology problem, it places
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itself at the boundary with the fields of Bioengineering and Medicine: the following
introduction is meant to give an overview of the many different challenges these fields
have faced in recent years and the solutions found to those challenges, motivating the
interest in the development of novel molecules as the one which will be described in this
work. In particular, two problems are highlighted: a) the insurgence of drug and an-
timicrobial resistance, and b) the problem of drug delivery, as they are both addressed
by the system in exam. Figure 1.1 provides a work flow of this introductory chapter,
to help the reader in identifying the sections of interest.
1.1 Antimicrobial resistance
For most of the last century, the development of new drugs rotated around the paradigm
that a drug is a small inorganic compound (of mass up to 900 Da), which intervenes
on a specific target of a mammal or bacterial cell. Very often the targets of interest
are (intracellular) proteins: out of the 695 small drugs approved by FDA (the Amer-
ican Food and Drug Administration agency) to target human molecules, 667 acts on
proteins. Similarly, 189 of the 198 approved to treat pathogens have a protein as their
target (with all the caveats coming from the challenges of identifying an unambiguous
target, especially when the drug binds to a protein complex or to a number of closely
related gene products [Santos et al., 2017]).
In presenting the aforementioned figures, the data were naturally split among the
drugs which act on human molecules, “repairing” a faulty process in the human body,
or the ones active against bacteria (commonly named antibiotics) which “disrupt” the
bacterium life cycle in order to kill or prevent the reproduction of the pathogen. It
appears evident that the pool of drugs available to the second purpose has a substan-
tially lower number of compounds than the ones addressing human molecules. This
comes from the nature of the action they perform: molecules targeting human proteins
need to be highly specific to avoid interference with other proteins or with healthy
cells, and in a sufficient number to address the variety of diseases affecting the human
body. Antibiotic must be non-toxic for human cells as well, i.e. their target must not be
shared between mammal and bacterial cells, but there is a less stringent requirement
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Figure 1.1: Figures a. Acetylsalicylic acid and j. Diphenyl-alanine in bond represen-
tation [VMD software Humphrey et al. [1996]]. Remaining figures adapted from: b.
Blair et al. [2015]; c. Kim [2017]; d. Torres et al. [2019]; e.Nguyen et al. [2011]; f. The
Innovation Society [2019]; g. Mettler Toledo [2018]; h. [Wikipedia, 2015]; i. Schoonen
and van Hest [2014]; k. Castelletto et al. [2016]; l. Kepiro et al. [2019]. The numbers
in red refer to the sections of this chapter in which the topic is treated in more detail.
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on their selectivity against different bacterial species. On the contrary, it is often useful
to have a broad-spectrum compound. This cross-species efficacy and at the same time
non-toxic property is obtained thanks to the evolutionary relationship among bacterial
species, and between bacteria and humans. While the first are closely related, and
therefore share homologous proteins with very similar structures, humans have less
folds in common with them, allowing for a resilience against bacteria-targeting drugs.
The full picture is actually more complex, as the set of bacterial species is very diverse,
and the cross-species effectiveness of some drugs does not extend to the whole bacte-
rial populations. This can be a positive feature, given the large amount of beneficial
bacteria that live in symbiosis with the human body (especially in the gut) and that
must be preserved for an optimal wellness.
Nevertheless, in the framework described above, it is understandable that first-time
research on antibiotics was satisfied with the development of a handful of potent, broad-
spectrum compounds. Penicillin, the first to be synthetically produced, was isolated
from a mould in 1928 by Alexander Fleming. It acts inhibiting the formation of a cross-
links between particular molecules (peptidoglycan) in the bacterial cell wall, binding
to the enzyme responsible for their catalysis, and thus preventing the complete wall
formation [Gordon et al., 2000] (for further details on the bacterial cell membrane see
Section 1.2.1). As foreseen from Fleming himself in his Nobel Prize acceptance speech,
some species of bacteria quickly became immune to penicillin, and this was achieved
in many ways: either by production of an enzyme that degrades penicillin, by subtle
changes in the structure of the penicillin-binding proteins to prevent such binding, or
again by removal of the drug from the cell through specially re-purposed efflux pumps
[Lobanovska and Pilla, 2017].
The mechanisms just outlined are not an exceptional characteristic of penicillin,
and many drugs lost their effectiveness against some bacteria from their discovery,
urging the research of new ones on a constant basis. By now, a broad knowledge has
been gathered on how bacteria escape the action of a drug: this understanding helps
interpreting the pitfalls of existing drugs and identifying the characteristics sought for
new compounds.
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(a)
(b) (c)
Figure 1.2: Mechanisms of antimicrobial resistance to small drugs. (a) Removal of
antibiotic B by efflux pump and inaccessibility of antibiotic C to the Penicillin Bind-
ing Protein target because of membrane impermeability. (b) Target site change via
mutation or protection. (c) Direct interactions with antibiotics causing its disruption
or structural modification. Reproduced from Blair et al. [2015].
1.1.1 Mechanisms of antimicrobial resistance to small drugs
Antimicrobial resistance can manifest through many different mechanisms, which can
be grouped in three main classes, in line with the three processes mentioned in the
example of the penicillin resistant bacteria.
Prevention of access to target A first class of resistance mechanisms aims at min-
imising the intracellular concentration of the antibiotic preventing its penetration or
maximising its efflux in the eventuality it has entered the cell (Figure 1.2(a)). Not all the
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molecules can enter the cell permeating the membrane, and this holds particularly for
hydrophilic antibiotics tackling Gram-negative bacteria, which are intrinsically poorly
permeable because of the presence of a double membrane [Delcour, 2009] (see Section
1.2.1). These molecules must then be imported into the cell through outer-membrane
porin proteins [Vargiu and Nikaido, 2012; Kojima and Nikaido, 2013]. Resistance arise
when porins are either replaced with more selective channels, which prevent the antibi-
otic penetration, or down regulated so that the internal concentration of the drug does
not reach a critical concentration [Lavigne et al., 2013]. Porin-coding genes can also
accumulate multiple mutations, to acquire the selectivity they lack in their wild type
[Poulou et al., 2013].
A complementary strategy to prevent drug influx is to employ bacterial efflux
pumps. Some of them are denominated multidrug resistance (MDR) efflux pumps for
their effectiveness in the task and are produced by many bacteria [Floyd et al., 2010;
Ogawa et al., 2012]. Over-expression of such efflux pump is observed in multidrug-
resistant bacteria, triggered by exposition to the drug. Such upregulation proceeds
via mutation in the relative regulatory network [Abouzeed et al., 2008], or simply as a
response to environmental signals [Nikaido et al., 2011]. Additionally, the genes coding
for them can be transferred via plasmids to other bacterial species [Dolejska et al.,
2013]. Indeed, bacteria are able to exchange genetic material with other individuals
via small rings of DNA in a process called conjugation [Sørensen et al., 2005], so that
advantageous resistant genotypes can spread quickly across species.
Change or modification of the antibiotic target The second class of resistance
mechanisms works modifying the antibiotic target: most antibiotics bind to their sub-
strate with high affinity and specificity, thus small modifications in the target structure
can disrupt an efficient binding, still allowing the target to maintain its normal function
(Figure 1.2(b)).
Mutations of some residues in the binding pocket (upon mutation in the gene
coding for it) or its post-translational protection via addition of chemical groups are
equally wide spread strategies. Notable examples of the first include the development
of methicillin- (an antibiotic in the penicillin class) resistant strains of S. aureus [Shore
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et al., 2011; Billal et al., 2011]. Again, several of these mutations are acquired by
horizontal gene transfer from other bacterial species. For post-translational protection,
the most relevant mechanism of chemical group addition is methylation, which, for
example, is very common when the drug target are rRNA subunits [Long et al., 2006]).
Direct modification of antibiotics Finally, bacteria can destroy drugs, usually
by hydrolysis, or modify them by transfer of a chemical group (Figure 1.2(c)). The
first drug-degrading enzyme discovered was penicillinase [Abraham and Chain, 1988;
Lobanovska and Pilla, 2017]. Since then, thousands of similar enzymes have been iden-
tified that can modify antibiotics of different classes [Livermore, 2008; Nordmann et al.,
2011]: these enzymes co-evolves with newly developed drugs, to include in their spec-
trum of action new compounds of composition similar to the ones they were originally
effective on [Woodford and Johnson, 2013].
Antibiotics constituted by large molecules with many exposed hydroxyl and amide
groups are instead particularly susceptible to addition of chemical groups. Many en-
zymes are responsible for this, and according to the chemical moiety added they are
grouped in acetyltransferases, phosphotransferases and nucleotidyltransferases [Wright,
2005].
1.1.2 Outlook on antimicrobial resistance
All together, the recent progress in understanding the mechanisms of antimicrobial
resistance has helped in directing the development of new drugs. In particular, it has
promoted the modification of existing compounds to escape the resistance developed
by bacteria.
It must be noticed that many of the available drugs are bacteriostatic agents as
opposed to bactericidal: i.e. they prevent the bacterium growth rather than kill it, as
they are meant to slow down the damage while host defence mechanisms eradicate it.
Thus, if an high dosage of a bactericidal agent may extinguish the bacterial population
and eradicate the disease, bacteriostatic drugs allow bacteria to start again the repro-
duction cycle once removed (if the host defence could not properly work), and are thus
more prone to “train” resistant bacteria.
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The severity of the AMR threat is such that it has been raised to the status of
national emergency in several countries, including UK. Strict regulations on the health,
agricultural and food industry sector must be taken to prevent the misuse of antibiotics,
as we are leaving the century in which antibiotics were discovered, to enter a phase in
which we count the number of the ones loosing efficacy [O’neill, 2016].
1.2 Alternative antibiotic strategies: antimicrobial peptides
In the landscape sketched above, the development of novel drugs is of crucial impor-
tance. The progress in understanding the mechanisms of antimicrobial resistance has
helped this process mainly promoting modification of existing compounds to escape
the resistance developed by bacteria.
However, it would be even more beneficial to have at disposal a new paradigm
for their design, in order to attack pathogens in a completely novel way, avoiding to
target pathways which are known to lead easily to resistance. Several novel materials
have been developed for the task, not to rely on small molecules and to exploit dif-
ferent mechanisms of action, for example antibodies, bacteriophages and antimicrobial
peptides [Mantravadi et al., 2019].
The use of pathogen-specific antibodies relies on mechanisms of the host immune
system, and bacteriophages therapy employs viruses which infect bacteria and archea
rather than eukarya. Finally, some peptides can have an active role against bacte-
ria, when their sequence possesses specific characteristics, and are thus referred to as
antimicrobial peptides and they are the main focus of this thesis. The following sub-
sections will explore their characteristics, modes of action, and the response of bacteria
against them. It is indeed crucial to understand the knowledge available on these mo-
lecules versus the questions that are still open, in order to direct the efforts of future
research. This holds in particular when the investigation proceeds by use of simplified
models, as the ones employed in Computational Biology. Meaningful results can be
obtained only if such modelling is performed in a sensible and informed fashion.
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Figure 1.3: Events occurring at the bacterial cytoplasmic membrane following initial
antimicrobial peptide (AMP) adsorption. Reproduced from Nguyen et al. [2011].
1.2.1 Membrane active peptides
Antimicrobial peptides (AMPs) are naturally produced by eukarya, either as stand-
alone sequences or embedded in larger proteins, as a first, weak, and broad-spectrum
defence against bacteria [Nguyen et al., 2011]. This pool of molecules has been selected
through evolution to be active against pathogens, suggesting that they will most likely
not cause resistance in a near future.
To exploit their potential and engineer AMP-like molecules, a careful characterisa-
tion and classification of such peptides must be done. This task has been carried on
throughout the past decades, but because of its complexity at present there are many
peptides with ascertained antimicrobial activity for which the mode of action is still
not fully understood [Ebbensgaard et al., 2015]. However, some general characteristics
of these sequences and some of the mechanisms they employ have emerged. Unsur-
prisingly, AMPs are heterogeneous in sequence, structure, targets and modes of action,
to tackle the different challenges bacteria pose. Their size can vary between 6 and 59
amino acids [Brogden, 2005]: despite being small with respect to the average size of
a protein in the human body, these macromolecules are hundreds of times larger than
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small molecule drugs and as such they penetrate and act on bacteria differently with
respect to them.
The most common target of AMPs is the bacterial membrane. Many of them cause
disruption of the microbial membrane while others translocate into the cytoplasm to
act on intracellular targets, and the combination of the two is not uncommon either
[Hancock and Sahl, 2006] (Figure 1.3). In general, it is widely accepted that membrane
interaction and its relative consequences are a key factor for the antimicrobial activity
of AMPs [Nguyen et al., 2011].
As such, we propose a brief overview of the structure of the bacterial membrane
[Silhavy et al., 2010], and of its differences with the one of mammalian cells, to better
understand how AMPs can be effective and selective on bacteria at once.
Structure of bacterial membrane The determinant driving the interaction be-
tween AMPs and bacterial membranes is the positive charge that many AMPs present,
opposed to the negative charge of the latter [Nguyen et al., 2011; Mahlapuu et al.,
2016]. It is striking that such simple mechanism, based on the presence of a certain
number of negatively charged lipids, holds across many bacterial species despite the
great variability found in their membrane composition. Indeed, based on the differences
in their cell envelope, bacteria are classified into two macro families, Gram-positive and
Gram-negative. In Gram-positive bacteria, the cytoplasmic membrane is surrounded
by a thick peptidoglycan layer, while for Gram-negative bacteria this membrane (which
assumes the name of internal one) is surrounded by a thin peptidoglycan layer and an
outer membrane [Silhavy et al., 2010; Lin and Weibel, 2016] (Figure 1.4).
Starting from the inside and proceeding outwards (from bottom to top of Figure
1.4), the cytoplasmic membrane of both Gram-positive and Gram-negative bacteria
is rich in phospholipids like phosphatidylethanolamine, which is neutral, and phos-
phatidylglycerol, cardiolipin, or phosphatidylserine, which have negatively charged
headgroups, highly attractive for positively charged AMPs [Silhavy et al., 2010; Lin
and Weibel, 2016]. Simplified models of this membrane often opt for a 1:3 ratio be-
tween negative and neutral lipids, giving a value of roughly 0.5 e/nm2. This is often
sufficient to promote the preferential interaction between this membrane and the pep-
1.2. Alternative antibiotic strategies: antimicrobial peptides 21
Figure 1.4: Structure of Gram-positive and -negative cell envelope. IMP: integral
membrane protein; CAP: covalently attached protein; LTA: lipoteichoic acid; WTA:
wall teichoic acid; LP: lipoprotein; OMP: outer membrane protein; LPS: lipopolysac-
charide. Reproduced from Silhavy et al. [2010].
tides - provided they get into its proximity. Perturbation of this membrane is highly
disruptive for the bacterium as many functions are associated to it: as bacteria do not
possess organelles, all the membrane-related proteins reside and perform their function
within the inner membrane.
In the case of Gram-negative bacteria (Figure 1.4, right), the inner membrane,
together with the outer one, delimits the periplasm space, an aqueous cellular com-
partment, which allows the sequestration of harmful substances and the transport of
nutrients. Inside the periplasm is situated the peptidoglycan cell wall. This substance
is made of a disaccharide cross-linked by penta-peptide side chains, and these repeated
units constitute the rigid skeleton of Gram-negative cells [Gan et al., 2008]. Peptido-
glycan is fundamental for cell life as its damage results usually in living but not viable
cells [Joseleau-Petit et al., 2007].
The outer membrane is covalently bonded to the cell wall through Brauns lipopro-
teins (or LP) [Asmar and Collet, 2018]. This membrane presents an asymmetric struc-
ture: phospholipids are present in the inner leaflet, while the outer leaflet is composed
of glycolipids, mainly lipopolysaccharides (LPS) [Silhavy et al., 2010]. These complex
molecules consist of lipid A, which presents multiple fatty acids, and a polysaccharide
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[Raetz and Whitfield, 2002]. The polysaccharide is made of an inner core, covalently
bonded to the lipid, an outer core, and finally a repetitive glycan polymer (O-antigen).
The O-antigen (top right in Figure 1.4) is the molecule exposed by Gram-negative
bacteria to the external environment and thus is the target of antibody recognition.
Given the complexity of the Gram-negative cell envelope, and especially the pres-
ence of the LPS layer, these bacteria are particularly impermeable to hydrophilic mo-
lecules, which are usually imported within the cell through porins and similar trans-
membrane proteins.
For Gram-positive bacteria (Figure 1.4, left) the inner membrane is enveloped in
a thick peptidoglycan layer. If its thickness in Gram-negative bacteria reaches a few
nanometers, in Gram-positive ones it spans from 30 to 100 nm. This thick layer is
threaded by long anionic polymers (the teichoic acids), mainly composed by glycerol
phosphate, glucosyl phosphate, or ribitol phosphate repeats [Swoboda et al., 2009].
Disseminated in this layer there are several surface proteins with various functions,
among which adhesins, which attach to components of the host extracellular matrix.
Gram-positive membranes are generally more permeable because they do not pos-
sess a double-membrane structure: the peptidoglycan layer is partially permeable to
small molecules, however positively charged drugs are likely sequestered by the nega-
tive teichoic acids, challenging their penetration but promoting a disruptive action at
the membrane level [Malanovic, 2016].
In addition to the aforementioned structures, many bacteria are coated with either
the S-layer, made of glycoproteins, or polysaccharised capsules Silhavy et al. [2010].
These external envelopes, and especially the S-layer, mediates a broad range of func-
tions, such as the cell wall formation, and, for pathogenic bacteria, influence the re-
sponse of the host immune system to them [Fagan and Fairweather, 2014]. The presence
of these layers increase the complexity of the bacterial membrane structure and thus
the challenges a drug must overcome to be effective against pathogens.
Finally, it must be remembered that many proteins tessellate the bacterial mem-
brane [Silhavy et al., 2010]. As such, the charge and fluidity of the membrane is not
only determined by the lipids present but, especially in proximity of the interface with
proteins, it can vary according to the identity and the local concentration of the pro-
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teins.
Comparison with mammalian membrane The fact that AMPs tackle negatively
charged membranes is crucial for their selectivity, i.e. that they are harmless for the
mammalian cells they are produced from [Glukhov et al., 2005]. This is possible be-
cause mammalian cells have a different membrane composition. They present a single
membrane, which is rich in proteins (up to 50% of its volume) and in lipids, and a
small percentage of carbohydrates, mainly embedded in glycoproteins, which promote
cell-cell recognition.
The lipidic component is abundant in zwitterionic phospholipids such as phos-
phatidylethanolamine, phosphatidylcholine, and sphingomyelin, providing a neutral
net charge [Spector and Yorek, 1985; van Meer et al., 2008]. Furthermore, the mam-
malian cell membrane has a high content of cholesterol [Yeaman and Yount, 2003; Lai
and Gallo, 2009], a sterol fat, which is proposed to stabilise the membrane ordering the
lipids around itself and thus regulating the membrane fluidity across different physio-
logical temperatures; it is also though to favour a better accommodation of the per-
turbations caused by AMPs [Zasloff, 2002]. Strictly speaking, some negatively charged
lipids are present in a few mammal cell types, however they are located in the inner
leaflet, while the zwitterionic phospholipids are more abundant in the outer leaflet, in
an asymmetric composition [van Meer et al., 2008; Matsuzaki, 2009]. This structure
promotes weaker interactions between AMPs and mammalian cells with respect to bac-
terial ones, as the former is driven mainly by hydrophobic interactions, while the latter
by electrostatic ones. The interaction is useful to quantify the perturbation of AMPs
on the membrane, and as such has been analysed in the present work.
Another relevant difference between bacterial and mammalian cells is that the first
ones have typically a higher transmembrane potential - the difference of electrostatic
potential between the inside and the outside environment. For bacteria it falls be-
tween −130 and −150 mV, while for mammalian cells between −90 and −110 mV
[Yeaman and Yount, 2003; Matsuzaki, 2009; Ebenhan et al., 2014]. Given that a po-
tential generates an electric field across the membrane, the higher this is, the higher
the resulting electric field pointing from outside to inside the cell. A field in such
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direction pushes cationic compounds on the outside of the membrane toward the mem-
brane itself. Therefore a stronger bacterial transmembrane potential may promote an
enhanced - and thus disruptive - interaction of AMPs with the cell, contributing to
AMPs selectivity between bacteria versus mammals [Yeaman and Yount, 2003].
1.2.2 Common mechanisms of action of AMPs
Investigating the perturbation and disruption of a bacterial membrane by antimicrobial
peptides is a key point of this work, therefore it is important to highlight the mecha-
nisms known so far through which AMPs reach this outcome. As already mentioned,
many AMPs have a positive charge which facilitates the binding to the membrane
via charge-charge recognition; accordingly, Arginine and Lysine residues are usually
abundant in AMPs sequences. However, the disruptive action takes place through
the interaction of AMPs with the hydrophobic core of the membrane, therefore their
sequences contain hydrophobic aromatic residues too, especially Tryptophan, which
favours the anchoring to the lipid core [Chan et al., 2006]. Overall, AMPs resort often
to adopt an amphiphatic structure to segregate the hydrophilic from the hydrophobic
amino acids and thus to act at the interface between membrane and solution. It is
interesting to notice that some of them fold into the active structure only nearby the
membrane, where they expose their hydrophobic components to face its core, while in
solution these ones are preferentially buried inside the peptide fold to be screened from
the solvent [Nguyen et al., 2011]. Common folds adopted by AMPs are both α-helix
or β-sheet rich structures. Amphiphatic α-helices present a charged side which is tai-
lored to face towards the phospholipid head groups and an hydrophobic ones which
is favourably buried into the acyl chains core. A similar arrangement is found for
structures rich in β-sheets, such as β-hairpins (Figure 1.5).
Membrane disruption Several models have been proposed to describe the exact
mechanisms of AMPs penetration after they bind to the cytoplasmatic membrane,
and how their action leads to membrane permeabilization (Figure 1.3) [Brogden, 2005;
Nguyen et al., 2011].
For a single copy of an amphiphatic helical AMP, the proposed mechanism of action
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Figure 1.5: Structure of some known AMPs. (a) Helical structures, (b) β-sheet struc-
tures, (c) disordered ones. Reproduced from [Nguyen et al., 2011].
suggests that initially the peptide is attracted with its charged side to the membrane
and lies parallel to its plane, with the hydrophobic side unfavourably exposed in so-
lution. Then the helix rearranges to have the two faces in the respective favourable
regions. Subsequently, the helix axis starts to form an angle with the membrane plane,
and finally inserts deeper into the lipid core, often spanning the full membrane thick-
ness [Ebenhan et al., 2014]. Similarly, for β-sheet rich structures, it is suggested that
they insert within the membrane after a first flat approach. The final insertion ar-
rangement depends on the peptide characteristics, length and specific structure, and
the interactions with other copies of the peptide.
The picture becomes more complex for oligomer-mediated insertion, i.e. when the
action is triggered by the combined action of many copies of the peptide. At low
peptide to lipid ratio, the favourable configuration is represented by peptides lying
parallel to the membrane plane as described previously [Yang et al., 2001]. An increase
in peptide concentration triggers the transition to an inserted state: the organisation
of AMPs inside the membrane core can assume different configurations, as described
below [Brogden, 2005; Nguyen et al., 2011; Ebenhan et al., 2014; Mahlapuu et al., 2016]
(see Figure 1.3).
The “barrel-stave” model proposes that AMPs insert perpendicularly into the bi-
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layer. Recruitment of peptides in the same area results in the formation of a trans-
membrane pore with a central lumen. The walls of the pore are constituted by the
hydrophilic face of the peptides, while their hydrophobic side is interacting with the
lipid tails around the pore. This model is adopted, for example, by the α-helical AMP
alamethicin, which forms voltage-dependent ion channels by aggregation of four to six
molecules [Spaar et al., 2004].
In the “toroidal” pore model instead, the insertion of peptides forces the phospho-
lipid to bend continuously from one leaflet to the other. The toroidal model differs
from the barrel-stave model as the peptides are always associated with the lipid head
groups even when they are perpendicularly inserted in the lipid bilayer. Toroidal pores
are induced by α-helical magainins, protegrins and melittin [Yang et al., 2001; Mat-
suzaki et al., 1996; Hallock et al., 2003], and lead to membrane perturbation which
extends further away from the pore than in the barrel-stave case. As a comparison,
alamethicin induced barrel-stave pores have an inner and outer diameters of 1.8 nm
and 4.0 nm respectively [Spaar et al., 2004], while magainin-induced toroidal pores have
variable sizes, with an inner diameter of 3.0-5.0 nm and an outer diameter of 7.0-8.4
nm [Matsuzaki et al., 1997].
Finally, in the “carpet” model, the accumulation of AMPs on the surface of the
membrane, laying parallel to it, causes tension in the bilayer: the membrane is dis-
rupted by them in a detergent-like manner, leading to the formation of micelles. The
critical threshold concentration triggers a cascade effect, as the first disruption allows
the penetration of AMPs in the inner side of the bilayer. The cooperation between
peptides on both sides of the lipid membrane enhances the AMP-induced curvature
causing accelerated disruption. The “carpet” model mechanism is observed for pep-
tides presenting an α-helical structure (like melittin [Ladokhin and White, 2001]) or
for several helices connected by short loops (ovispirin [Yamaguchi et al., 2001]).
The prevalence of examples with an helical structure derives from the fact that the
understanding of how helical AMPs function is often easier than the one of β-sheet
rich structures. Indeed, helices have a well defined fold (at least nearby the membrane
environment), a compact structure, and often a clear segregation of complementary
patches that can attract other copies of the peptide and thus promote the self-assembly
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process necessary for pore formation.
On the contrary, many β-sheet AMPs have a more flexible structure, and more
diversified mechanisms of action [Nguyen et al., 2011; Mahlapuu et al., 2016]. AMPs
rich in β-sheets can be divided into β-hairpins and peptides from the defensin family
[Nguyen et al., 2011]. Many representative of the first class disrupt bacterial membranes
via formation of toroidal pores: as an example, porcine peptide protegrin I assembles
into a β-barrel structure when in contact with anionic membranes and triggers toroidal
pore formation. Instead, it folds into β-sheet aggregates on the surface of cholesterol
containing membranes, thus acting selectivity on bacterial membranes only [Tang and
Hong, 2009].
In the case of defensins, many mechanisms are known according to the specific
member of the family [Lehrer, 2004; Kagan et al., 1990; Takeuchi et al., 2004]. Although
various descriptions of membrane damage have been reported, and include ion channels,
transmembrane pores and extended rupture of the membrane, they are likely related,
being a modulation of a similar acting principle.
The aforementioned models provide an important insight into how AMPs work.
However, they are often obtained under artificial conditions, i.e. on model membranes.
The composition of these membranes is necessarily simplified with respect to the true
bacterial envelope, retaining often only one lipid layer made of few lipid species. Re-
ducing the variety of lipids present in the model membrane is justified by the similar
chemical characteristics lipids have (e.g. hydrophobic tails versus polar/charged head).
However, a significant percent of the bacterial membrane is constituted by proteins,
which can cover up to the 30% of the surface [Hsu et al., 2017]. The density of proteins
on the surface and their large size is such that all the regions in the membrane are
influenced by their presence, due to electrostatic interactions with the proteins and the
consequent reduced lipids mobility, up to 2 nm away from it [Hsu et al., 2017]. The po-
ration models presented before are obtained for bulk, unperturbed lipids: especially for
the toroidal model, a large radius is required to allow the smooth transition necessary
to create the toroidal shape. In the presence of proteins in biological concentrations,
little to no region of bulk lipids is found. Thus, AMPs are must work in a different way
and produce different pore shapes: whether the protein is stabilising or destabilising
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the membrane depends on the specific case in exam, but it is not unlikely that the
lipid-protein boundary constitutes a region of peptide insertion given the discontinuity
present there.
In light of these considerations, poration models and poration experiments on model
membranes are still important to compare the action of different AMPs and test novel
ones, but might not explain the efficacy of AMPs in a complete fashion.
Alternative mechanisms of action Finally, many non-lytic mechanisms are sug-
gested for AMPs, especially for β-sheet structures: defensin A from P. terramovae
reduces the cytoplasmic potassium concentration [Brogden, 2005], partially depolar-
ising the inner membrane. Tachyplesin from horseshoe crabs is able to bind to the
minor groove of DNA, interfering DNAprotein interactions [Yonezawa et al., 1992].
Bovine lactoferricin can act synergistically with other antimicrobial agents by affecting
the transmembrane potential and proton-motive force, resulting in inhibition of ATP-
dependent multi-drug efflux pumps [Gifford et al., 2005]. Moreover, after translocation
within the cell, bovine lactoferricin can also inhibit DNA, RNA and protein synthesis.
Section 1.5.1 will treat in detail the functioning of this AMP, distinguishing its role
as membrane active peptide as opposed to intra-cellular targeting compound. Many
works have focussed on locating the section of the sequence performing the membrane
disruptive activity [Tomita et al., 1994; Schibli et al., 1999], to understand whether it
retains the efficacy regardless of the fold. These type of investigations provides the dis-
covery of minimal functioning antimicrobial blocks, which promotes the understanding
of how AMPs work in general, and boost the design of synthetic AMPs tailored for
specific functions.
1.2.3 Mechanisms of resistance to AMPs
Antimicrobial peptides were introduced here as a class of new drugs and a possible
solution to the crisis of antimicrobial resistance. Any new drug entering the pool of
the clinically approved compounds is (at least temporary) a solution to the problem
of resistance; but it must be clarified that bacteria can develop resistance to AMPs
too. Nevertheless, this is generally not based on dedicated genes that are conferred
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by horizontal gene transfer, as in the case of many antibiotics resistance mechanisms
[Peschel and Sahl, 2006]. Because of that, a certain increase in bacterial resilience after
exposure to the peptidic drug is to be expected, but it is less likely to spread quickly
to other species.
Some of the mechanisms of AMPs resistance are similar to the ones employed by bac-
teria to counteract small molecule drugs, for example over-expression of efflux pumps
to dispose of AMPs, degradation of the peptide by extracellular enzymes and seques-
tration by the bacterial or biofilm matrix to prevent accession to the target [Peschel
and Sahl, 2006].
Differently with respect to antibiotics hydrolysis, AMPs proteolitic degradation
is operated by proteases, secreted on the extracellular side of the membrane specifi-
cally to destroy other proteins. Linear AMP are more prone to this type of degrada-
tion [Sieprawska-Lupa et al., 2004], as opposed to the ones presenting disulfide bonds
[Peschel and Sahl, 2006], such as defensins, which nevertheless can be hydrolysed by
more specific enzymes [Nelson et al., 2011].
But the most specific mechanism of AMPs resistance concerns modifications of the
bacterial cell envelope: bacteria modify the characteristics of their surface to prevent
the efficient binding of an AMP, even in the eventuality that the peptide reaches the
bacterial envelope intact. The target of such modifications are different for Gram-
positive and Gram-negative bacteria, according to their distinct cell envelopes. for
example, Gram-positive bacteria change the structure of their teichoic acids (TA): D-
Alanylation of TA observed in S. Aureus adds a positive charge to it, reducing the
attraction of cationic AMPs and in turn increasing the cell wall density, so reducing
the surface permeability [Saar-Dover et al., 2012].
In Gram-negative bacteria a positive charge can be added to lipopolysaccharides
(LPS) by addition of amine-containing molecules [Moskowitz et al., 2004] or by remov-
ing phosphate lipids (which have a negative charge) from lipid A [Wang et al., 2006b].
Moreover, the cytoplasmic membrane can be modified as well, as this is the final target
of many antimicrobial peptides: in the eventuality that AMPs successfully reach this
membrane, they are attracted to its surface by the negative charge of the lipids compos-
ing it, in particular phosphatidylglycerol (PG) and diphosphatidylglycerol (DPG, also
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called cardiolipin). Their negative charge can be masked by amino-acylation of the PG
head group, so that the final compound repels AMPs through electrostatic interaction
[Peschel et al., 2001]; alternatively the overall rigidity of the cytoplasmic membrane can
be enhanced, by an increase in saturated acyl chains which has been proven to confer
resistance [Kumariya et al., 2015]. To be noticed that resistant bacteria often employ
many of the aforementioned strategies at the same time [Band and Weiss, 2014].
1.2.4 Principles of AMP design
The study and classification of AMPs provide knowledge on the characteristics a se-
quence must have to perform an antimicrobial function. As discussed in Section 1.2.2,
there are some features which, comprehensively, help in discriminating AMPs against
non antimicrobial peptides. The constantly increasing amount of data available is gath-
ered in several curated databases (APD3 [Wang et al., 2016a], DBAASP2 [Pirtskhalava
et al., 2016], dbAMP [Jhong et al., 2019], antiBP2 [Lata et al., 2010], amPEP [Bhadra
et al., 2018]), which catalogue AMPs (or subclasses of them, like membrane active,
biofilm active or haemolytic peptides) based on such features.
To recapitulate, AMPs are charged moieties, usually cationic, and their potency,
but also their haemolytic activity, is often related to their net charge [Jiang et al., 2011].
They can assume both α-helical and β-sheet fold; which helps creating an amphiphatic
structure, to accommodate both the charged residues mentioned and the hydrophobic
ones they possess as well. Finally, they need good solubility to prevent aggregation in
the aqueous environment before reaching the target.
The knowledge of AMPs sequence-activity and structure-activity relationships is
beneficial to design new peptides with improved characteristics. In particular, improved
specificity against bacterial species; stability against the action of proteases (allowing
a longer residence time in the body); and low cytotoxicity at the therapeutic dose
required. The need for such improved peptides lies in the fact that natural AMPs
constitute a first broad spectrum defence that our body employs against infectious
bacteria, and thus they are often of mild potency. However, foreseeing their application
as future drugs, it is desirable to tailor them to fulfil different criteria according to the
infection to treat. At the present state of the art, a golden rule for the design of such
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sequences is still missing, however several methodological approaches to AMP design
have been explored, and they can be grouped in three main lines: template based
studies, biophysical studies and virtual screenings [Fjell et al., 2011].
Template based studies The main idea behind template based methods consists
in modifying existing antimicrobial sequences in the direction of the desired charac-
teristics. As such, the effort is restricted on a subset of all possible sequences. The
most widely explored templates are helical peptides, because several of them (cecropin,
magainin and protegrin) have been well characterised [Wang et al., 2015a].
Alanine scanning [Migoń et al., 2018] and all amino acids scanning [Hilpert et al.,
2005] performed for every residue in a sequence, provide information on the role of
each of them, pointing at the most suitable mutations. High-throughput methods for
synthesis and characterisation allow nowadays for such thorough investigation in the
case of short AMPs [Hilpert et al., 2005]. However, these methods focus on single
amino acids and can not take into account the interplay between residues, nor the
three dimensional structure of the peptide. Because of this, often the results of these
studies cannot be generalised to other sequences, hence the recent effort to integrate
structural information on template based models [Liu et al., 2018; Jiang et al., 2011].
A complementary approach to single point mutations on known peptides consists
in designing minimal antimicrobial blocks: synthetic AMPs have been produced with
only Lysines-Leucine, or Arginine-Valine combinations to produce amphipathic helices
[Deslouches et al., 2005]. Text based models where amino acids constitute the letters
and patterns occurring in natural AMPs are the grammar rules are trying to capitalise
this findings into general rules [Loose et al., 2006; Cipcigan et al., 2018; Spänig and
Heider, 2019].
Biophysical studies Biophysical studies aim at understanding the functioning of
AMPs investigating their structure. Free energy perturbation, Molecular Dynamics
(MD) simulations and thermodynamics calculations can all provide knowledge on how
the three dimensional arrangement of residues is important to allow their functional
role. These techniques give an insight into the mechanism of action of an AMP but
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their drawback lays in the high computational cost, preventing the reproduction of
phenomena of the order of millisecond and a systematic study of many sequences at
once. A detailed overview of the state of the art, advantages and drawback of MD
simulations will be given in Chapter 2.
The strength of biophysical studies lay primarily in the fact that they exploit the
whole information available on a system (sequence, structure, chemistry). Thus, they
can single out the interactions that are crucial for a mechanism, clarifying whether
they can be transferred to a different environment. In this respect, they provide a
generalisable knowledge applicable to different systems and to the design of novel AMPs
at the atomistic level. Extensive examples of this workflow are given in Section 2.4.
Virtual screenings Contrary to biophysical assays, virtual screening methods are
employed to analyse a large number of sequences, when an experimental or computa-
tional test of all of them would be prohibitive. The concept of these methods consists
in identifying descriptors which allow to predict the potency of the sequence: from the
analysis of a database of AMP with known activity, a model is created and used to
score novel synthetic sequences [Fjell et al., 2011; Kleandrova et al., 2016].
The recent evolution of machine learning (ML) techniques, and artificial neural
network in particular, gave a great impulse to virtual screening of AMPs (for a his-
torically informed review see [Fjell et al., 2011; Veltri et al., 2018]). Machine learning
appears particularly suitable to the task as the potency of AMPs is determined by the
combination of many factors, the relative weight of which can be difficult to identify.
Moreover, it can help in the identification of relevant features traditionally overlooked.
Machine learning algorithms require a consistent pool of data to be trained in
a satisfactory way. However, modern high-throughput synthesis methods, together
with surrogate measures of bacterial killing, are allowing to assessed the antimicrobial
properties of thousands of sequences at once [Cherkasov et al., 2009]. This is a first
step toward an automated and general procedure for AMP design.
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1.2.5 Clinical applications
Antimicrobial peptides have been studied for many years, however the push to capitalise
them has been delayed by many factors, including production costs, and lack of interest
in the face of more potent small molecules. The constant increase of AM resistance
has resulted in more effort focusing on AMPs, mainly from small biopharmaceutical
companies, and at present several of these preparations are in clinical trials, either in
phase 1 or 2 [Naafs, 2018].
The two major problems encountered so far for AMPs sequences in trial are the
liability to proteolytic degradation, and the unknown toxicology profile when adminis-
tered systemically [Hancock and Sahl, 2006]. For the last reason in particular, many of
them are in trial for topical use only, as they are deemed unsuitable for internal admin-
istration. Design of novel AMPs can be tailored to improve the liability to degradation,
for example introducing D-amino acids, non natural amino acid analogues of opposite
chirality, which, with appropriate formulations, are mimetic to the immune system
[Wipf et al., 2009]. Moreover, machine learning protocols can help in pre-screening
their toxicity through virtual screening methods.
Overall, antimicrobial peptides remain a promising tool to counteract infections
and, as their design is still - comparatively - in its infancy, there is room to explore
novel applications and synthesise improved sequences apt to get to the clinical stage.
1.3 Gene therapy
Alongside the new compounds used to counteract bacterial infections, we want to bring
the reader’s attention to another class of therapies which is relevant for the work of this
thesis and has been developed in the last decades for the treatment of non infectious
diseases: gene therapy. In recent years it has greatly evolved and gained attention for
the treatment of tumours, genetic diseases and complex acquired disorder [Anguela and
High, 2019]. The key concept is the delivery of genetic material to cells of diseased state
which possess a faulty copy of a gene, to influence its expression. Such fault can result
in lack of synthesis of the protein of interest or in its misfold and/or misfunction. The
correction can be performed in three different ways (Figure 1.6) [Anguela and High,
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Figure 1.6: Principles of gene therapy. Reproduced from Anguela and High [2019].
2019]: introducing an healthy gene copy to restore the normal functionalities of the
protein of interest; suppressing a detrimental gene (particularly useful in the case of
cancer, to impede cancer cells replication); or correcting base pairs mutations to restore
the original healthy sequence (gene editing).
Despite the challenges posed by the development of genome editing tools, and the
risk associated to them (for example the possibility of deleterious insertional muta-
genesis or deleterious immune responses), at present six gene therapies have received
approval in the Western world [Anguela and High, 2019], with many more undergoing
regulatory review.
One of the main problems in the development of such therapies lies in the identifi-
cation of a suitable vector for the genetic material, either DNA, microRNA (miRNA)
or small interfering RNA (siRNA). Delivery of free genome in solution results in poor
internalisation and low therapeutic effect. Thus nowadays the outlook of gene therapy
research lies not only in improving specific cargos, but also in the research of appropri-
ate vectors with low toxicity, low induced immune response and high delivery efficiency.
Viruses can be used, modifying their genome to include the necessary sequence and re-
move the ones promoting viral replication [Naldini, 2011; Mingozzi and High, 2011]
(see Section 1.4.1), but synthetic vectors are now investigated for a virus-free delivery
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strategy. The system studied in this thesis proposes, among its other functions, to
deliver genetic material into human cells.
1.4 Delivery of therapeutic material
The problem of gene delivery sets a parallel with the small drug one, introduced at the
beginning of the chapter. Indeed small molecules need delivering agents to be efficiently
internalised in the cells, in the same manner that genes do, and it is known that some
barrier (such as the Blood Brain one) are more selective in the classes of molecules they
allow to permeate [Pattni and Torchilin, 2015; Krol, 2012].
To reach the aimed organ, therapeutic molecules must be compatible with the dif-
ferent cellular environments they cross, but be preferentially retained, and act only
on the ones they are designed for. This implies a subtle balance between an invasive
activity on one side, and mimesis on the other, to minimise the possibility that the com-
pound is recognised as dangerous and disposed by the immune and reticuloendothelial
systems.
For the above reasons, research has focused on developing systems to assist the
delivery of drugs. A mimetic carrier can not only improve delivery, but also be designed
to selectively bind to particular tissues, or to trigger the drug release after a delay in
time, or only upon changes in environmental variables (for example pH), to reduce drug
concentration in non targeted regions Pattni and Torchilin [2015]. A stand alone field
of research has then focused on the development of delivery vehicles irrespective from
the quest for new drugs. The optimised products of the two separate efforts can then
be paired according to the condition to address, to give a successful therapy.
At present, both organic and inorganic molecules have been employed to build
drug vehicles, to offer a range of different physico-chemical characteristics useful to
target different cells [Hughes, 2005]. Inorganic materials, such as metal nanoparticles or
carbon nanotubes, are in experimental phases and hold promise for promoting sustained
drug release [Boisselier and Astruc, 2009; Depan et al., 2011], while inorganic polymers
have been employed extensively and since a long time as drug eccipients [Lammers
et al., 2009; Liechty et al., 2010; Nicolas et al., 2013].
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The use of organic molecules instead aims at mimicking the materials present in
the body, such as lipids, DNA and peptides, in an effort to reduce toxicity and favour
the internalisation of the vehicle in the target cells. In particular, lipids have been
widely employed for the delivery of both soluble and insoluble drugs thanks to their
amphiphatic structure [Pattni et al., 2015; Jain and Pillai, 2017; Yingchoncharoen
et al., 2016; Bunker et al., 2016]. DNA scaffolds instead are a novel tool still at the
experimental stage which have been proven successful in delivering anticancer agents
[Zhang et al., 2014; Jiang et al., 2012].
But peptides are the focus of this work, and these molecules prove once more
they can have functions beyond the ones they are naturally designed for. In the next
paragraph we elucidate some rationale and examples of how peptide can be tuned for
assembly and thus for the needs of drug delivery.
1.4.1 Peptidic scaffolds
A widely used and trustworthy mimetic vehicle comes, quite surprisingly, from the
world of pathogens: viruses have co-evolved with humans, to be able to penetrate
into cells where they complete their reproductive cycle [Lobo et al., 2009]. Therefore
their capsid, the peptidic shell encapsulating the viral genome, is highly suitable for
cell penetration. The first application sought historically was to employ genome-free
viruses to stimulate the natural immune response against the respective genome-loaded
ones, creating viral vaccines - similarly to how inoculation of dead bacteria counteracts
their infections [Lauer et al., 2017]. Later in the history, their potential as cargo carrier
was pursued modifying the original genetic material to include sequences beneficial for
the host cell, and inactivate their duplication [Daya and Berns, 2008]. Since then, many
efforts have focused on synthesising in vitro gene-free capsids, either as they appear
in nature [Wu et al., 2009] or designing artificial building blocks which assemble in so
called Virus-Like particles (VLPs) [Schoonen and van Hest, 2014] aimed at triggering
a lower immune response (Figure 1.1, i). Similarly to other delivery vehicles, the
surface of VLPs can be functionalised with additional molecules to improve the target
selectivity and biocompatibility, while the peptidic scaffold grants robustness to the
structure. Finally, VLPs loaded with drugs can be tuned for an efficient intra cellular
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release [Ma et al., 2012].
A step further in engineering peptidic structures is the design of self-assembling
functional blocks from first principles. Indeed, self-assembling peptides can form nanos-
tructures ranging from nanoparticles to nanotubes, nanofibers, nanorods and hydrogels
[Fan et al., 2017]. The variety of amino acid available makes peptidic structures com-
patible with both hydrophilic and hydrophobic drugs, according to their amino acid
composition [Ma et al., 2012]. The peptidic self-assembly is modulated by the peptide
length and its hydrophobic or hydrophilic character, given by its amino acid compo-
sition: simple phenylalanine dipeptides (Figure 1.1, j), were shown to assemble in a
multi-scale process into nanotubes able to load drug molecules [Silva et al., 2013]. The
relatively small diphenylalanine building block is nevertheless complex as it bears two
charged termini (as the process is observed at neutral pH), and two aromatic hydropho-
bic rings, so that the dipeptide is driven towards assembly by the hydrophobic forces
acting on the phenylalanine side chains and the complementary charges of the termini.
In a different approach, longer sequences (which organise spatially in well studied
α-helical or β-sheet secondary structures) can be employed to guide the assembly at the
tertiary structure level (see some examples in Figure 1.5). This knowledge is possible
as proteins are a fundamental component of the human body and as such an updated
database of their structure is available (the Protein Data Bank [Berman et al., 2000])
and can be queried to understand how small peptides hierarchically assemble into larger
units. Finally, the vast literature on their interactions with membranes, cell receptors
and in general biological components, can inspire the design of building blocks sensible
to particular triggers within the body. From this background, the outlook of protein
design often goes in the direction of synthesising exotic, non natural geometries for
multifunctional materials [Yeates, 2019; Malay et al., 2019].
1.5 Closing the circle: an antimicrobial drug delivery vehicle
Twice in this introduction peptide design has been brought to the reader’s attention.
First, it can produce antimicrobial peptides with improved potency and/or selectivity,
and/or reduced toxicity. Second, it can engineer self-assembling building blocks for the
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formation of delivery scaffolds. As design is not bound to natural rules, it can foresee
and imagine multifunctional materials which are not observed in nature. In particular,
the question arises whether it is possible to engineer peptides able to perform both an
antimicrobial and a delivery function at once.
Self-assembling antimicrobial compounds would have a twofold interest for medical
applications. First of all, the assembly is functional to the antimicrobial activity:
many AMP sequences have a weak potency, and only a high (critical) concentration
can trigger the bactericidal mechanism (e.g. the insertion into the membrane or its lysis,
see Section 1.2.2). Second, the assembly can perform additional delivery functions, if
it is able to either organise in a tailored structure (for example a capsule able to host
a drug), or to co-assemble with the cargo of interest.
Out of all the possible applications, an ideal scope is perhaps the use of such vehi-
cles to deliver drugs to treat metabolic or genetic diseases: while the cargo tackles a
defect of the host system, the vehicle can counteract the proliferation of bacteria. This
is particularly important when the host immune response is weakened and normally
harmless infections can spread and cause damage. As such, the cargo is not bound
to be a small molecule, as long as it can effectively co-assemble with the peptidic car-
rier. As mentioned in the previous section, gene therapy is also an actively expanding
field which looks with interest at the development of vehicles. Given that viruses have
been the first choice for DNA/RNA delivery so far, peptidic carriers seem their natural
evolution.
Given the above premises, it is evident the importance of pursuing the research
on novel multifunctional peptidic materials. As mentioned when discussing AMPs
design, to better understand these systems, each of them must be characterised by
itself, as a generalised knowledge is still lacking. With this aim, this thesis proposes
to elucidate the behaviour of a specific synthetic self-assembling peptide, suitable for
antimicrobial activity and gene delivery strategies. Its characterisation will complete
the knowledge on its mechanisms of action and complement the general information
already known on the class of such functional building blocks. This is crucial to engineer
new synthetic blocks with improved characteristics, either regard their antimicrobial
activity, assembly performances, or tailored cargo delivery.
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(a)
(b)
Figure 1.7: Capzip molecule: (a) scheme of chemical formulation, reproduced from
Castelletto et al. [2016]; (b) 3D bonds representation: backbone in yellow, amino acids
side chains colored by residue type (blue positive, green hydrophilic, white hydropho-
bic) [VMD software Humphrey et al. [1996]].
1.5.1 The capzip molecule
The molecule capzip [Castelletto et al., 2016] (Figure 1.7) has been designed to perform
the functions mentioned above at once. To recapitulate, the properties it must possess
are:
1. assembly into nanoscale virus-like capsules with and without nucleic acids. This
ensures that the vector can autonomously form and thus there is flexibility in the
choice of the cargo;
2. antimicrobial activity of the molecule itself and of the capsule on a time scale
useful for therapeutic applications;
3. promotion of gene transfer into mammalian cells when the peptide is co-assembled
with the RNA strands, without causing cytotoxic and haemolytic effects.
Its design aims at building a template structure of minimal complexity, in order
to synthesise only a short sequence. Arguably, short sequences are flexible in their
assembly, as they do not rearrange into defined secondary structure: it is thus even more
important to understand them and prove whether also small blocks can form ordered
architectures. To satisfy the short sequence criterion and the required properties of the
assembly, two design principles emerged: first the employment of a non-linear structure,
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and second the use of a template antimicrobial sequence which is short and has proved
antimicrobial efficacy.
There is indeed some evidence suggesting that the branching of short peptidic se-
quences without secondary structure tunes their three dimensional assembly [Gudlur
et al., 2012; Breger et al., 2017; Zhao et al., 2018b]. Indeed, linear short structures can
pack parallel one next to the other (as amyloids), while branching prevent this tight
structure and favours more open ones. Moreover, many viral structures have a 3- or
5-fold symmetry at each of their vertices [Schoonen and van Hest, 2014]: reproducing
this, albeit in a different structure, is likely to improve its assembly properties. For
these reasons, a short peptidic scaffold constituted by a β-Alanine and two Lysins which
can host other peptidic branches has been engineered as core of the capzip molecule.
Regarding the second principle, the antimicrobial sequence selected has been derived
from the AMP bovine lactoferricin, which is in turn a portion of the lactoferrin protein,
and is six amino acids long (see next paragraph). Three copies of it are covalently
bonded to the N-terminus of the scaffold sequence and to the nitrogen atom of the
Lysin side chains (Figure 1.7(a)). As AMPs are usually cationic, and indeed the overall
structure has a +6e charge at physiological pH, the co-assembly with anionic RNA
sequences is arguably naturally inherited by the molecule.
Lactoferrin Lactoferrin is a 80 kDA iron binding protein present in milk (in which it
is most abundant, hence its name), saliva and other secretions, as well as in leukocytes
(Figure 1.8(a) shows the bovine homologue of the human protein). It works as an iron
binder and provides a natural defence against bacteria and fungi [Sánchez et al., 1992;
Arnold et al., 1977, 1980; Kirkpatrick et al., 1971; Jahani et al., 2015], constituting a
first defence for infants.
Lactoferrin contributes to bacterial suppression in several ways. At present, its
known modes of action fall in three categories: first, thanks to its iron sequestering
capabilities, it removes essential substrate required for bacterial growth [Farnaud and
Evans, 2003]; second, it is implicated in the stimulation of different immunological cells
(killer cells [Shau et al., 1992], polymorphonuclear leukocytes, and macrophages [Gahr
et al., 1991]); finally it interacts with bacterial membranes and binds to the lipopolysac-
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(a)
(b)
Figure 1.8: (a) Bovine lactoferrin protein (PDB code 1BLF): transparent cartoon
representation, colored by secondary structure. In red is highlighted the portion of
sequence corresponding to lactoferricin. In green, the 6 amino acid antimicrobial se-
quence. In pink spheres the iron ions. (b) Bovine lactoferricin protein (PDB code
1LFC); cartoon representation, colored by secondary structure. In green, and in bond
representation color coded by amino acid type, the 6 amino acid antimicrobial se-
quence. [VMD software Humphrey et al. [1996]]
charides of the bacterial wall, oxidising them and affecting the membrane permeability
with consequent cell lysis [Farnaud and Evans, 2003]. The peptide fragment respon-
sible for binding lactoferrin to the bacterial membrane, named lactoferricin (Lfcin),
has been identified near its N-terminus and found to have a more potent bactericidal
effect than intact lactoferrin on a wide range of bacteria [Gifford et al., 2005; Bellamy
et al., 1992; Tomita et al., 1994; Wakabayashi et al., 1996] (Figure 1.8(b) shows the
bovine homologue of human Lfcin). Similarly, an even shorter subsequence of human
lactoferricin has been proven effective against bacteria as it depolarises the cytoplasmic
membrane decreasing the pH gradient [Aguilera et al., 1999].
The bovine homologue of lactoferricin (LfcinB, Figure 1.8(b), PDB code 1LFC) has
often a higher bactericidal potency than its human counterpart [Cochran et al., 2001]
and therefore has been more extensively studied. It is a 25-amino acid sequence which
adopts a helical conformation in the full structure but, once isolated, crystallises in a
β-hairpin with a disulfite bridge nearby the terminals which stabilises the fold, but was
shown to be not essential for the bactericidal activity [Cochran et al., 2001]. In solution,
it adopts a flexible conformation, as assessed by NMR experiments [Hwang et al., 1998].
Further experiments on LfcinB subsequences identified a shorter antimicrobial core,
constituted by the six amino acids RRWQWR [Schibli et al., 1999]. This core presents
a characteristic Tryptophan zipper motif WQW, which appears very often in nature in
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Figure 1.9: Example of Tryptophan zipper hairpin (PDB code 1LE0). Cartoon rep-
resentation, colored by secondary structure, and bond representation for Tryptophan
residues. [VMD software Humphrey et al. [1996]]
β-turns and β-sheets, paired to another copy of the same motif [Cochran et al., 2001]
so that Tryptophan rings from facing strands are packed tightly against each other in
an alternated way (Figure 1.9).
The six amino acid sequence contains both charged and hydrophobic residues, in line
with the usual composition of antimicrobial peptides. Accordingly, its antimicrobial
action is likely derived from the interaction with biological membranes through charge
recognition first and aromatic rings insertion in a second moment.
To further elucidate this mechanism, several experimental investigations have been
carried on, both on LfcinB and its subsequences. The binding of its antimicrobial
core to sodium dodecyl-sulfate micelles was studied [Schibli et al., 1999], suggesting
a favourable interaction of the aromatic residues with the micelles surface. Similar
experiments were performed on large unilamellar vesicles, constituted by lipids mod-
elling biological membranes [Nguyen et al., 2005]: ePE:ePC was chosen as a model
of a mammal membrane, and ePE:ePG or ePC:ePG for a bacterial one (ePE egg α-
phosphatidylamine, ePC egg α-phosphatidylcholine, ePG egg α-phosphatidylglycerol,
with ePG anionic). The experiments showed preferential binding to the latter ones,
based on Tryptophan fluorescence, suggesting a selective antimicrobial action on an-
ionic membranes. Additional experiments performed on other LfcinB subsequences,
some of which introduced mutations [Tsutsumi et al., 2012; Arseneault et al., 2010],
investigated the binding to different model membranes. However, as both the systems
and the experimental conditions are slightly different each time (in terms of length of
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the original sequence and the type of membranes used), it is difficult to give a unified
interpretation of the modes of action of lactoferricin-derived peptides.
Finally, an alanine scanning has attempted to clarify the role of each amino acid in
the antimicrobial activity of the original 25 amino acid LfcinB peptide [Strøm et al.,
2002]. The results suggested a membrane binding function for the Tryptophan residues,
in line with one of the roles Tryptophan assumes in antimicrobial sequences [Chan et al.,
2006]. Another possible role, however, involves its propensity to form hydrogen bonds,
in which case the residue would position itself at the interface between solution and
membrane, rather than inside the latter, which happens when the Tryptophan residue
has the function of binding the peptide to the membrane [Chan et al., 2006].
The designed block From the active core of LfcinB (of sequence RRWQWR), a mu-
tated sequence was obtained to comply the design criteria of a self-assembling building
block. Two mutations were introduced to favour the assembly of arms belonging to dif-
ferent molecules in an antiparallel fashion. Specifically, given that the original sequence
is found in a β-sheet (at least in the crystal lattice) facing a non-homologous one, the
mutations aim at promoting β-sheet formation when two pairs of the same sequence
are in proximity. Therefore, the Glutamine residue and the C-terminal Arginine of the
lactoferrin motif were replaced with Threonine and Glutamic acid residues to have a
self-complementary sequence RRWTWE: the pairing is promoted by the attraction of
opposite charges at the ends of the sequence. Three copies of this sequence were thus
covalently bonded to the scaffold as described previously (Figure 1.7(a)), to obtain a
self-assembling molecule hosting multiple copies of an antibacterial sequence.
An additional layer of complexity has been added in the experimental investigation
by synthesising a capzip molecule formed by D-amino acids only. The rationale behind
this choice lays in the enhanced stability of D-peptides against proteolysis and their
possibly low immunogenicity [Uppalapati et al., 2016; Arranz-Gibert et al., 2018; King
et al., 1994], while the fold of the final molecule remains similar to its L- version.
Moreover, as antimicrobial peptides bind to membrane rather than dock to a specific
protein, their D-epimer is likely to retain the activity of the L- counterpart [King et al.,
1994; Bland et al., 2001]. This approach opens a new landscape in the field of peptide
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design, as it virtually multiplies the space of sequences available by a factor 2N , with
N the length of the sequence selected.
1.5.2 A viable systems: experimental background and question
A set of experiments has been performed to verify that capzip had the characteristics
it was designed for. The results obtained on the molecule have been published in
Castelletto et al. [2016], while more recent investigations extended and consolidated
the previous findings [Kepiro et al., 2019].
Experimental results First, the assembly ability has been tested: the peptide (L-
version) did not assemble in pure water (as verified by Dynamic Light Scattering),
likely because of charge-charge repulsion, while in biological buffer (MOPS, 10 mM) at
physiological pH of 7.4, it formed capsules with dominating size range of 20-200 nm.
This was confirmed by images of the capsules obtained with multiple techniques, namely
transmission electron microscopy (TEM), atomic force microscopy (AFM), and cryo-
scanning electron microscopy (SEM) (Figure 1.10(a)). Analogous and more systematic
investigation on D-capzip brought to similar conclusions (Figure 1.10(b)), restricting
the dominant size range from 20 to 40 nm of diameter. Interestingly, some of the images
collected showed ring structures, likely derived from collapsed capsules, suggesting they
are hollow. Fluorescence microscopy of a capsule assembled from fluorescein labelled
capzip confirmed this hypothesis, showing that the signal was coming from the walls
of the structure only.
The fine structure of these assemblies appeared irregular to the resolution of the
miscoscopy techniques employed and could not be fully determined. Some insight was
given by Circular Dichroism (CD) spectra, which showed a profile characteristic of β-
turns and contained elements of a β-sheet structure and of indole rings (minima at λ ∼
200 nm and 214 nm) (Figure 1.11).
The assembly process was also tested and monitored in combination with small
interfering RNA (siRNA) sequences. The co-assembly of a 21 base pairs double strand
siRNA sequence with the peptide showed the formation of structures similar to the
ones with peptide only: CD spectra highlighted the helical signal from RNA together
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Figure 1.11: Circular Dischroism spectra for capzip capsules (solid line) and capzip
with siRNA (30 µM, dashed line). Reproduced from Castelletto et al. [2016]
with the features proper of the peptide (Figure 1.11, dashed line). These co-assembled
structures were tested for siRNA delivery in HeLa cells, using a fluorescent Alexa-
labelled siRNA (Eurogentec, UK). The experiment showed that the internalisation
occurred within the first hours from the transfection, suggesting an endocytic uptake
(Figure 1.12, a). The presence of the peptide enhanced the internalisation with respect
to the one obtained from a pure siRNA control (Figure 1.12, a), and was comparable
with the uptake obtained with the standard transfection agent Lipofectamine R©. Cell
viability was assessed monitoring the level of green fluorescence protein expressed by
the HeLa cell line chosen, which was stable over the first five hours of incubation with
capzip, after which the fluorescence signal decayed.
Similar transfection experiments the fluorescent siRNA combined with D-capzip
were assessed through flow cytometry assays. This method counts the number of fluo-
rescent cells and can process thousands of them at once, giving large scale information
on the efficacy of the transfection. Such assays confirmed that also D-capzip enhance
the siRNA uptake in measure comparable with Lipofectamine R© performances (unpub-
lished results).
To further quantify the level of RNA internalisation, a micro RNA (mRNA) knock-
down experiment was performed on a HeLa cell line with two housekeeping genes,
ACTB (β-actin, targeted) and GAPDH (reference). The silencing of β-actin mRNA
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Figure 1.12: a: fluorescence micrographs of HeLa cells expressing green fluorescent
protein used as internal background fluorescence for Alexa647-labelled siRNA, at 1/5
N/P (neutral to positive) molar ratios (green: GFP, red: siRNA). b: knockdown fitness
of capzip and commercial Lipofectamine R© or N-TER R© (positive controls) normalised
against siRNA alone (negative control) and the total counts of viable cells. Reproduced
from Castelletto et al. [2016].
was detected 22 ± 2 hours after transfection. Its knockdown “fitness” (Figure 1.12, b)
was computed relative to cells treated with siRNA alone (background) and normalised
against viable cell counts. Capzip fitness was lower than Lipofectamine R© one, however
cells treated with capzip remained viable longer, suggesting that capzip has little cy-
totoxicity. The experiment was performed at neutral to positive charge ratio close to
one (where each siRNA molecule has a -42 e charge and capzip a +6 e charge). Test
experiments performed at higher peptide-to-siRNA ratio showed no improved uptake.
Finally, the peptide exerted an antimicrobial function: both the L- and D- non-
assembled peptides were effective against Gram-positive and negative bacteria (S. au-
reus, B. subtilis, M. luteus - positive - and E. coli, P. aeruginosa, S. typhimurium,
K. pneumoniae - negative). The minimum inhibitory concentrations (MIC), the low-
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Figure 1.13: B: E. coli cell fractions treated with D-capsids and ampicillin (means
and standard error obtained for 3332 cells hosted in 2331 independent microfluidic
channels). C and D: electron micrographs of microtomed E. coli cells before (C) and
after (D) treatment with D-capsids (scale bar 200 nm). Reproduced from Kepiro et al.
[2019].
est concentration which prevents visible growth of the bacterium, was typical of other
antimicrobial agents. This antimicrobial action extended also to cell types which are
not susceptible to ampicillin (Figure 1.13, B). Additionally, no haemolytic effects were
observed on human erythrocytes, i.e. the concentration required to achieve 50% cell
death compared to untreated cells (LC50) was larger than 10 times the MIC necessary
to kill most bacterial species.
To better understand the type of action capzip performs on the bacteria, electron
micrographs of E. coli cells were taken before and after the treatment. Figures 1.13
C and D show the membrane disruption and the leakage of intracellular material after
the introduction of capzip. A more detailed view of the effects of a capzip capsule on
the bacterial membrane was provided by experiment on Supported Lipid Bilayer with
negative total charge (mixed DLPC and DLPG, 3:1 ratio). Deposition of capsules on
them created localized pores within minutes, as proven by AFM experiments repeated
in time. The pore depth ranges between 1.4 and 2.2 nm, which is smaller than the
radii of the capsules, but is sufficient to disrupt the structure of the membrane (Figure
1.14).
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Figure 1.14: Antimicrobial activity of capzip capsules on bacterial model membranes
(Supported Lipid Bilayer). (a) Confocal micrographs of stained bacterial cells after
16 hour incubations with and without capzip. White histogram bars denote total
cell counts (%) for bacterial colonization with capzip after subtracting background
adhesion taken as 100%. (b) AFM topography of SLBs during capzip incubation in
solution. White boxes and arrows highlight individual capsule conversions into pores
(color scale 6 nm). Cross sections show the evolution of this capsule into a pore in
real time. (c) Representative cross-sections of capsules and pores. Reproduced from
Castelletto et al. [2016].
Finally, to prove the viability of capzip as antimicrobial agent in vivo, it was used
to counteract methicillin-resistant S. aureus (MRSA) infections in G. mellonella larvae.
The particular bacterial strain used was susceptible to vancomycin, which could be used
as control: the larvae treated with capzip showed survival rates significantly higher than
the untreated control, and comparable to those treated with high doses of vancomycin
[Kepiro et al., 2019] (see Appendix A.1).
Open questions Despite the success of the experiments mentioned above, there is
much information still to be uncovered on the precise action of such peptide. Specif-
ically, both the assembly process and the antimicrobial mechanisms contain some un-
known.
Regarding the former, it is important to understand (a) which amino acids or sub-
structures allow the pairing of molecules, (b) whether such pairing is specific or not,
(c) how reversible it is, and (d) how rigid the final structure is. Regarding the latter,
it must be highlighted (a) what moieties in the membrane the peptide binds to, and
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(b) how this binding affects the full membrane structure.
Finally, as there is evidence that the assembled molecule is a more powerful an-
timicrobial compound than the single one, it is interesting to understand whether any
cooperative action is taking place, or the enhanced antimicrobial power of the assembly
is due only to the localised higher concentration of antimicrobial sequences.
Even if further experiments or future improvements in the techniques already em-
ployed might tackle some of the aspects above in the future, arguably no experimental
outcome can provide an atom-by-atom knowledge of the processes of interest in any
time soon. Ideally though, one would like to track with the finest level of details, both
in space and time, the processes happening in any of the environments capzip has been
exposed to (physiological solution, supported lipid bilayers, bacterial extracellular ma-
trix, mammal cell membrane and cytoplasm). The impossibility of pursuing that leaves
large gaps in the understanding of the system.
1.6 A computational approach to understand capzip
The gaps mentioned in the characterisation of capzip prompts for new investigations
in order to complement the knowledge already provided.
Beside the quest to enrich the fundamental knowledge on self-assembling peptides
and antimicrobial ones, the understanding of this very system is crucial for its further
development. We already outlined in Section 1.2.4 how AMP design can proceed from
already viable templates and empirical principles, when first principles are not available.
Similar rules hold for designing self-assembling peptidic materials, to obtained tailored
delivery vehicles (see Section 1.4.1). Therefore, a full knowledge of the interactions
between capzip molecules and between their assembled structures and the membrane
will drive the engineering of new likewise peptides. A knowledge-driven design would
hopefully provide new blocks suitable for a double action as the one capzip performs,
and this in a shorter amount of time than a research based on a less informed trial-
and-error procedure of mutations in the chemical composition of the molecule. A few
examples of possible knowledge-related improvements include the following:
• understanding the molecule-molecule interactions classifies the robustness of the
1.6. A computational approach to understand capzip 51
assembled structure and the possibility of designing blocks which disrupt under
particular chemical conditions only;
• the knowledge of capzip binding mode to the bacterial membrane might suggest
its suitability as a broad range spectrum compound versus the possibility of tuning
its action against specific pathogens;
• querying the electrostatic profile of the assembled structure suggests which type of
molecules, other than siRNA, could be efficiently co-assembled and thus delivered.
In recent years, computational techniques are becoming increasingly accessible and
sophisticated and can usefully complement incomplete experimental knowledge to give
more insights into how biological systems work (see Chapter 2). For this reason, it
seems natural to employ such techniques to study the capzip system as well. Zooming
into the details of the interactions can be performed via a theoretical modelling of the
system, and thus through the simulation of its evolution in time, starting from the
knowledge of the chemical composition of its parts. The technique this work focuses
on is Molecular Dynamics simulations, which aims at reproducing the behaviour of
a system of atoms in a classical description using basic physical laws, as it will be
described in detail in the next chapter.
Thus, it is the aim of this thesis to prove that Molecular Dynamics simulations
can clarify the assembly mechanisms of capzip and its interactions with biological
membranes, in order to gather more information on the system and contribute in the




olecular Dynamics simulations have been rightly defined as the ‘Computa-
tional Microscope’ [Lee et al., 2009; Dror et al., 2012] as they offer otherwise
inaccessible insights into the molecular details underlying conformational changes of
proteins and nucleic acids. Computational methods and tools based on MD are rou-
tinely applied in structural biology to quantitatively characterise the dynamics and
thermodynamics of proteins and their complexes. MD simulations and the associated
force fields are commonly used in the process of structure determination from NMR
data or in theoretical structure prediction from homology models [Vogel and Huster,
2017; Heo and Feig, 2018]. In particular, simulations of the structure help in relieving
the artefacts deriving from the experiments, or in determining the correct conforma-
tion in cases when the experimental measure or the homology modelling has a large
uncertainty.
Modelling and simulating a biological system consists in describing its components
and their mutual interactions, by implementing the laws of physics in the attempt
to reproduce the dynamics of phenomena observed in nature. A quantum mechanics
description would be the most accurate, but it is computationally too expensive to
achieve for large systems. To facilitate the task, several simplified models have been
devised, each suitable to investigate particular cases. In particular, a popular approach
is a classical mechanics description of the dynamics (classical : quantum mechanics
effects are relevant on very short time and length scales only. Therefore, for systems
of biological relevance (at the microsecond time scale and nanometer length scale) the
classical approximation is sufficiently accurate, and a model computationally affordable.
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Another computational method for tackling similar problems is to adopt a prob-
abilistic approach rather than MD: instead of using the laws of mechanics to evolve
the system, a random sampling of its states is performed to find the most energeti-
cally favoured ones. This procedure, the Monte Carlo (MC) method, partially relieves
the computational burden with respect to a dynamic approach, as it does not need to
compute the forces acting on the particles, but only the energy of the system. MC
simulations have been successfully used in situations where the system can get trapped
in an energy minimum if simulated through MD, while it is deemed that many more
minima are present, and thus a more extensive sampling is sought [Liu et al., 2012].
However, MC does not capture dynamical properties and thus can be unsuitable for
some questions posed on biological systems. Despite the focus of the present work is
Molecular Dynamics, it is important to be aware of alternative computational tech-
niques as a complementary tool which can boost the understanding of the system.
We briefly present here the core theory and implementation of classical MD simula-
tions, especially discussing the parametrisation of the different force fields used in this
work, as a consistent part of it focuses on testing and implementing MD simulations pa-
rameters. Understanding their methodology provides an interpretative key with which
simulations must be designed, run and interpreted in each specific case [van Gunsteren
et al., 2006]. We will also discuss the strengths and limitations of MD simulations and
their comparison with experiments. A review of relevant successes of MD simulations
will complete the chapter.
2.1 Algorithms for Molecular Dynamics: the Newton’s law
In a classical MD framework, Newton’s second law of motion rules the dynamics, stating
that the acceleration a that a particle is subject to at time t, depends on the total force
F acting on the particle itself and on its mass m (bold denotes vectorial quantities):
F(t) = m · a(t) . (2.1)
As the acceleration a(t) is the second derivative of the position r(t) with respect to
time, given the initial position and velocity of the particle (r(t0), v(t0)), their temporal
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evolution can be computed integrating a(t) = F(t)/m as follow:
















dt′′ dt′ . (2.3)
In the case of complex biomolecular systems with many particles and multiple interac-
tions acting between them, it is impossible to integrate analytically Equation 2.2, while
a different and feasible approach consists in discretising it. The idea is to consider very
short time steps of length ∆t, so that in such intervals the forces are (almost) constant,
and the integration of Equation 2.2 becomes trivial. A careful choice of the values to
integrate allows to reduce the approximations derived from such approach. For exam-
ple, choosing the velocity value at time t0 + ∆t/2 (and not at t0) decreases the error
down to orders of (∆t)4 (rather than (∆t)2). This framework is at the basis of the























This algorithm can thus “solve” every possible Newton equation, at the expenses of
some precision.
Constraint algorithms Considering that MD deals with bonded atoms belonging
to multi-atoms molecules, the length of these bonds must be kept within a physically
meaningful value. As the approximate procedure mentioned above may however give
raise to unphysical configurations, constraint algorithms are applied after the update
of atoms positions, to restrict the change in bond length. The ones used in this work
are SETTLE [Miyamoto and Kollman, 1992] and LINCS (Linear Constraint Solver)
[Hess et al., 1997]: the first is an exact implementation of the solution for rigid bodies
of three elements only (such as water molecules in their atomistic description), while
the second finds an approximate solution for molecules with more atoms.
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Thermostats and barostats In addition to the constraint algorithms listed above,
specific algorithms are needed to realistically reproduce the simulation’s conditions of
choice in terms of Temperature and Pressure.
In most cases, we are interested in simulating a system at constant temperature,
which corresponds to a constant average kinetic energy Ek (with the average performed
over time). Despite this condition seems less restrictive than imposing a constant Ek
at each time, the fluctuations from the average value must be distributed according to
a specific statistics.
Statistical mechanics has investigated the problem identifying the possible states
of a closed mechanical system in thermal equilibrium with a heat bath at a fixed
temperature [Gibbs, 2010]. This states form the so called canonical ensemble, which
can be completely defined knowing the number N (and identity) of the particles, the
temperature T , and the volume V of the system itself. Many other ensembles are
possible, according to the restrictions imposed on the system: for example, if the
volume V is allowed to vary but it is kept constant the pressure P (a quantity we
will define in the following paragraphs), we obtain the isothermal-isobaric ensemble,
defined by N , P and T . Again, a constant number N , volume V and total energy E
define the microcanonical ensemble. These are the most common situations one wishes
to reproduce in a Molecular Dynamics simulations, and thus effort has been directed
to ensure their behaviour is reproduced at best in the simulations outcome.
Regarding the situations at constant temperature, the approximations performed
by the MD algorithm lead the kinetic energy to drift from its initial value. To ensure
that temperature is maintained throughout the simulation, thermostat algorithms have
been devised to rescale the velocities of selected particles.
The thermostats used in this work are the Berendsen [Berendsen et al., 1984] and
velocity rescale [Bussi et al., 2007] ones. They both rescale the velocities of all the
particles in the simulation at each time step. For Berendsen, the rescaling factor λ is
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where E0k is the target kinetic energy and τT is a time interval multiple of ∆t which
regulates the strength of the coupling. A value of τT equal to ∆t would suppress all
thermal fluctuations, while in real systems they are still allowed. Even with larger τT
though, this thermostat gives incorrect results as it can not maintain the correct distri-
bution of velocities during the evolution of the dynamics, thus violating the statistics
of the canonical ensemble. To solve this problem, the velocity rescale thermostat was









with Nf the number of degrees of freedom in the system and dW a Wiener noise
[Durrett, 2010] which ensure fluctuations are sampled correctly.
The other relevant quantity, pressure, is defined as the average quantity of motion
exchanged between the particles and the walls of the box they are confined to, which
depends on their frequency of collision. Most MD simulations are run under periodic
boundary conditions, i.e. a particle which exits from the simulation box during a move
is brought back on the opposite side of the box. This mimics the presence of an infinite
number of equivalent boxes one next to the other, and alleviates the finite size effects
implicitly modelling an infinite simulation box. As particles are not effectively bouncing
on the walls, the pressure is computed from the velocities of the ones trespassing the
box boundaries during a move. Barostat algorithms rescale the size of the simulation
box to adjust the collision frequency and thus the pressure to the target value.
As a note, pressure is an intensive quantity, i.e. a local physical property of a system
and does not depend on the system size or the number of particles in it (extensive
quantities). However, both these quantities are involved in its computation in the
framework used. From the classic kinetic theory of gases, for a homogeneous gas of N






Thus, rescaling the size of the system (extensive) and dividing N (extensive) by this
quantity, will influence the pressure (intensive).
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Usually all the box dimensions are rescaled by the same amount. In the case of
anisotropic systems like lipid simulations, an anisotropic coupling can be enforced: for
these systems, the membrane patch is usually parallel to one side of the simulation box,
and spans the whole side area. In this way, it joins with its periodic images, without
any water molecules in between. This is convenient as it shields the hydrophobic core
of the membrane from water, moreover it ensure that the membrane remains planar.
Indeed, isolated patches of membrane tend to fold into vesicles to minimise their energy.
In the situation where the membrane joins its periodic images, to compute pressure,
the box sides parallel to the membrane plane are rescaled separately with respect to
the one perpendicular to it. This is because lateral pressure exerted by the lipids is
expected to be different with respect to the one of water.
The barostats used in this work are the Berendsen [Berendsen et al., 1984] and
Parrinello-Rahman [Parrinello and Rahman, 1981] ones. The Berendsen barostat is
analogous to its thermostat counterpart, as it defines a scaling factor for the velocities
(and thus the coordinates) based on the target and effective pressure P0 and P , and a
coupling time τP :
v∗ = v
(




where β is the theoretical isothermal compressibility. As also the Berendsen barostat
suffers from problems regarding the correct sampling of fluctuations, the Parrinello-
Rahman is used for production runs. It introduces the constraint of constant pressure
in the dynamical equations of the systems (in a Lagrangian approach) which allows to
reproduce correctly the isobaric ensemble.
It must be noticed that the use of the correct barostat is crucial when measuring,
e.g., the true isothermal compressibility of the system K (as opposed to the theoretical
value β introduced in Formula 2.9). This quantity is defined as the relative volume
change as a response to a pressure change, and is directly related to the fluctuations of





Clearly, an incorrect distribution of fluctuations would produce a wrong estimate of
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this quantity.
Finally, when choosing a thermostat and barostat to be used in conjunction, one
must check in the literature for their mutual compatibility to obtain the correct isothermal-
isobaric ensemble. For this reasons indeed, some pairings are not implemented in the
standard MD engines.
2.2 Force fields
Force fields for classical MD simulations provide the expression of the potential energy
of a system. Thus they determine the forces employed in Newton’s law ruling the
dynamics. They usually rely on the breakdown of interactions into several independent,
additive and derivable terms, identified on an empirical physical basis.
We report here the functional form of the GROMOS force field [Oostenbrink et al.,
2004; Schmid et al., 2011; Reif et al., 2012] implemented in the GROMACS MD sim-
ulation engine [Berendsen et al., 1995; Abraham et al., 2015, 2018], as an example of
a classical force field. Other force fields can have slightly different implementations,
however the general classification of interactions and the type of functional forms used
are similar.
Covalent (bonded) interactions Covalent interactions are modelled with poten-
tial energy terms representing bond stretching, angle bending, improper and proper
dihedral angles torsion. The functional form of the potential energy function for each
of them aims at a simplified, classical description of the atomic motion of molecules.
Often, it is modelled as a harmonic-like vibration around the equilibrium position,
regulated by a constant. In the GROMOS force field, this translates in the equations
displayed in Table 2.1, where for proper dihedrals, the convention states that φijkl is
the angle between the (i, j, k) and (j, k, l) planes; with i, j, k, and l four subsequent
atoms, for example along a protein backbone. A value of zero for φijkl corresponds
to a cis configuration (penalised) and π to a trans (favoured). The integer n denotes
the number of equally spaced energy minima available in a 360◦ turn. The same con-
ventions hold for improper dihedrals ξijkl, which are used to ensure ring planarity and
control the chirality of tetrahedric centres.
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Table 2.1: Functional form of bonded interaction in the GROMOS force field imple-
mented in GROMACS.
It must be noticed that these types of potentials cannot model the rupture of a
bond.
Non bonded interactions Non bonded interactions include the short range Pauli
repulsion, the van der Waals attraction, and the long range electrostatic term.
The first two can be modelled together by a Lennard-Jones potential. Its functional
form, describing the interaction between two neutral atoms at distance r, models the
long range dispersion with a r−6 behaviour typical of the dipole-dipole interactions
found in noble gases (London dispersion forces), while the Pauli term is approximated










Two parameters, ε and σ, tune the interaction strength and the equilibrium distance.
They are fitted against experimental data and are specific of each pair of atoms species.








with ε0 the dielectric constant of vacuum and εr the relative dielectric constant, intro-
duced to properly take into account the screening provided by the material surrounding
the object (usually water), as polarisability is not included in this description.
The treatment of non-bonded interactions requires particular care because of their
long range nature: in every point of the simulation box many forces from distant atoms
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are acting at the same time, making the prediction of the outcome difficult. The van
der Waals forces decay fast, therefore the tail of their functional can be cut after a
threshold distance with little impact on the outcome; while Coulomb interactions, with
their slower decay, must be taken into account throughout the whole simulation box.
Many algorithms have been devised to efficiently compute them, like the Particle Mesh
Ewald [Essmann et al., 1995] or the Reaction Field [Tironi et al., 1995] approaches.
Finally, all biomolecular force fields, and in particular their van der Waals interac-
tions, are parametrised to describe systems at room temperature, therefore simulations
performed at substantially different temperatures must be interpreted carefully.
2.2.1 Classification of force fields
Many force fields for classical MD simulations adopt a functional form equal or similar
to the one described above. Their difference lies in the number of degrees of freedom
modelled, in a hierarchy of descriptions proceeding from detailed to coarse (Figure 2.1).
Three possible classes of descriptions are:
• all-atoms force fields, where all the atoms are present in the description, and
represented as spheres of variable size according to their van der Waals radius
(e.g. proportional to σ in a Lennard-Jones model). Examples of all-atoms force
fields are AMBER [Maier et al., 2015; Dickson et al., 2014; Wang et al., 2004],
CHARMM [MacKerell et al., 1998; Klauda et al., 2010; Huang and MacKerell,
2013] and OPLS all-atom [Jorgensen and Tirado-Rives, 1988].
• united-atoms force fields, similar to the previous ones but where non-polar hy-
drogens are incorporated in the heavy atom they are bonded to. The “united”
atom is given a new σ parameter and increased mass according to how many
hydrogen it includes. The GROMOS force field [Oostenbrink et al., 2004; Schmid
et al., 2011] follows this philosophy, and OPLS has also a united atom version
[Jorgensen et al., 1996].
• coarse-grained force fields, which group together in one unique bead few atoms,
to reduce the number of variables to compute. The clustered atoms are such
that their mutual distances are expected to vary little with respect to the ample
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Figure 2.1: List of popular simulation force field for biomolecules, ordered from de-
tailed to coarse (reference to the relative papers in Section 2.2.1). On the left, snapshot
of notable systems simulated with the force fields CHARMM (adapted from Lipkin
et al. [2017]); GROMOS (adapted from Macpherson et al. [2019]); SIRAH (adapted
from Machado et al. [2017]) and MARTINI (adapted with permission from Samsudin
et al. [2017]).
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movements of components of the system far away from each other (which will
be grouped in different beads). The MARTINI [Marrink et al., 2007; Monticelli
et al., 2008; de Jong et al., 2013] and SIRAH [Machado et al., 2019; Barrera et al.,
2019] force fields belong to this category.
We now give a more detailed insight of the characteristics and parametrisation strategies
of the atomistic and the coarse-grained force fields employed in this work.
2.2.2 The GROMOS force field
All-atom and united atom force fields are parametrised against first-principle or ex-
perimental values. While for the all-atom force fields AMBER and CHARMM the
parametrisation is based on ab initio quantum mechanics calculations refined against
experimental data [Maier et al., 2015; Dickson et al., 2014; Wang et al., 2004; MacKerell
et al., 1998; Klauda et al., 2010], the united-atom GROMOS force field relies on the
reproduction of heat of vaporization of small molecules and free enthalpies of solvation
of small compounds in different solvents, at physiological temperatures and pressures
[Oostenbrink et al., 2005; Schmid et al., 2011; Reif et al., 2013]. These procedures sets
not only the constants of the bonded interactions, but also the partial charges of the
atoms inside a molecule: as no electrons are included for the sake of efficiency, their
redistribution across atoms which are bonded is modelled through fractional charges
assigned to each atom (while the total charge of a molecule must sum to an integer).
Moreover, it is assumed that the parametrisation performed for small moieties can be
transferred to a larger compound including these moieties. This limits the number of
chemical groups to be described in order to simulate biomolecules.
In every MD simulation, the description of water is crucial. Out of the many water
model proposed, the GROMOS parametrisation has been performed with a flexible
simple point charge (SPC [Berendsen et al., 1981]) model. This description represents
water as a three atoms molecule, with a negative charge on the oxygen and positive com-
plementary charges on the two hydrogen atoms, and allows flexible hydrogen-oxygen
bonds. This model reproduces correctly the density and dielectric permittivity of water
[Mark and Nilsson, 2001]. To be noticed that, from the point of view of the compu-
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tation, water molecules are the vast majority of the particles involved in a simulation
and thus a significant fraction of the computer time is spent in updating their positions
and calculating solvent-solvent interactions.
The improvement of computational techniques and reparametrisation strategies
prompts the periodical release of newer versions of force fields. In the present work,
we employed version 53A6 of the GROMOS force field [Oostenbrink et al., 2004] for
the set of simulations involving peptidic assembly in solution, while we switched to
54A7 [Schmid et al., 2011] and 54A8 [Reif et al., 2013] for the simulations involving bi-
ological membranes. While it is advisable to always have a coherent set of parameters
across simulations, to compare their outcome in a consistent manner, when extend-
ing the system simulated to include membranes, we deemed the newer parameter sets
more suitable because of the improvements introduced in the phosphocholine head
parametrisation [Marzuoli et al., 2019] (see Chapter 4 for a complete discussion on
lipid parametrisation in GROMOS).
2.2.3 The SIRAH force field
The first coarse-grained force field we introduce groups multiple atoms in one bead but
aims at maintaining chemical and structural details of the biomolecules described. As
such it sets itself between the atomistic GROMOS description, and the coarse-grained
MARTINI force field [Marrink et al., 2007; Monticelli et al., 2008; de Jong et al., 2013]
which will be introduced in the following.
Two different approaches are taken to develop a coarse-grained force field: top-
down and bottom-up. In the first, parameters are fitted directly to global quantities
derived from experiments, as performed in the atomistic GROMOS parametrisation.
In the second, coarse-grained simulations results are fitted to outcomes from atomistic
ones.
SIRAH [Darr et al., 2015; Machado et al., 2019; Barrera et al., 2019] is a top-
down force field derived to fit structural properties of proteins. It aims at reducing the
complexity of an atomistic description while still being able to reproduce the correct
secondary structure of proteins across a wide variety of folds contained in the PDB,
together with a correct representation of their dynamics.
2.2. Force fields 64
Figure 2.2: Description of amino acids and nucleic acids in the SIRAH force field.
Reproduced from Institut Pasteur de Montevideo Group of BioMolecular Simulations
[2019].
To obtain this, it opts for a non-uniform granularity, i.e. according to the region
of interest a different number of heavy atoms is grouped in a bead, from a minimum
of two up to four. In the case of proteins, it maintains the backbone flexibility by
grouping NH, CαH and CO in three different beads, while side chains are represented
with less details, generally grouping three atoms together. A schematic of the mapping
for each amino acid is shown in Figure 2.2. Contrary to force fields where the amino
acid backbone is mapped to one bead only, the SIRAH description allows to reproduce
secondary structures without recurring to additional constraints. The dual granularity
approach is based on physico-chemical intuition, and is more difficult to generalise
than a uniform one. Nevertheless, the force field has been recently extended to lipids
[Barrera et al., 2019], while it comprised a parametrisation for DNA molecules since
its infancy.
The modelling of water in a coarse-grained force field is also critical: usually, a few
water molecules are grouped together in one bead. This has two implications: water
particles are large and thus cannot solvate very narrow pockets; moreover, collapsing
the molecules in one single point in space removes the separation of charges, and the
characteristic dipole every water molecule should have is lost. The dipole of water is
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responsible for hydrogen bonds formation and for the electrostatic screening observed
in an aqueous solution. Such screening can be roughly modelled tuning the relative
dielectric constant, but as this is a mean field approach, it cannot account for local
effects. To partially obviate to that, SIRAH force field maps four waters to a tetrahedral
molecule, with one bead on each vertex: all the bonds are rigid, and the structure serves
the purpose of having a repartition of plus and minus charges, by assigning a positive
charge to two vertices and the opposite charge to the other two, giving a polarisable
structure. The geometrical arrangement reproduces the tetrahedral network of water
molecules observed in its liquid state, which is characteristic of this fluid and tunes its
remarkable properties (as the high specific heat capacity, and the non-linear relationship
between density and temperature in its liquid state). Finally, ions are represented as
spheres including the ion and the first hydration shell comprising 6 water molecules.
Based on the above premises, SIRAH force field simulations of different peptides
and proteins in solution proved to match the relative NMR results, showing a good
reproduction of secondary structures; simulations of lipids randomly oriented in water
showed the formation of an organised bilayer, and the expected behaviour of a few
transmembrane proteins in model membranes was correctly reproduced [Machado et al.,
2019; Barrera et al., 2019].
2.2.4 The MARTINI force field
The MARTINI force field is a popular coarse-grained description of biological molecules
[Marrink et al., 2007; Monticelli et al., 2008; de Jong et al., 2013]: developed originally
with a focus on lipids, it has then been extended to include proteins, small ligands and
DNA/RNA molecules 2.3.
MARTINI opts for a four-to-one approach, i.e. four heavy atoms are grouped in
one bead. The number of bead types has been kept to the minimum necessary to
represent biological molecules. They are organised systematically in polar, non-polar,
apolar, or charged, and each type has a number of subtypes with increasing polarity to
differentiate the chemical nature of the underlying atomistic structures. This systematic
approach can be easily transferred to new compounds, without the need of introducing
new bead types. The only exception is represented by rings molecules, where a two-to-
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one approach is needed to maintain the circular topology.
The MARTINI force field chooses a top-down approach to parametrise non-bonded
interactions, tuning them against experimental partitioning free energies between po-
lar and apolar phases, while bonded interactions are derived from reference all-atom
information, in a bottom-up approach.
The four-to-one mapping implies that the amino acid backbone is represented by one
bead only, preventing the description of directional bonds which are key to reproduce
the secondary structure (Figure 2.3(a)). The bonded parameters partially account for
this, favouring for each residue type the backbone conformation in which it is most likely
found (as computed from the Protein Data Bank - PDB [Berman et al., 2000]). When
this is not sufficient, the protein can be constrained around a given structure through an
elastic network model approach which constraints residues to keep their mutual position
through harmonic potential applied on their backbone beads (ElNeDyn [Periole et al.,
2009]). However, both the backbone parametrisation and the use of ElNeDyn imply
that local energy minima of the natural structure are not well sampled in MARTINI
simulations, biasing the understanding of the structure dynamics.
The MARTINI force field provides two water models (Figure 2.3(c)). The standard
one groups four water molecules in one bead only, loosing the polarisability typical of
water, the effect of which is partially restored with the use of a high dielectric constant.
The polarisable water model [Yesylevskyy et al., 2010] maps instead four water molecule
to a single “inflated” water, i.e. a three-beads molecule with the same shape of a single
molecule, but expanded, and a charge splitting which can account for the water dipole.
Overall, the MARTINI force field pushes the limits of simplification to enhance the
simulations speed-up, with considerable gain in efficiency with respect to atomistic or
even SIRAH simulations. Despite it can not capture some fine details of the systems
studied, it has been successfully applied to describe the behaviour of many biological
membranes [Khalid et al., 2019; Samsudin et al., 2017], lipid self-assembly [Marrink
et al., 2007] and peptide-membrane binding [Song et al., 2019]. The (re)introduction of
a more detailed water model allowed the description of electroporation processes and
the translocation of ions through bilayers [Yesylevskyy et al., 2010].




Figure 2.3: Description of amino acids (a), example lipids (b) and water models (c)
in the MARTINI force field. In (c) the orange sphere represents the van der Waals
radius of the central atom. Reproduced from Monticelli et al. [2008]; University of
Calgary Biocomputing Group [2016]; Yesylevskyy et al. [2010]
2.2.5 Backmapping techniques
Coarse-grained descriptions are very effective in reproducing long time scales; how-
ever, to retrieve finer details after such extensive exploration, backmapping techniques
have been designed to obtain atomistic configurations from the coarse-grained ones
[Wassenaar et al., 2015]. These backmapped structures can in turn be simulated at
the atomistic level to explore the short time scale movements around such interest-
ing conformation. The easy conversion between the two resolution, gave rise to many
multiscale studies applied to biomolecular systems [Lee et al., 2012].
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2.3 Validation and challenges of MD simulations
Validation of MD simulations is performed by comparison with experiments: the same
properties obtained experimentally are computed from the MD trajectory as well, and
the two compared. If these are correctly reproduced, it is usually assumed that the
simulation is sampling the correct ensemble of states and then one can identify in the
simulation the determinants responsible for the experimental outcome of interest, which
are not accessible by the experiment itself.
The comparison however is not always easy: often the experimentally measured
quantity is an average in time and/or space (for example Circular Dichroism spectra or
SAXS profiles of a peptide in solution) and many different combinations of computa-
tionally derived structure ensembles can produce compatible results. It is still challeng-
ing to compare experimentally derived ensembles and the ones derived by molecular
simulations. Indeed the extracted average properties may be different, so it is impor-
tant to understand which are the relevant ones playing a role in the measured ensemble
before attempting comparisons.
Thus, in the validation of MD outcomes, it is important to have a critical attitude
and to interpret the result within the validity of the approximation [van Gunsteren
et al., 2008]. Indeed, agreement may arise from either a simulation that reflects correctly
the experimental system; but also when the property examined is insensitive to the
details of the simulated trajectory, or it can be a result of compensation of errors,
which is more likely to occur for systems with a high number of degrees of freedom.
Similarly, disagreement may hint at an error in the simulation (either in the model,
the implementation, or simply the estimated simulation’s convergence) or an error in
the interpretation and/or conditions of experimental set-up (either in the result itself
o its interpretation), so that both must be carefully checked to improve a convergence
in the agreement. Some apparently negative results may suggest or stimulate new
experimental settings to validate the hypotheses one was set to test [Gonçalves et al.,
2013; Meißner et al., 2014].
Additionally, simulations still suffer from the limited computational time available:
most of the times, the real experimental system is simply too large to be reproduced
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and the time scale of the process too long. Simulations are thus confined to explore
a restricted space, implying that the initial conditions must be chosen carefully to
optimise the search and avoid any bias which might persist for the whole length of the
simulation. The use of enhanced MD techniques can increase the chances of sampling
relevant states [Bernardi et al., 2015]. As a non comprehensive list of these techniques,
we mention replica-exchange algorithms [Best et al., 2005] which combine together
multiple simulations held at different conditions; local potential-energy elevation (or
metadynamics) [Barducci et al., 2010, 2011] which avoids the re-sampling of already
visited conformations adding an energy penalty to them; umbrella sampling [Mills and
Andricioaei, 2008] which reconstructs free-energy barriers from simulations performed
at specific values of the coordinate along which the barrier exists; or finally the simple
use of higher temperature to overcome energy barriers [Kirkpatrick et al., 1983].
Finally, one should keep in mind that the force fields used are far from optimal,
partly because they rely on approximate functional forms, and partly because it is
difficult to find experimental observables measured with the desired resolution able to
discriminate between sets of parameters.
Nevertheless, it remains important to note the contribution that Molecular Dynam-
ics simulations have played in disclosing important details behind biophysical processes
and in unravelling molecular details not accessible to experiments.
2.4 MD simulations: successes
Consistently with the focus of this thesis, we will privilege examples of simulations
investigating antimicrobial peptides as well as self-assembling ones, showing how com-
putational techniques can help the design of novel molecules with improved specific
characteristics.
2.4.1 Simulations of antimicrobial peptides
MD simulations of antimicrobial peptides are quite well documented since the first de-
velopments of the technique. Such peptides are a suitable system for a computational
investigation as, in most of the cases, their mechanisms of action are not completely
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understood from the experimental information available (see Section 1.2.2). As exper-
iments prove that even the mutation of one single residue in short AMPs can change
remarkably the antimicrobial activity of the sequence (see Section 1.2.4), it is then clear
that their action is governed by subtle atomic interactions, so that MD simulations,
with their atomistic resolution, can help understanding this aspect.
Systems As mentioned in the previous chapter, it has been proposed that most AMPs
act through a process of attraction to the bacterial membrane, possible aggregation
with other copies of the same sequence, insertion, and membrane lysis. The time scales
of the overall process (at least of the order of microseconds and up to seconds) are
accessible using coarse-grained techniques, but not - or rarely - atomistic ones. For
this level of description instead, the different steps are usually investigated separately,
based on prior hypotheses: for example, the peptide can be positioned close to the
membrane surface [Wang et al., 2012b], or placed directly within the membrane core
with different insertion depths to verify which configurations are the most disruptive
ones [Lipkin et al., 2017]. The full insertion process will be then reconstructed from
a “stepwise” knowledge combining the different states sampled. For these reasons,
the choice of the conformation to simulate, i.e. the initial conditions in terms of the
mutual position of peptide and membrane, is crucial, as it likely biases the simulation
towards the sampling of a particular subset of configurations. Recent advances in the
computational power are making possible the simulations of the full process even at the
atomistic resolution for simple enough systems [Ulmschneider, 2017; Sun et al., 2015],
nevertheless the “stepwise” approach is still common and the preferred one in case of
complex AMP systems.
Model membranes The second important choice in the setup of a simulations of
antimicrobial peptides concerns the model of the membrane to simulate. In an effort
to keep complexity low, bacterial and mammal membranes are often modelled with
a minimal number of lipids. Usually, models of bacterial membrane retain as only
key characteristic an overall negative charge, with about 25% of anionic lipids (−1 e
charge) [Lipkin et al., 2017; Wang et al., 2012b; Zhao et al., 2018a; Chen et al., 2019].
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For a model mammal membrane instead, only zwitterionic lipids are employed, with
the occasional inclusion of cholesterol, as it is deemed important in describing more
realistically their behaviour [Lipkin et al., 2017; Wang et al., 2012b; Zhao et al., 2018a;
Chen et al., 2019; Risselada and Marrink, 2008]. Because of their simplicity, these
systems are used in experiments [Castelletto et al., 2016; Tang and Hong, 2009; Glukhov
et al., 2005], making possible a direct comparison with simulations. Therefore, even if
these simple membranes do not model accurately the structure of the cellular envelope,
simulations and experiments of these systems provide a first explanation of some steps
of the antimicrobial activity, with the two techniques complementing and validating
each other.
Nevertheless, attempts to model cell membranes more accurately have been pur-
sued. This can be performed at the atomistic level [Piggot et al., 2011] but the task
is especially suited for a coarse-grained description, as the inclusion of all the elements
of the cell membranes results in quite large systems for which atomistic computations
started only in recent years to be affordable. Accordingly, coarse-grained (MARTINI)
simulations have been incorporating more and more components into model mem-
branes, describing the bacterial inner membrane, the bacterial wall, and finally the
combination of the two [Khalid et al., 2019] (see Figure 2.1, bottom). These large
scale, coarse-grained simulations provide information on the mechanic characteristics
of the system: for example, simulation of the outer membranes of Gram-negative bac-
teria combined with the peptidoglycan layer (which, in bacteria, is positioned between
the two membranes) elucidated how the distance between the two is variable, thanks
to the presence of Braun’s lipoproteins [Asmar and Collet, 2018] which act as a bridge
between them, and can bring them closer by bending and tilting. On the other hand,
the permeability of membranes to ions and small compounds needs to be assessed at the
atomistic level, and to access informative simulation time scales, smaller and simpler
systems must be chosen for the task (e.g. the inner membrane only), often together
with enhanced MD techniques such as metadynamics, umbrella sampling, and replica
exchange umbrella sampling. [Sun et al., 2016; Piggot et al., 2011; Carpenter et al.,
2016; Pokhrel and Maibaum, 2018].
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Force field comparison Finally, simulations of the peptide interaction with a model
membrane are clearly determined by the parametrisation of the force field employed
for protein and lipids (and by their mutual consistency). There are multiple evidence
suggesting that different force fields produce very different outcomes when simulating
the same system, under the same conditions [Wang et al., 2014; Bennett et al., 2016;
Sandoval-Perez et al., 2017]. This is also valid for simulations of pure lipid patches (see
Chapter 4), resulting in incompatible values of area per lipid, organisation of the tails
and energetic profiles across the membrane, and thus has an impact in the simulations
of AMPs interacting with a membrane.
For example Wang et al. [2014] observed significantly different levels of unfolding
for the AMP melittin within a model membrane at the change of the force field, namely
CHARMM27 and 36 (for protein and lipids respectively) [MacKerell et al., 1998; Klauda
et al., 2010], OPLS all atoms (for protein) and united atoms (for lipids) [Jorgensen et al.,
1996] and GROMOS 53A6 [Oostenbrink et al., 2004]; while Bennett et al. [2016] proved
that the propensity of the synthetic AMP CM15 to form pores strongly depends on
the force field used but also on some extent - at least at the time of the work - on the
MD engine used (GROMACS compared to NAMD [Phillips et al., 2005]).
A more systematic investigation was performed by Sandoval-Perez et al. [2017], who
focussed on the reproduction of membrane-protein interactions (in GROMOS 54A7
[Schmid et al., 2011], CHARMM36, Amber14SB/Slipids [Jämbeck and Lyubartsev,
2012] and Amber14SB/Lipid14 [Dickson et al., 2014]). While all of the force fields were
able to reproduce the overall positioning of transmembrane proteins in the case studies
tested, they showed discrepancies for amino acid side chains insertion depth and energy.
Interestingly, all parametrisations gave a very broad minimum for the insertion position
of Tryptophan, in line with the different roles this amino acid is supposed to assume:
either an anchoring point positioned deeper in the hyrophobic region, or a partner for
hydrogen bonding with the hydrophilic heads [Chan et al., 2006].
The subtle differences between parametrisations lead to the conclusion that for every
particular system tested, the comparison with at least one experimentally measured
quantity would be the only way to assess the simulations performance accurately.
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Figure 2.4: (Left) A cartoon image comparing the disordered toroidal pore state (lack
of a well defined peptide orientation) to the traditional view. (Right) A snapshot of the
disordered toroidal pore from simulations of melittin in DPPC. Peptides in cartoon,
lipids in lines, water and ions in bead representation. Reproduced from Sengupta
et al. [2008].
Simulations of membrane-peptide interaction: examples Even in the context
of a simplified scenario and with the caveats coming from the parametrisation chosen,
simulations of antibacterial peptides on a membrane have been successful in elucidating
some AMPs mechanisms. The first important contribution consists in the introduction
of the disordered toroidal pore concept: as explained in the previous chapter (Section
1.2.2), the models of membrane poration due to AMPs consist often in ordered struc-
tures where many peptides gather together to contour a pore (see Figure 1.3), and they
are either in contact with the hydrophobic tails of the lipids (barrel-stave model), or
with their head, as lipid molecules bend around the pore to keep their tails screened
from the outside environment (toroidal pore model). However, simulations of the short
helical peptide magainin MG-H2 [Leontiadou et al., 2006], among others, showed that
a single copy of the helix inserted at an angle with the normal to the membrane plane,
and was sufficient to displace the lipids around in a non organised manner, and form a
water-filled pore (Figure 2.4).
Regarding possible rearrangements of the antimicrobial peptide structure when in-
teracting with a membrane, simulations of cathelicidin LL-37 on pure POPG (anionic)
and POPC (zwitterionic) lipid patches showed that LL-37 has a propensity to bind to
the former, as expected due to the opposite charge that membrane has with respect to
the cationic peptide [Zhao et al., 2018a]. However the simulations highlighted also that,
in contact with POPC, the helical secondary structure was lost, while the interaction
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with POPG preserved it, suggesting that the spatial arrangement of the residues, and
not only the overall chemical character, is important for their action. Such type of
information is hardly available to experiments or through a theoretical reasoning.
The improvements in computational resources is slowly pushing the extent of simu-
lation time to the microsecond time scale. Thus in a recent example, the translocation
of the helical PGLa peptide through the membrane has been observed as a rare event
dependent on the concentration of the peptide. This event happened on the multi mi-
crosecond time scale without the formation of an organised pore [Ulmschneider, 2017].
The in silico experiment still benefited of an enhanced sampling in the form of a higher
temperature as simulations were run at 363 K (rather than the usual 303 K), but no
pre-insertion of the peptide was performed. This study shed light on a possible mech-
anism of permeabilisation which is usually overlooked in favour of processes involving
organised channels and pores.
Similarly, simulations were able to shed light on the mechanism of translocation of
Arginine-rich peptides [Sun et al., 2015]. These sequences have high positive charge,
but despite this, possess a high propensity to penetrate membranes, overcoming the
hydrophobic region represented by the lipid tails. Very similar peptides where the
Arginines were swapped with Lysines showed no significant penetration. A commonly
used explanation considers polyarginine translocation a quasi-equilibrium process, but
this does not explain the selectivity against Lysines rich peptides. After extensive sim-
ulations of the two systems (multiple, hundreds of nanosecond long runs), the proposed
mechanism involves the spontaneous formation of pores initiated by random (thermal)
fluctuations of the position of the lipids: in some of these rare events, the transient
pore would be occupied by a peptide (a precursor), which slows down the pore closure.
In such situation, the translocation of other copies of the peptide is highly favoured
(if their concentration is sufficiently high) as they aggregate with the precursor inside
the membrane and are then pushed toward the opposite side where there is a lower
charge density. Differently from polyarginines, polylysines have a much lower aggrega-
tion propensity, so that the presence of a precursor peptide inside the membrane does
not induce an enhanced insertion of further peptides.
The last example brings the attention on whether oligomerisation is necessary for
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Figure 2.5: Cartoon representation of the different assembly mechanism that allow
polyarginines but not polylysines to translocate through spontaneously formed pores.
Reproduced from Sun et al. [2015].
an efficient antimicrobial activity. Contrary to oligomerisation in solution, which can
happen on shorter time scales, the spontaneous aggregation of peptides on a membrane
surface requires a long time, as the structures must diffuse on the membrane to meet
each other, and many other competing processes (such as insertion) are happening at
the same time. MD simulations offer insights on this aspect as well.
In a recent example, simulations of maculatin (an helical AMP) showed that the
pores it forms can include a variable number of helices and thus assume many different
conformations [Wang et al., 2016b]. The suggested process of pore formation proceeds
via insertion of a single residue, closely followed by other ones which are able to pene-
trate the membrane thanks to the lipid defects already created by the first peptide.
Similar investigations were carried on also for other aggregating cell penetrating
peptides, which are not antimicrobial: as such, some of them aim at inserting within
cells without necessarily causing poration. One example is constituted by the influenza
fusion peptides, which have been extensively studied with a simulation set up similar to
the one mentioned for AMPs: a few copies of the peptide positioned on a model mem-
brane oligomerised into aggregates of different sizes and inserted into the membrane,
perturbing its local curvature [Haria et al., 2014; Collu et al., 2015].
To be noticed that, when investigating oligomerisation, the size of the system must
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necessarily be increased to include all the copies necessary to form the aggregates ob-
served experimentally. As such, with the present accessible computer time, not all the
systems can be investigated from unbiased initial conditions. In the case of protegrin,
a β-hairpin antimicrobial peptide which has been long though to act through the for-
mation of transmembrane β-barrels, many variables can influence the outcome of the
unknown final structure. To overcome such problems, a semi-systematic investigation
has been carried on by Lipkin et al. [2017], simulating different assembly (see Figure
2.1, top). Microsecond long simulations discriminated which ones of these initial con-
figuration formed stable pores for the whole length of the simulations, and the ones
which were disrupted. As in the previous example, several different possibilities were
found stable in solution, suggesting that single AMPs might have multiple mechanisms
of insertion into membranes.
Most of the examples above employ atomistic descriptions of the system, but sim-
ilar investigations have been carried on also using the MARTINI force field. As an
example, MARTINI simulations of maculatin and aurein on POPC membranes showed
different propensities for pore formation versus aggregation, showing that the coarse-
grained model retains enough details and chemical information to reproduce different
membrane-perturbing behaviours [Balatti et al., 2017]. Nevertheless, the developers of
the MARTINI model themselves pointed out how some aspects of pore formation might
not be captured in a satisfactory way [Marrink and Tieleman, 2013]. For example the
penetration of water can be misrepresented, as can be expected from a model which
clusters four water molecules together (indeed some pore conformations allow for the
passage of fewer water molecule, if not one, at the time). As such, the MARTINI
membranes can be overstabilised, and have less propensity to break and porate, with
respect to their real counterpart.
In general, the outlook of simulations of antimicrobial peptides interacting with
membranes goes in the direction of reproducing longer time scales thanks to the en-
hanced computational power available. This enhanced power would also reduce the
need to use biased initial conditions or higher temperatures to speed up the simula-
tions. Moreover, gathering the contribution of the whole community, simulations will
likely go in the direction of modelling more accurately the bacterial membrane (see
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previous paragraph). Finally, the force field issue must be solved in collaboration with
experimentalists, finding new tests and experimental quantities to compare the com-
putational outcome with, and make the different parameters sets converge toward a
similar description of the phenomena observed, which is consistent with the experi-
mental results.
Simulation-aided AMPs design The role of simulations in aiding AMPs design
has been briefly sketched in Section 1.2.4. As pointed out, MD simulations are hardly
a tool to analyse large dataset, therefore the investigation focuses on a few selected
sequences.
Simulations can be helpful in integrating structural information which is otherwise
lacking: such approach was followed by Liu et al. [2018] to complement the chemical
features available on a dataset of short AMPs, and the overall information was used
to feed a predictor of AM activity of novel sequences. Preliminary results showed that
this improved significantly the ability of the predictor to discriminate whether a new
sequence was suitable for antimicrobial activity or not.
Another commonly followed approach consists in using simulations to elucidate the
reasons why a particular mutation is effective in terms of increased activity or decreased
toxicity. Mutation screenings can be afforded experimentally on short sequences, but
they are usually limited to single point mutations, as testing all the possible combined
mutations is prohibitive. However, once assessed the importance of a given substitution,
it is interesting to understand the mechanism behind it. For example, simulations of
ovispirin and a mutant peptide with reduced toxicity showed that the bend of the helix
in the latter was responsible for mitigating the interaction with mammal membranes
and thus reducing haemolysis [Khandelia and Kaznessis, 2005]. In another example,
temporin and a derived sequence with improved activity were investigated. Simulations
showed that the mutant had a reduced aggregation propensity in water, so that more
copies were ready to bind to the membrane and thus disrupt it [Farrotti et al., 2017].
In general, the protocol of integrating simulations and design is usually customised
according to the system in exam, as the field has not reached yet a systematic organ-
isation. However, it is clear that simulations used in conjunction with experimental
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testing can be used to optimise already available AMP sequences, and thus contribute
to device design rules for the creation of synthetic peptides with tailored properties.
2.4.2 Simulations of self-assembling peptides
Self-assembling peptides are another fascinating and challenging topic that MD sim-
ulations can help investigating. Simulating such systems implies different challenges
with respect to the ones faced when simulating AMPs on membranes [Frederix et al.,
2018; Orsi, 2018].
In theory, the set up of the system is quite straightforward: only the solvent charac-
teristics and optionally the experimental salt concentration need to be matched, then
choosing a random initial configuration of the molecules - in the desired concentra-
tion - would allow the simulation of the process of interest. In reality, to reproduce
the dilution employed in experiments, a considerable volume needs to be simulated to
host enough copies of the peptide to observe the assembly of large enough oligomers.
With this approach, the time scale useful to witness a spontaneous assembly would
greatly exceed the computational time available. For that reason, two main strategies
have been adopted to follow assembly processes: coarse-grained simulations and/or the
use of pre-assembled structures. In the following we give a few examples of these two
strategies. Other routes include the choice of an implicit solvent model [Jusufi, 2013;
Spaeth et al., 2011], or the use of a Monte Carlo sampling which can sometimes be less
time consuming as it does not evolve the system through dynamics, but generates new
configurations at random and accepts the ones energetically favoured [He et al., 2001;
Majumdar et al., 2019; Luo and Robinson, 2015].
Many studies have been performed with the coarse-grained MARTINI force field to
witness assembly of surfactants [Wu and Yang, 2012], polymers [Wang et al., 2012a;
Bochicchio and Pavan, 2017], lipids [Lee and Pastor, 2011; Brocos et al., 2012] or
peptides [Guo et al., 2012; Seo et al., 2012]. Regarding the latter, the assembly in
water of peptide amphiphiles (PAs) into cylindrical fibers has been simulated [Lee
et al., 2012], showing a transition from small micelles to long fibres (Figure 2.6). This
example of minimal PA structures is particularly interesting for the study of AMPs
as well, as it shares with them the amphiphatic character, so that having a general
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Figure 2.6: Process of peptide amphiphiles (PA) fiber formation assessed through
MARTINI simulations. Hydrophobic tails in red, peptides in gray. Reproduced from
Lee et al. [2012].
knowledge on how AMP analogous sequences assemble together would help in tuning
their aggregation properties in water prior to the delivery to the membrane.
The second approach consists in preparing the system in pre-assemble states that
are somewhat suggested by experimental evidences, and further to this using MD sim-
ulations to verify whether the conformations are kept or disrupted, and which one is
the one most energetically favoured. In the work mentioned about peptide amphiphiles
[Lee et al., 2012], pre-assembled fibres have been simulated at the atomistic level, to
confirm the stability of the structures found with a coarse-grained approach.
The same approach has been widely employed also in cases where the final assembly
was hypothesised to have a high degree of order, achievable only with a long sampling
[Gudlur et al., 2012].
Similar procedures have been crucial in elucidating the assembly process of viral
capsids. Capsids are very large systems and the assembly of their protein subunits
is mediated by energy barriers. For these reasons, pre-assembled systems have been
simulated to understand the interaction between the components and thus the first
mechanisms of the assembly. This has been done recurring to ultra coarse-grained or
elastic network models [Grime et al., 2016; Abi Mansour and Ortoleva, 2014] first, and
only in the most recent computational advances to atomistic simulations [Perilla et al.,
2016; Hadden and Perilla, 2018; Abi Mansour and Ortoleva, 2014].
The examples above show how Molecular Dynamics simulations have been employed
for the investigation of many different systems, adapting the resolution, set up and
2.4. MD simulations: successes 80
the techniques related to better query the systems of interest. Such overview suggests
then that simulations would be a suitable tool to investigate the system of interest of
this work, namely the self-assembling antimicrobial peptide capzip. The two aspects
of its behaviour will be studied separately, adopting the necessary approximations and
strategies to make the simulations efficient and to query the related questions at each
time.
The details of the systems simulated and the specific parameters used for each
case can be found in the relative sections of the following chapters, together with an
extensive explanation of the motivation of the choices made.
Chapter 3
Capzip simulations
In Chapter 1 we introduced the molecule capzip and its properties, highlighting the
unknowns of its mechanisms of action. In Chapter 2 we presented a review on Molec-
ular Dynamics simulations, showing their past successes in elucidating the behaviour
of self-assembling and antimicrobial peptides. Now, we employ this technique to un-
derstand better our system of interest. Given the complexity of the unit, and the little
atomistic information available, modelling the assembly of such peptide must proceed
in a stepwise manner.
The first aim is to elucidate which structures it can form in solution and what
interactions are keeping the molecules together. To understand the latter it is important
to retain the highest level of detail possible, and for this reason we resorted to atomistic
simulations first. However, reproducing the natural assembly from a dispersed solution,
as observed in the experiments, has an high computational cost when choosing an
atomistic level of detail. Thus, we simulated increasingly complex pre-assembled blocks,
verifying each time their behaviour in solution and inferring whether they are suitable
to form a stable supramolecular structure. This approach, fully explained in Section
3.1, led to the model of a minimal capsule, which has been subsequently investigated
at coarser levels to explore its behaviour on longer time scales.
This multiscale approach constitutes also an interesting methodological investiga-
tion as, to our knowledge, it compares for the first time the performances of the SIRAH
force field [Machado et al., 2019; Barrera et al., 2019] versus the MARTINI one [Marrink
et al., 2007; Monticelli et al., 2008], without or with polar water [Yesylevskyy et al.,
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2010], at the level of protein description (while for lipids a comparison is included in
Barrera et al. [2019]). Indeed, when choosing a coarse-grained representation, it is cru-
cial to understand how the simulations results deviate from the atomistic counterpart
due to the model, assuming that the atomistic is the most accurate one. This helps
in selecting the appropriate description for the system and the questions that can be
investigated with each coarse-grained force field.
Out of the pre-built capzip structures, a few selected ones were simulated in contact
with model membranes, bacterial and mammalian, to understand the determinants of
their antimicrobial activity. Details on these simulations and the specific techniques
employed to promote the interaction between the peptide and the membrane are given
in Section 3.2.
3.1 Modelling the assembly
Subunits simulations As previously mentioned, the antimicrobial sequence of cap-
zip is designed with opposite charges at its extremes to favour an antiparallel β-sheets
pairing with other copies of itself (Figure 3.1, A-B). MD simulations of two RRWTWE
sequences paired in this fashion (Figure 3.1, B) confirm that the assembly is stabilised
by the interactions between opposite charges (statistics gathered over 16 replicas, each
run for 20 ns). Moreover, backbone hydrogen bonds form between Tryptophan residues
of facing strands, after a shift of the mutual positions of the chains which brings Tryp-
tophans in front of each other (see the scheme in Figure 3.2). Finally, π-stacking
interaction (parallel or T-shaped) between Tryptophan side chains contributes to the
interaction as well, albeit in minor measure (Figure 3.3(a)-(b); details on the computa-
tion are explained in Section 3.3). The T-shaped orientation is favoured with respect to
a parallel stacking, consistently with the fact that the latter produces an unfavourable
repulsion between the planar faces of the rings [Hunter et al., 2001]. Thus, Tryptophan
residues dictate the interdigitation of facing residues in the two chains.
Analogous simulations of two RRWTWE sequences paired in a parallel way show
loosening of the pairing and in some cases the flip of one sequence to rearrange with
respect to the other in the antiparallel manner, confirming that the antiparallel ar-
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Figure 3.1: A. Capzip molecule: formula, with arms in blue characters and central
scaffold (residue RKGB) in black lines; and bonds/surface representation, with surface
color coded by amino acid type (blue positive, green polar, red negative, white hy-
drophobic). B: detail of two arms paired in an antiparallel β-sheet (bond and cartoon
representation, backbone in green and side chain color coded by amino acid type). C:
pentagonal subunit (bonds and cartoon representation, green and yellow for the two
different layers): ten antimicrobial molecules arranged in two stacking pentagons. D:
detail of the double layer of each pentagonal subunit (bonds representation of side
chains is color coded by amino acid type, and backbone in cartoon representation,
green and yellow for the two different layers). E: atomistic structure of the buckyball
bilayer simulated (bonds and cartoon representation of backbone only, green outer
layer, yellow inner layer). [VMD software, Humphrey et al. [1996]]
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Figure 3.2: Presence of backbone hydrogen bonds between two facing antiparallel
RRWTWE chains. The pairs highlighted in blue, green and pink corresponds to three
different chains arrangements, shown in the schemes below the histogram. Bonds are
labelled by amino acid pairs, named as in the schemes and underlined with matching
color; occupancy is averaged over 16 simulations of 20 ns each.
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(a)
(b)
Figure 3.3: Presence of parallel or T-shaped π-stacking between each possible pair
of facing Tryptophan residues in two RRWTWE chains arranged in an antiparallel
β-sheet. For each replica the map gives the fraction of time for which a parallel or
T-shaped π-stacking interaction has been observed (total simulation time 320 ns).
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rangement is favoured.
The hydrophobic interactions between Tryptophan residues (in white in Figure
3.1, B) results in the creation of a hydrophobic patch which includes four of them
on one side of the β-sheet plane. This generates an amphiphilic structure where the
hydrophobic core is segregated from the remaining charged residues distributed around.
The combination of two stacking β-sheets, paired to match their hydrophobic patches,
constitutes an effective supramolecular assemblies to reduce the solvent exposure of
such residues (Figure 3.1, D).
Oligomer simulations This pairing strategy, however, needs to be applied in the
context of assembly of complete molecules, i.e. three arms joined by the central scaffold.
From now on, we will denote the central scaffold as RKGB residue. This was the name
given to the moiety by the ATB server [Malde et al., 2011; Koziara et al., 2014] used to
compute its atomistic parameters (see Section 3.2). The quasi three-fold symmetry of
capzip suggests a regular geometric arrangement; at the same time simulations of a sin-
gle molecule in solution highlight its flexibility, proposing that multiple arrangements
can be accommodated by the molecule. The best examples of geometrically organised
protein structures can be found in viral capsids, which are composed by the regular
repetition of highly symmetric protein subunits. Inspired by this, we tested whether a
geometrical organisation can represent a stable capsule, choosing as minimal represen-
tative geometry a truncated icosahedron (buckyball, Figure 3.1, E). This shape has 12
pentagonal faces and 20 hexagonal ones.
Preliminary atomistic simulations (100 ns) were run on a pentagonal subunit (Fig-
ure 3.1, C), where ten antimicrobial molecules are arranged in two stacking pentagons.
Capzip arms are paired in antiparallel β-sheets to form each pentagon, and the two of
them are facing with their Tryptophan residues in contact (Figure 3.1, D). The simula-
tions proved the cohesion between molecules belonging to the subunit. Specifically, the
number of contacts between backbone Cαs augmented slightly in the first 20 ns (Figure
3.4(a)), due to the compaction of the unpaired external arms toward the core of the
structure (see Supplementary Figure 3.40), which made the Coulomb energy decrease.
Moreover, for each pair of facing chains (see definition in Figure 3.4(b)), we computed
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(a) (b)
Figure 3.4: (a) Number of backbone contacts during a simulation of a pentagonal
subunit. (b) Variability of the inter chain average distance between the 30 facing
chains in the pentagon. The 30 pairs defined as facing are the chains belonging to the
same β-sheet (5 for each of the two stacking pentagons), and for each stacking β-sheet
the 4 possible inter-pentagon (inter-layer) pairs of chains.
the distance between their centres of mass. Figure 3.4(b) reports the variance of these
distances normalised by their average value, as a measure of the cohesion of the sub-
unit, showing that in the majority of the cases less than 2% of variability is observed.
Overall, the block is not rigid, and does indeed deform and go back to the pentagonal
shape multiple times in the simulation, but it is keeping the original pairing of the
molecules.
Capsule simulations The pentagonal subunit respects the building principles of β-
sheet pairing between antimicrobial sequences. Moreover, the double layer structure
allows to partially screen the hydrophobic residues from the solvent, as they are in
favourable contact with each other (Figure 3.1, D). Twelve of these units can be used
to build a truncated icosahedron (Figure 3.1, E): they constitutes its pentagonal faces,
while the hexagonal ones are formed when the arms extending from the pentagons join
together.
Each capzip molecule is centred in one vertex of the polygon, with the arms laying
alongside the edges departing from it. On each edge two arms coming from opposite
sides meet in an antiparallel fashion. The full truncated icosahedron (Figure 3.1, E)
has two concentric layers, for a total of 120 molecules, and initial radius of 7.7 nm.
Thus it will be called buckyball bilayer in the following. As anticipated, this geometry
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represents a minimal model of the possible structures capzip adopts in solution.
The structure was simulated at atomistic and coarse-grained levels, respectively
with the GROMOS 53A6 [Oostenbrink et al., 2004], SIRAH [Machado et al., 2019] and
MARTINI [Marrink et al., 2007; Monticelli et al., 2008] force fields (with both standard
and polar water [Yesylevskyy et al., 2010]). From the final configurations of the MAR-
TINI coarse-grained model (standard water), atomistic coordinates were obtained and
simulated, to be compared with the original atomistic dynamics. Moreover, additional
simulations were run at all the coarse-grained levels on a buckyball monolayer (i.e. built
from pentagonal subunits made by one pentagon only), to prove whether the bilayer is
more energetically favoured.
Finally, a test study on self-assembly was performed with one of the coarse-grained
representations (MARTINI with standard water), starting from capzip molecules ran-
domly placed in solution.
Capzip-membrane simulations A multiscale analysis is needed also to investi-
gate the antimicrobial activity. Being highly costly to simulate the buckyball bilayer
on a membrane at the atomistic level, the pentagonal subunit employed to build the
complete structure (Figure 3.1, C) was taken as representative of the latter. It was
simulated parallel to the membrane plane, with its center of mass at 1.5 nm from the
phosphate plane (Figure 3.5(a)), to avoid spending time in sampling conformations
with the peptide far from the membrane. This, together with a tailored use of an
applied electric field (see Section 3.2), speeds up simulations considerably. To observe
the natural binding of the peptide to the membrane, the process of the buckyball bi-
layer approaching a model membrane was simulated with a MARTINI coarse-grained
description (Figure 3.5(b)). The use of the MARTINI polar water [Yesylevskyy et al.,
2010] allowed for the introduction of an external electric field, to compare the coarse-
grained simulations with the atomistic ones which employ analogous conditions.
Two membrane compositions were simulated for both resolutions, a model bacte-
rial and a model mammalian membrane, to identify the different interactions with the
peptide. The first one presents 25% of anionic lipids (DLPG), and the remaining zwit-
terionic (DLPC), while the second has only DLPC lipids. The choice of the bacterial
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(a) (b)
Figure 3.5: (a) Atomistic structure of a pentagonal subunit on a 740-lipid bacterial
model membrane of composition DLPC/DLPG 3:1 (initial configuration). Peptide
backbone in line and cartoon representation; lipids in cyan lines (DLPC) and blue
ones (DLPC), all lipids phosphate in golden van der Waals beads. (b) coarse-grained
(MARTINI) representation of the buckyball bilayer on a 2880 lipids bacterial model
membrane (final configuration of the trajectory). Protein in bonds representation:
green outer buckyball layer, yellow inner one. Lipids in line representation, coloured
by bead type, and lipids phosphate in golden van der Waals beads. [VMD software
Humphrey et al. [1996]]
model was dictated by the experiments performed on capzip [Castelletto et al., 2016],
and the mammalian one was built with the same zwitterionic lipid as for the bacterial
to simplify the comparison, e.g. to have membranes with comparable thickness and
mechanical properties.
3.2 Simulations details
All simulations were performed with the GROMACS software, version 5.5 and 2016
[Berendsen et al., 1995; Abraham et al., 2015, 2018].
3.2.1 Atomistic simulations
Simulations in solution The atomistic coordinates for the peptidic supramolecular
assemblies described in Section 3.1 (Figure 3.1, E) were built combining GROMACS
tools and the MOE software [Chemical Computing Group ULC, 2018]. Simulations
were run with the GROMOS 53A6 force field [Oostenbrink et al., 2004]. Parameters
for the central residue connected with the peptidic chains were computed with the
ATB server [Malde et al., 2011; Koziara et al., 2014]; the ones for the bonds joining
this residue to the antimicrobial side chains were derived from the values tabulated in
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the force field for analogous ones. A python module has been designed to manipulate
GROMACS topology objects for the GROMOS force field and add peptide bonds at
the location required (see Appendix A.3 for details). This is useful for multibranched
peptides which are not supported by the standard GROMACS tools, and for which a
manual implementation would be otherwise needed.
The systems were solvated with single point charge (SPC) water [Berendsen et al.,
1981] and counter ions were added (Na+ or Cl−); further ions were introduced to
reach the concentration of 150 mM, to reproduce the experimental conditions. For
simulations of a single β-sheets, or of the pentagonal subunit in solution, the systems
were energy minimised with a steepest descent algorithm, then equilibrated in the NVT
ensemble with decreasing positional restraints at increasing temperatures (100 K, 200
K, 250 K, 300 K and respectively 1000, 1000, 500, 250 kJ/mol·nm2 restraints, 100 ps
each); then in the NPT ensemble, without restraints, at the same temperatures steps
and for the same time. Production followed for 100 ns.
For the buckyball bilayer structure the above equilibration was insufficient. Due
to the construction procedure, two thirds of the arms are not properly paired along
the edges, and with a short equilibration they drift away from each other within a
few nanoseconds. Therefore, after an NVT equilibration as above, strong flat-bottom
restrains (1000 kJ/mol·nm2) were placed between the center of mass of imperfectly
aligned arms throughout the NPT heating, to penalise their mutual separation with
respect to their initial distance (100 ps runs at 100 K, 200 K and 250 K and 35 ns at
300 K). This was followed by a series of 10 ns runs at 300 K with decreasing flat-bottom
restraints (750, 500 and 250 kJ/mol·nm2) and by a free production run (100 ns). Three
different replicas were run, generated from the final configuration of the 300 K NPT
run with 1000 kJ/mol·nm2 restraints.
Throughout all the simulations, the temperature was maintained by independently
coupling the protein and the solvent (plus ions) to two external temperature baths using
a velocity rescale thermostat [Bussi et al., 2007] with coupling constant τT of 0.1 ps. The
pressure was kept at 1 bar by Berendsen [Berendsen et al., 1984] or Parrinello-Rahman
barostat [Parrinello and Rahman, 1981] (for the equilibration phases and the production
run respectively) using an isotropic coupling, with isothermal compressibility of 4.5 ×
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10−5 bar−1 and coupling constant τP of 1 ps. Electrostatic interactions were treated
using the smooth Particle Mesh Ewald (PME) algorithm [Essmann et al., 1995] with a
Fourier grid spacing of 0.12 nm, and a short-range cutoff of 0.9 nm. The van der Waals
interactions were treated with a plain 0.9 nm cutoff. All atomistic runs were performed
using a 2 fs time step. An overview of the simulations of peptide assemblies in solution
is given in Table 3.1.
Simulation with membranes The atomistic coordinates for the bacterial mem-
brane bilayer were built with the PACKMOL software [Mart́ınez et al., 2009], from
pdb files of a single DLPC [Poger et al., 2010] and DLPG [Kukol, 2009] molecule.
Two bilayers were built, made respectively of 512 and 740 lipids, with composition
DLPC/DLPG (3:1). The initial area per lipid was set to 0.70 nm2, above the values
found experimentally for either lipid species (0.608(12) nm2 for DLPC [Kučerka et al.,
2011] and 0.656(12) nm2 for DLPG [Pan et al., 2012]). An area per lipid compatible
(equal within the error) with the experimental values was reached during a 400 ns equi-
libration (see details below), the final configuration of which was used for simulations
with the peptide. Given the analysis performed on the bacterial bilayer (see Section
3.5.1), for DLPC we opted for simulating a large membrane only. Accordingly, we
produced a bilayer with 748 lipids and initial area per lipid of 0.68 nm2.
For membrane-peptide atomistic simulations, the initial configuration was generated
from the equilibrated bilayer and the equilibrated pentagonal subunit (after 100 ns
run with positional restraints on the Cα), placing the subunit plane parallel to the
membrane and close to it (Figure 3.5(a)). The inflategro script [Kandt et al., 2007] was
used to solve the partial overlap of peptide side chains with lipid molecules, removing
the overlapping lipids if necessary. The two bilayers fit the pentagonal subunit with
respectively 3.5 nm and 5.4 nm distance between its periodic boundary images (along
both x and y).
For simulations involving membranes, the version 54A7 of the GROMOS force field
[Schmid et al., 2011] was initially chosen and it is thus used for simulations of the
512-lipid bilayers, but, upon further research, version 54A8 [Oostenbrink et al., 2005;
Reif et al., 2013] was deemed more suitable and thus selected for the runs on the larger
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membranes. Lipid parameters were taken from [Poger et al., 2010] for DLPC, while
for DLPG they were built from the ones available in the literature for POPG [Kukol,
2009].
The simulations set-up is as above, except for the use of three thermal coupling
groups (peptide, membrane, water plus ions), a semi-isotropic pressure coupling, and
a larger cut off radius for both Coulomb and van der Waals interactions (1.2 nm).
Additionally, for the 512-lipid membrane, a Reaction Field [Tironi et al., 1995] was
used instead of PME long range electrostatic treatment (with cut off radius 1.4 nm),
inherited from the setup of the simulations used for lipids parametrisation. This was
changed to PME when simulating the larger membrane, to be more consistent with the
protein parametrisation. Control simulations on membrane bilayers without peptide
showed that the results in terms of area per lipid are compatible with the ones obtained
using PME.
Each membrane bilayer was first equilibrated for 50 ps in NPT conditions at 50
K, then the temperature was gradually increased up to 300 K in 500 ps, and finally a
400 ns production was run. A similar equilibration procedure was followed for peptide-
membrane systems.
Additional simulations were performed applying an external electric field to the
membrane, pointing from the side hosting the peptide to the opposite one, to mimic the
membrane potential and verify how the peptide affects the response to external stimuli.
In a first run the field was increased by 20 mV/nm steps every 200 ns (or 10 mV/ns
when reaching the critical value), until poration was induced (at 130 mV/nm). Another
simulation was performed for both the 512 and 740-lipid bilayers with the peptide,
with the threshold field of 130 mV/nm, starting from the unperturbed membrane
configuration (three replicas each). As a control, analogous test simulations were run
on the 512-lipid bacterial bilayer without the peptide, assessing the electroporation
threshold at the higher value of 140 mV/nm.
To be noticed that the field across the bacterial inner membrane can be estimated
to be around 35 mV/nm, and across the mammalian one around 20 mV/nm (an esti-
mate computed from, respectively, a -130/-150 mV and -70/-90 mV potential [Yeaman
and Yount, 2003; Wilson et al., 2011] and an estimate membrane thickness of 4 nm).
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However, previous computational work often explored the effects of higher fields, up to
500 mV/nm [Tieleman, 2004; Böckmann et al., 2008; Piggot et al., 2011], to witness
poration within the simulations time, according to the resources available.
An overview of the simulations of peptide-membrane systems is given as well in
Figure 3.1 (control simulations on pure membrane are listed in SI Table 3.8).
3.2.2 SIRAH coarse-grained simulations
SIRAH coarse-grained simulations were run with the SIRAH force field, version 2.0
[Machado et al., 2019]. Peptide coordinates for the buckyball geometry were obtained
from the atomistic ones using the converter distributed with force field, with a cus-
tomised mapping for the central residue. Parameters for the central residue were built
from comparison with similar chemical moieties. All simulations were run adding Cl−
counter ions to balance the positive charges of the peptide and additional Na+ and Cl−
ones to reach a 150 mM concentration.
While for simulations of the peptide buckyball in solution our multiscale procedure
includes SIRAH, for simulations on membranes we focussed on atomistic and MARTINI
simulations only. This has been performed in the interest of time, and due to technical
difficulties in preliminary SIRAH runs with membranes (in particular in tuning the
pressure coupling). This is likely due to a suboptimal equilibration procedure; indeed,
there are few benchmarks on SIRAH for lipids so far [Barrera et al., 2019], and none
for systems as large as the one studied here.
For SIRAH simulations, the temperature coupling was performed with a velocity
rescale thermostat [Bussi et al., 2007] and coupling constant τT of 0.1 ps, and the
pressure coupling at 1 bar pressure, with 4.5 × 10−5 bar−1 isothermal compressibility,
using a Parrinello-Rahman barostat [Parrinello and Rahman, 1981] with a τP of 6 ps.
Electrostatic interactions were treated using the PME algorithm [Essmann et al., 1995],
with a short-range cutoff of 1.2 nm and relative dielectric constant of 1. The van der
Waals interactions are treated with a 1.2 nm cutoff and no long range corrections.
After energy minimization, a 4 ns NVT equilibration was run at 300 K, followed
by a 10 ns NPT run, both with positional restraints (1000 kJ/mol·nm2) on the solute.
Two 10 ns run (NPT ensemble, 300 K) were then performed with backbone restraints of
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1000 and 100 kJ/mol·nm2, respectively. Similar to the procedure adopted for atomistic
simulations, flat bottom positional restraints (1000 kJ/mol·nm2) were enforced on the
unpaired arms during the latter. After this, three additional 10 ns equilibrations were
run at 300 K, with no backbone restraints and decreasing flat bottom ones (respectively
750, 500 and 250 kJ/mol·nm2). Finally the production run was carried on for 1 µs. All
runs were performed with a 20 fs time step.
3.2.3 MARTINI coarse-grained simulations
For MARTINI [Marrink et al., 2007; Monticelli et al., 2008] coarse-grained simulations,
peptide coordinates were obtained from the atomistic ones using martinize.py [de Jong
et al., 2013] with a customised mapping for the central residue. Parameters were
obtained with the same script for the arms, while pycgtool.py [Graham et al., 2017]
was used for the central residue. Parameters for the joining bonds were derived from
tabulated values of analogous ones.
Initial coordinates for the self-assembly simulations were obtained with GROMACS
tools, placing the desired amount of coarse-grained molecules in the simulation box
with random positions. The side of the cubic box was chosen as 44 nm, and three
different peptide concentrations were simulated: 1.25 mM (60 molecules), 2.50 mM
(120 molecules) and 10 mM (480 molecules), all for 10 µs.
The bacterial and mammalian model membranes, hosting 2880 lipids each, were
built with insane.py [Wassenaar et al., 2015], with composition DLPC/DLPG (3:1)
and pure DLPC respectively. The simulations parameters used for lipids are consistent
with Marrink et al. [2004]. The peptide-membrane systems were built placing the
buckyball at a minimum distance of 1 nm from the membrane surface.
For all standard MARTINI simulations, counter ions only were added, while for the
ones run with Polar MARTINI, additional Na+ and Cl− were inserted to reach a 150
mM concentration.
For simulations with the standard water model, the temperature coupling was per-
formed with a velocity rescale thermostat [Bussi et al., 2007] with a coupling constant
τT of 1 ps. An isotropic or semi-isotropic pressure coupling was applied (simulations of
peptide in solution and peptide on membrane respectively) at 1 bar pressure, with 4.6
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× 10−5 bar−1 isothermal compressibility, using a Berendsen [Berendsen et al., 1984] or
Parrinello-Rahman barostat [Parrinello and Rahman, 1981] (equilibration and produc-
tion phase respectively) with τP of 2 ps or 12 ps. Coulomb interactions were treated
with a Reaction Field scheme [Tironi et al., 1995] and cut off radius of 1.1 nm, van
der Waals interactions with a cut off scheme and the same cut off radius. The relative
dielectric constant is set to 15. Simulations performed with the polar water model were
run with the parameters above, except the relative dielectric constant set to 2.5, and
the choice of a PME scheme for the long range Coulomb interaction (1.2 nm cut off
radius). The choice of the respective dielectric constant and electrostatic treatment is
in agreement with the optimal setup found in the parametrisation publications of the
respective water models.
For simulations of the capsule in solution, for both water models, after energy
minimization, four 10 ns equilibration runs (NPT ensemble, 300 K, 10 fs time step) were
performed with flat bottom positional restraints on the unpaired arms (respectively at
1000, 750, 500 and 250 kJ/mol·nm2) - as done for the other force fields. Finally the
production run was carried on for 1 µs. All runs were performed with a 20 fs time step.
It is interesting to notice that the MARTINI force field with the standard water
model produced very similar results with or without such refined equilibration pro-
cedure, as confirmed by simulations of the buckyball run after a short unrestrained
equilibration only (500 ps, 1 fs timestep). However, we choose to follow the same pro-
cedure as for the other force fields to have more consistent results, and be certain that
the differences observed are due only to the parametrisation an not to the equilibration
procedure.
From the final configurations of two out of the three standard MARTINI replicas,
atomistic coordinates were obtained using the MARTINI backward tool (version 5)
[Wassenaar et al., 2014] and run for additional 200 ns with the set up used for atomistic
simulations.
The equilibration for the self-assembly simulations (run only with the standard
MARTINI model) included only an energy minimization, followed by a 1 ns equilibra-
tion with the Berendsen barostat, before switching to Parrinello-Rahman for the 10 µs
production.
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The membranes used in MARTINI simulations are equilibrated for 1 µs with stan-
dard water and the final configuration is used to build the peptide-membrane systems,
together with the capsule structure (obtained after the equilibration runs). The full
system is energy minimised, equilibrated for 500 ps and production is followed for 10
µs for simulations with the standard water, and 500 ns with polar water (due to the
faster binding and the speed up granted by the electric field).
The adoption of polar water allows to perform electroporation experiments also with
the MARTINI force field (while the standard water, not bearing a dipole, is unable to
screen the externally applied electric field, resulting in unphysical effects). We thus
resorted to a procedure similar to the one employed for atomistic simulations, testing
an external electric field of magnitude 20 mV/nm and 40 mV/nm, without proceeding
further as the latter gave poration in presence of the peptide. It is possible that longer
simulations would allow to observe this behaviour even with lower values of the force
field, however, in the interest of time, we selected these two for further investigation.
We selected a configuration from the early stages of poration (at 40 mV/nm), where
the pore showed a diameter of 2 nm, and prolonged the simulation switching to isotropic
pressure coupling. This allows the pore to expand in a controlled manner. Indeed, in
a semi-isotropic pressure coupling scenario, the pressure in the z direction suddenly
decreases when a pore forms, as water can pass through the membrane. This is also
the direction of the applied electric field. The barostat algorithm reacts decreasing
the z side of the box, in an effort to restore the target pressure in this direction, but
to accommodate all the molecules the box must necessarily expand in the x and y
directions in an excessive way.
Control simulations with the two values of the electric field mentioned were per-
formed on the membrane alone. The same procedure, i.e. simulations with capsule and
electric field plus control simulations on the membrane only was applied to the pure
DLPC membrane as well (except for the additional simulation after poration, as this
is not observed for the DLPC membrane).
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Table of simulations of capzip assemblies
Peptides Lipids Box (nm) C (mM) E (mV/nm) Time (ns) Rep.
United atom GROMOS (GR)
β-sheet – 4 0 – 20 16a
PS (10) – 12 0 – 100 1a
BB (120) – 22 150 – 100 3a
BB-back (120) – 22 150 – 200 2a
PS (10) 512 (b) 12 150 – 500 2b
PS (10) 740 (b) 14 150 – 500 1c
PS (10) 740 (m) 14 150 – 500 1c
PS (10) 512 (b) 12 150 130 75P , 20P , 71P 3b
PS (10) 740 (b) 14 150 130 60P , 50P , 70P 3c
PS (10) 740 (m) 14 150 130 20P , 28P , 39P 3c
Coarse-grained SIRAH (SI)
BB (120) – 22 150 – 1000 3
BM (60) – 22 150 – 1000 2
Coarse-grained Polar MARTINI (MA P)
BB (120) – 22 150 – 1000 2
BM (60) – 22 150 – 1000 2
BB (120) 2880 (b) 30 150 – 10000 1
BB (120) 2880 (b) 30 150 20 500 1
BB (120) 2880 (b) 30 150 40 168P 1
BB (120) 2880 (m) 30 150 – 10000 1
BB (120) 2888 (m) 30 150 20 500 1
BB (120) 2888 (m) 30 150 40 500 1
Coarse-grained MARTINI (MA)
BB (120) – 22 150 – 1000 3
BM (60) – 22 150 – 1000 1
Random (60) – 22 0 – 10000 1
Random (120) – 22 0 – 10000 1
Random (480) – 22 0 – 10000 1
BB (120) 2880 (b) 30 0 – 10000 2
BB (120) 2880 (m) 30 0 – 10000 1
Table 3.1: Table of simulations of capzip assembly in water and on membranes. Pep-
tides: PS - pentagonal subunit; BB - buckyball bilayer; BB-back - buckyball bilayer
backmapped; BM - buckyball monolayer; Random - random initial configuration. In
parenthesis, the number of capzip molecules. Lipids: number of lipids and model,
with (b) - bacterial model (DLPC/DLPG 3:1), (m) - mammalian model (DLPC).
Rep: number of replicas. Force field indicated in bold headers: GR - united atom
GROMOS (a version 53A6 [Oostenbrink et al., 2004], b 54a7 [Schmid et al., 2011],
c 54a8 [Reif et al., 2012]), SI - coarse-grained SIRAH [Machado et al., 2019], MA -
coarse-grained MARTINI [Marrink et al., 2007; Monticelli et al., 2008], MA P - coarse-
grained MARTINI with polar water [Yesylevskyy et al., 2010]. Superscript P in the
time length denotes observation of poration. For electroporation simulations on pure
membranes, see Supplementary Table 3.8.
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3.3 Analysis
All the analysis was performed combining tools from GROMACS [Berendsen et al.,
1995; Abraham et al., 2015, 2018], MDAnalysis [Michaud-Agrawal et al., 2011; Gowers
et al., 2016] and packages developed for the purpose (see A.3).
In Section 3.1 we presented an evaluation of the occurrence of π-stacking between
Tryptophan residues in the β-sheet simulations. The computation was performed as
follow: for each pair of Trp residues, we computed the minimum distance between the
centre of mass of their side chains benzene rings (in function of time), as well as the angle
formed by their two planes. We consider as candidates for an aromatic interaction rings
which were between 0.45 and 0.7 nm of distance, accordingly to the classical definition
[Burley and Petsko, 1986] and what found generally in crystal structures [Anjana et al.,
2012]. Then, we defined a parallel π-stacking if the angle between the ring was smaller
than 45◦, and a T-shaped (perpendicular) one if the angle fell between 80◦ and 100◦
(as observed in the majority of T-shaped stacking in crystal structures) [Anjana et al.,
2012]. Occupancy was found normalising the number of frames in which the interaction
appeared by the number of frames considered for the analysis (2000 × 16, 1 ever 100
ps).
For the β-sheet simulations and whenever in the following we mention hydrogen
bond computations, this was performed using the default set up of GROMACS. With
such setup, a donor atom (with a polar hydrogen bonded to it) and an acceptor one
are classified as interacting through hydrogen bond if the donor-acceptor distance is
smaller than 0.35 nm and the hydrogen-donor-acceptor angle is smaller than 30◦.
3.3.1 Simulations in solution
Several analysis on the structure and chemico-physical properties of the simulated
buckyball bilayer in solution were performed.
• The Radius of gyration (Rg), and Root Mean Square Deviation with respect to
the initial configuration (RMSD) were computed (GROMACS).
• To get the average distribution of the mass of the capsule around its center, the
Radial Distribution Function (RDF) of protein masses around their center of mass
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was computed (GROMACS), considering only the second half of the trajectory.
The profile was fitted with a Gaussian function (R software [R Core Team, 2015]):
the position of its maximum can be taken as the average radius of the capsule,
and its Full Width at Half Maximum (FWHM) as an estimate of the capsule wall
thickness.
• The dynamical character of the structure was assessed computing the correlation
of motion between molecules (GROMACS). The central atom (or bead) from
which the arms depart was taken as reference. For all the pairs (i, j) of such
reference positions, the covariance of motion was computed along each direction.
The total covariance was obtained as: σ2(i, j) = σ2x(i, j) + σ
2
y(i, j) + σ
2
z(i, j).
Finally the measure was normalised to obtain the correlation:
corr(i, j) =
σ2(i, j)√
σ2(i, i) · σ2(j, j)
. (3.1)
• The pairing of the arms was quantified as follow. Two arms are defined as paired
if their center of mass is closer than a cut off distance of 1.2 nm (GROMACS and
R postprocessing). This simple measure discards more precise information on the
orientation of the chains with respect to each other, and aims at checking whether
the network of molecules present in an ideal buckyball structure is maintained.
In the ideal buckyball, contacts within the same layer sum up to 90 for each layer
(and so 180 in a bilayer). This measure can be easily applied to any description
(atomistic or coarse-grained) without disagreement in the interpretation. Given
the loose character of the measure, we considered only the pairings surviving
more than 90% of the simulation time.
• To characterise the chemical determinants that promote the assembly, we in-
vestigated the interactions between amino acids of different types, computing
the number of contacts between backbone and side chains of single amino acids
(function implemented in MDAnalysis, see Appendix A.3). We filtered for the
ones present at least 50% of the simulation time, and remove the ones between
residues in the same arm, finally we classified them by amino acid type. Backbone
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contacts are computed considering Cαs of residues (or the corresponding coarse-
grained bead); side chains ones using selected reference atoms/beads (respectively
for GROMOS, SIRAH and MARTINI: CZ/BCZ/SC2 for Arg, CZ2/BNE/SC4 for
Trp, OG1/BPG/SC1 for Thr and CD/BCD/SC1 for Glu); finally mixed ones if
the proximity is between a Cα and the side chain reference position. The distance
threshold is set to 0.6 nm.
• For atomistic simulations, the inter molecular hydrogen bonds between amino
acids have been computed (as explained previously with GROMACS) and grouped
by amino acid type, and by region of occurrence (e.g. between two backbones,
side chains or connecting a backbone atom and a side chain one).
• The Solvent Accessible Surface Area was computed for each amino acid (GRO-
MACS). Its value was averaged in time and over all the residues at the same
position in the capzip sequence. For atomistic runs, it was also normalised over
the reference value for the corresponding residue type X, obtained as the theo-
retical measure of its SASA in a Gly-X-Gly tripeptide [Tien et al., 2013]. The
resulting QSASA takes into account the size of the side chain, giving a measure
of exposure which can be compared between different amino acids. This normal-
isation is however inappropriate for coarse-grained models, due to the differences
between the atomistic SASA obtained in experiments and the beads employed in
the simulations, so that only the absolute SASA values are given.
• Finally, the contribution to the total energy of the system deriving from Coulomb
and Lennard-Jones interactions were compute (GROMACS), breaking them into
interactions between protein components and between protein and solvent.
3.3.2 Simulations on a membrane
Many properties can be extracted from a membrane simulation. We report here the
ones selected for analysing the simulations including membranes and capzip, while
Chapter 4 gives an extensive overview of more of them, reiterating and expanding the
description of the ones listed below.
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• We monitored the area per lipid (ApL), i.e. the average space available to each
lipid on the (local) membrane plane. In the case of approximately flat membranes
aligned to the xy plane, this can be assessed from the product of the lateral
dimensions of the simulation box divided by the number of lipids in one leaflet.
For highly curved membranes, as the ones obtained under the effect of a strong
electric field, this measure does not reflect the true spacing between lipids. In that
case the true ApL was computed through the algorithm developed by Braun et al.
[2011]: this first identifies the undulating reference surface of the membrane u(r)
fitting a Fourier series to a set of reference positions (one atom per lipid, presently
the Phosphorus atom or the Phosphate bead for coarse-grained simulations), then












where the gradient ∇u(r) is zero for a perfectly flat surface.
• For atomistic simulations, the deuterium order parameters SCD of the acyl chains
is a good measure of their relative orientation and whether the chains adopt for
it a narrow range of values [Van Lehn and Alexander-Katz, 2014; Douliez et al.,
1998; Piggot et al., 2017]. The orientation θ with respect to the outward leaflet
normal is computed for each carbon-hydrogen bond in a given position i along





〈3 cos2 θi − 1〉. (3.3)
As the GROMOS force field employs a united-atom representation, the tetrahe-
dral positions of the hydrogens are constructed based on the neighbouring carbons
positions.
• Another measure of the regular packing of lipids in the xy plane (parallel to the
membrane surface) is given by the hexagonal order parameter S6 [Uppulury et al.,
2015], usually employed to quantify the transition to a gel phase. Specifically, each










Figure 3.6: Scheme of S6 computation: in black the reference chain i, in red the chains
belonging to the neighbouring chains set {n}; r was chosen as 0.65 nm.
average x and y position of its carbon atoms. For each chain j the neighbouring
chains {n} were identified as the ones within a 0.65 nm radius from j (Figure









with θjk the angle between the vector connecting j and k, and the x axis (and i
the imaginary unit). A chain is in gel phase if it has an hexagonal order parameter
larger than 0.72 [Uppulury et al., 2015].
• To evaluate the mobility of lipids on the membrane plane, for each simulation
we extracted the trajectory of the phosphorus atom of every lipid, removing
the jumps derived from the periodic boundary conditions treatment, to have a
continuous evolution of the positions. The resulting trajectory must be centred
to remove the drift of the whole system, and this can be achieved in two ways:
either considering the two leaflets separately and centring each of them within the
simulation box at each time frame (LCOM procedure) or considering the bilayer as
a unique object and translating its center of mass at the origin of the simulation
box for each time frame (BCOM procedure). Figure 3.7 illustrates the procedures
in two cases, showing how they differ if a leaflet translates with respect to the
other one.
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The MSD of each lipid in one leaflet was computed as a function of time: for a
lipid i and a given time t, the displacement r2i (tstart + t) was computed for all
tstart such that (tstart + t) is within the simulated time. The average over the
start times and over the lipids (belonging to the same specie and leaflet) gave the
MSD(t):
MSD(t) = 〈〈r2i (tstart + t)〉start〉i. (3.5)
This computation was performed discarding the first part of the trajectory, the
exact amount of which depends on the system, and it was chosen monitoring the
area per lipid. The diffusion coefficient D was obtained from a linear fit of the
MSD(t), following Einstein equation in two dimensions [Einstein and Fürt, 1956]:
〈r2〉 = 4Dt. (3.6)
The fit was performed in the regions which showed a linear dependence. This
implied discarding the first interval of the profile, where the behaviour is not
linear, and the last one, where the poorer statistics leads to more noisy data. We
choose 50 ns for both of them for atomistic simulations and 100 ns for MARTINI
ones. This was done for each simulation condition of the respective resolution.
As a final step, the D values from the two leaflets are averaged.
As a short hand notation, we will call the D coefficient obtained from a LCOM
removal as pure diffusion, while the one obtained from a BCOM removal as global
diffusion. The former measures the pure random movement of a lipid with respect
to its neighbours, the latter is influenced by possible collective movements of one
leaflet with respect to the other.
For atomistic simulations of the protein on the membrane, further analysis included
the following:
• we analysed the network of hydrogen bonds between the protein and lipids, clas-
sifying the interactions by the protein residue type and the lipid species (or lipid
moiety) between which they occur. Hydrogen bonds are evaluated as described
previously;
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Figure 3.7: Scheme of two different procedures for centring a trajectory of a lipid
bilayer: from the Original configuration, coordinates are translated to remove either
the bilayer or each leaflet movement. The collection of final frames, one for each time
step, gives the trajectory used to compute the MSD of lipids and thus diffusion.
• for selected simulations the aforementioned diffusion constant was computed se-
lectively on the lipids which, at the initial time, were within a threshold distance
from the protein or, conversely, further away from it. In this case, the trajectory
was centred with respect to the peptide centre of mass, to understand how lipids
move with respect to it;
• the insertion depth of each amino acid in the membrane was calculated as the
difference between the z position of the lowest atom of the amino acid and the
average of the maximum z coordinate of the five lipids closest to it. This allows
to take into account undulations of the membrane by considering the local z
coordinate. As for an optimally packed membrane in gel phase each lipids has 6
neighbours, the value of 5 reflects approximately the number of first neighbours
in a bilayer in fluid phase.
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Figure 3.8: Final configuration from an atomistic simulation of a buckyball in solution
(100 ns, Replica 1): bonds and cartoon representation, backbone only, green external
layer and yellow internal one. [VMD software Humphrey et al. [1996]]
3.4 Results: capsule in solution
We list here the results for simulations of the capsule in solution: starting from the
atomistic simulations, we then proceed to compare them with different coarse-grained
models. However, when applicable, the plots present the results from all the parametri-
sations at once, anticipating the discussion of Section 3.4.2, as this makes the compar-
ison easier. In all the plots of the section, atomistic results are color coded in violet, as
opposed to yellow (SIRAH), cyan (standard MARTINI) and dark green (Polar MAR-
TINI). Results are shown for Replica 1, unless otherwise specified. The analogous
results for Replica 2 are shown in the Supplementary Material (Section 3.7, Figures
3.31-3.39). Supplementary Movies SI M1, SI M2 and SI M3 show GROMOS, SIRAH
and Polar MARTINI runs (Replica 1); for the two coarse-grained force fields simulations
of the monolayer are displayed as well (see Section 3.4.3).
3.4.1 Atomistic simulations
Global capsule structure Atomistic simulations of the buckyball in solution show a
consistently equilibrated structure across the three replicas run (Figure 3.8 and SI movie
1). This is proven by both the stable value of the protein Rg and the almost plateauing
backbone RMSD (Figure 3.9(a) and (b)). It is interesting to notice that previous
simulations performed with a shorter equilibration, without the phase of employing
flat bottom restraints, lead to the immediate disruption of several connections in the
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(a) (b)
(c)
Figure 3.9: (a) Rg and (b) RMSD computed on the Protein backbone. Results are
displayed for simulations performed in GROMOS (100 ns), SIRAH, MARTINI and
MARTINI with polar water (all 1 µs). Inset: zoom on the GROMOS values. (c)
RDF of Protein masses around their center of mass, displayed for the same simulation
set up as in (a,b). For each label of the legend, the bar has length of the respective
FWHM of the Gaussian function fitting the data (thickness estimate). All results are
showed for Replica 1 of each simulation set-up.
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Figure 3.10: Distribution of the correlation of motion between different molecules in
the buckyball simulations. Black band: median of the distribution; box: first and
third quartiles; whiskers: maximum and minimum, outliers excluded (hollow dots).
Results are shown for Replica 1 of each simulation set-up.
buckyball network, resulting in larger Rg. This suggests that the structural pairing
present in the buckyball can form only when the chains are in close contact. This
is compatible with the long time of assembly observed experimentally (up to 7-10
hours): the closer the chains need to be to trigger the assembly, the rarer this event is
statistically happening. Also, this implicitly proves that the self-assembly simulations
starting from disordered states will not lead easily to such ordered configurations.
The RDF of the protein masses around the buckyball centre shows no masses nearby
the origin (Figure 3.9(c)) and this means that the buckyball remains hollow (given the
way RDF is computed and normalised, a uniformly full object would display a flat
distribution). A fit of the RDF to a Gaussian curve returns a mean value of 5.1 nm
and a FWHM of 2.2 nm, which gives an estimate of the bilayer thickness. A similar
computation is repeated for the inner and outer layer separately, providing 1.1 nm
of distance between the means of the two distributions. This interlayer distance is
compatible with the one between the backbones of stacking β-sheet in structures like
densely packed amyloids (1.0 nm [Sunde et al., 1997]).
This thickness value hints at the fact that the two layers are closely packed. This is
confirmed by the analysis of the pairwise correlations of motion: molecules at the same
polar coordinates (i.e. stacking radially one on the other) have a positive correlation
and so move coherently, while the ones at opposite poles, as well as the ensemble of all
possible pairs, do not show particular correlation (Figure 3.10).
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Figure 3.11: Number of paired arms within the same layer and between layers. Cut
off distance between arms center of mass equal to 1.2 nm. Only contacts existing more
than 90% of the simulation time are counted. Results are shown for Replica 1 of each
simulation set-up.
Contacts between arms The measure of how many arms in the buckyball network
remain paired for more than 90% of the simulation time is shown in Figure 3.11.
An average of 160 pairings is observed between arms belonging to the same layer
(summing over inner and outer), and around 20 only for inter-layer ones. This first
value correspond to slightly less than 3 pairing per molecule, which would be the
value in a perfectly icosahedral structure. This 10% reduction of the arms shows that
the structure is not rigid, and some pairings are lost, but nevertheless it maintains the
majority of its network of interaction in place. On the contrary, few inter layer contacts
are observed within 1.2 nm distance cut off: the arms belonging to two different layers
are separated by the space spanned by their side chains, and this keeps the average
positions of their backbones at a distance greater than the cut off chosen.
Contacts between residues Figure 3.12 shows the number of contacts between
backbones and/or side chains of amino acids which survive more that 50% of the
simulation time. They are classified by amino acid type and normalised over the number
of residues present for each type (so this takes already into account the fact that there
are two Arg and Trp per arm of capzip, but one Thr and Glu only).
The number of backbone contacts per residue is around 1 for Threonine (Thr) and
Glutamic acid (Glu), 0.7 for Arginine (Arg), and 1.2 for Tryptophan (Trp) residues
(Figure 3.1, B). Thus, on average each residue is paired with another one, except for
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Figure 3.12: Number of contacts per residue type in each arm of capzip: each bar shows
the average number for the residue on the x-axis; its color is split by the identity of the
partner residue (color coded as in the x-axis legend). For mixed contacts the residue
on the x-axis contributes with its backbone. The parametrisation is reported along
the y-axis. Results are shown for Replica 1 of each simulation set-up. Only contacts
existing more than 50% of the simulation time are considered.
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Arginines: only two thirds of them are engaged, likely because some Arg residues are
at a terminal positions, and as such they tend to extend in solution, unpaired. On
the contrary, Tryptophan is more prone to form contacts, because of its hydrophobic
character and central position in the sequence.
The bar plot shows also that there is no strictly fixed arrangement between arms: for
example, Tryptophan residues are not paired mainly to Tryptophan ones, as the optimal
arrangement would dictate, suggesting flexibility in the structure. Nevertheless, this
specific residue has clearly a prominent role in forming contacts with the neighbours
both at the backbone level and at the side chains one through cation-π interaction with
Arginine (central column of Figure 3.12).
Hydrogen bonds interaction Some of the contacts mentioned above are mediated
by hydrogen bond interactions, so the average number of inter molecular hydrogen
bonds occurring during the simulations is computed, divided by the number of mole-
cules and classified by residue type. We further separate the hydrogen bonds occurring
between backbones and/or side chains. Tryptophan contributes to a large number of
backbone hydrogen bonds (Figure 3.13, A), especially with other Tryoptophan residues,
consistently with what found in the analysis of contacts carried on previously. Arginine
side chains are the most prone to establish H-bonds as a donor with many different
amino acid side chains (Figure 3.13, B), but especially with Glutamic acid as expected
from the facing positions they occupy in the network arrangement and their opposite
charges which attract them closer. Similarly, a common interactions is between Arg
side chain (donor) and Glu backbone (Figure 3.13, C), and between Arg backbone
(donor) and most of the other side chains (Figure 3.13, D).
Chemical characteristics of the surface: SASA Finally, it is important to un-
derstand what residues are exposed at the surface of the structure, especially in view
of future applications: in order to make the peptide co-assemble with other products,
the two must have a compatible chemical character. The average Solvent Accessible
Surface Area (SASA) for every amino acid along capzip arm (Figure 3.14) shows that
half of the accessible surface is represented by the charged residues Arginine, while
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Figure 3.13: Average number of hydrogen bonds per residue occurring between amino
acids, including the central scaffold RKGB, for a 100 ns atomistic simulation of the
buckyball in solution. Result are shown for Replica 1. For each bar, the residue on the
x-axis is the acceptor, and the bar is split by the identity of the donors. In the case
of Backbone - Side chain and Side chain - backbone, the first mentioned correspond
to the acceptor (and thus the residue on the x-axis).
Tryptophan contribute to it for less than one quarter, despite having bulky side chains.
For atomistic simulations, we can compare the SASA of each residue of type X with
the reference SASA computed by theoretical modelling of a Gly-X-Gly tripeptide [Tien
et al., 2013]. The resulting ratio QSASA is greater than one for both the Arginines:
while for the terminal one (ARG1) it is consistent with the absence of a residue on one
of the sides, the fact that also the second has QSASA > 1 proves that these residues are
highly exposed in solution. On the contrary, Tryptophan has values around 0.5, due
to its propensity to be buried inside the structure, while Glutamic acid and especially
Threonine have value closer to one, showing no particular burying.
D-amino acids The results presented above are derived from simulations of the
capsule composed by standard amino acid (L-form). As explained in Chapter 1, some
experiments focussed on the opposite chiral form (D-version) for stability and immuno-
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(a) (b)
Figure 3.14: (a) Solvent Accessible Surface Area (SASA) per molecule, divided by
residue types. Results are shown for Replica 1 of each simulation set-up. (b) Nor-
malised SASA over the reference SASA computed for each amino acid type X as the
value in a Gly-X-Gly tripeptide.
Figure 3.15: Energies of L- and D-amino acids buckyball bilayer. Average values for
the second half of the simulation. Two replicas are shown for L-amino acids (L1 and
L2), one only was run for D-amino acid (D).
genicity reasons. Experimental work shows similar behaviour for the two enantioners
in solution, because they are mirror images of each other.
Accordingly, simulations of D-amino acids should not give any discrepancy with
what found before. As a control, we performed one run with such mirror system - and
suitable amino acids parameters to keep the D-chirality - finding a similar behaviour
of the capsule (i.e. differing from the L- simulations as much as the L- replicas differ
among them - Figure 3.15).
This investigation can be performed only at the atomistic level as the coarse-grained
models employed represent the Cα and the hydrogen attached to it as a unique bead,
loosing then the chirality of this centre.
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3.4.2 Multiscale comparison of model capsule
We performed a multiscale analysis simulating the capsule structure with different
coarse-grained force fields, with a twofold aim: first we wanted to simulate the assembly
for a longer time, to observe how its structural properties are maintained on the medium
time scale (of the order of the microsecond). Second, we believe that proving the
stability of the capsule with different descriptions strengthens the evidence that the
assembly proposed is indeed a favourable arrangement of the molecules in solution.
As mentioned before, to this aim we compared simulations run with the SIRAH,
MARTINI force fields and MARTINI used in conjunction with polar water (Polar
MARTINI). The investigation is also useful to elucidate where the descriptions differ
and to infer the advantages of each model. We first comment on the quantities already
analysed at the atomistic level (if applicable), and then we extend the analysis to
simulations of a monolayer capsule, which has been modelled to verify whether the
hypothesis that a bilayer structure is necessary to grant stability was true.
Coarse-grained global structures As foreseeable, the structures obtained with
coarse-grained force fields are slightly different among each other and with respect to the
atomistic one. The SIRAH bilayer capsule has a structure more expanded with respect
to the atomistic one, with a skewed and broader RDF profile, while MARTINI provides
a more compact configuration, and finally Polar MARTINI a slightly more expanded
structure than standard MARTINI, with a comparable thickness. Respectively, for
SIRAH, MARTINI and Polar MARTINI the average radius is 6.0 nm, 4.6 nm and 4.8
nm, with 2.9 nm, 1.9 nm and 1.9 nm average thickness - see Figure 3.9(a) and (c).
The difference between the two MARTINI models is likely due to the better properties
of solvation of charged groups in the Polar MARTINI description [Yesylevskyy et al.,
2010], united with the fact that the buckyball contains a high number of them.
The correlation of motion between molecules for all the coarse-grained force fields
is similar to the atomistic one, with a slight anticorrelation between molecules at the
opposite poles for MARTINI and Polar MARTINI (Figure 3.10). This is due to the
contraction happening at the beginning of the simulation, when the capsule adjusts to
the equilibrium size, which depends to some extent on the force field. These effects are
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more pronounced for the MARTINI force fields, probably due to the greater cohesion
between the beads which makes them moving coherently.
Coarse-grained contacts analysis The number of chains paired in the SIRAH
simulations is fewer than in the atomistic ones (Figure 3.11), in line with a more
expanded structure, while MARTINI simulations propose a higher number, consistently
with the reduced size of the capsule. In particular, the contacts between the two layers
are significantly higher in MARTINI. This is expected when the two layers are closer, as
suggested by the values of the stacking molecules correlation. Finally, Polar MARTINI
agrees with the high number of inter layer contacts of MARTINI, but suggests a partial
loss of contacts within the same layer. However, as the structure is compact, the overall
shape is still maintained, even without such precise pairing of the arms.
Breaking down the contact analysis by residue type (Figure 3.12), each coarse-
grained force field shows a different organisation due to the models of the side chains
volumes, which thus occupy a different fraction of the space available. Nevertheless,
in all the representations, Tryoptophan has a prominent role in establishing contacts
with its neighbours at the backbone level, while different force field disagree on the
role of the side chains. Quite surprisingly, the SIRAH force field does not promote
interactions between side chains a part from the Tryptophan ones with themselves.
This seems due to the more expanded structure of the capsule and consistent with
the larger solvation of the amino acids, which are more exposed in solution (see next
paragraph discussing SASA values). Finally, none of the coarse-grained force fields seem
to capture the preferential cation-π interaction between Arginine and Tryptophan, as
can be expected from a less detailed description.
Coarse-grained SASA The values of SASA cannot be compared between force
fields, because of the different dimensions of the beads and the number of them em-
ployed to describe the residues. However, it is interesting to notice that consistently
across force fields, Arginine constitutes around half of the exposed surface, with the
exception of SIRAH, where the more expanded structure results in all the residues to
be quite exposed (Figure 3.14(a)). This confirms that these charged residues are more
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exposed in solution, while Tryptophan ones are buried.
Energetic profile The above results point out that every coarse-grained force field
has a particular propensity for an equilibrium distance between peptidic components.
This is due to the different solvation property of the water model chosen, and to the
balance between the different components of the energy. To better understand this, we
computed the Coulomb and Lennard-Jones contribution to the energy due to Protein-
Protein interactions or Protein-Water ones. Figure 3.16(a) plots these values averaged
over the second half of the simulated time for the atomistic and each coarse-grained force
field (for atomistic and SIRAH description the Protein-Protein terms include both the
short range interactions and the 1-4 interactions, i.e. the ones computed between atoms
separated by three bonds, as they are computed separately during the simulations. For
MARTINI models instead they are grouped together in the short range term).
Considering the Coulomb component, it is clear that the mean field approach of
standard MARTINI, which consists in adopting a high relative dielectric constant (ε =
15) to compensate the absence of water dipoles, decreases sensibly the contribution of
the Protein-Protein electrostatics with respect to the two other models. This approach
reduces all the Coulomb interactions, while in reality the screening effect due to the
water can be seen only, e.g., on distances larger than about 1 nm in a 0.1 M salt
solution. This simplified approach instead screens also the contribution of two nearby
atoms separated by a distance less than the size of a water molecule. Due to the
r−6 behaviour of the Coulomb interaction, these short scale contributions are clearly
important for the total Coulomb energy. The partial reversion to ε = 2.5 performed
by Polar MARTINI, together with the introduction of a water dipole, increases the
amount of the Coulomb contribution by 10-fold (in absolute value). Interestingly, this
is higher than the ratio εstandard/εPolar ∼ 6, likely because the reduced short range
screening also allows a stronger interactions between opposite charges, bringing them
closer and thus contributing more (negatively) to the Coulomb energy.
SIRAH simulations instead are run at ε = 1, and present a Coulomb component
2.5 times larger than the one of Polar MARTINI, suggesting that the two models
give a similar energy contribution, which is then rescaled by their respective dielectric
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(a)
(b)
Figure 3.16: (a) Protein-Protein and Protein-Water non-bonded interactions, nor-
malised per molecule. Values obtained as average on the second half of the trajectory
of Replica 1 for each simulations set-up. (b) Ratio between the Protein-Protein and
Protein-Water interactions for each force field, for Coulomb and Lennard-Jones re-
spectively; or between Coulomb and Lennard/Jones, for Protein-Protein an Protein-
Water interactions separately (note the log scale on y). Values computed as for plot
(a). Points are misaligned along x to facilitate the reading.
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constant. Finally, the atomistic model (ε = 1) suggests even higher (in absolute value)
Coulomb energy, roughly the double of SIRAH ones.
These differences in Coulomb energies affects both the Protein-Protein and Protein-
Water interactions consistently (Figure 3.16(b), left), but they have consequences on
the dynamics because they change the proportion of Coulomb energy with respect to the
Lennard-Jones contribution (Figure 3.16(b), right). These interactions are not changed
between the two MARTINI models, making them predominant in standard MARTINI,
where electrostatics are weak, while they are competing with the Coulomb contribution
in Polar MARTINI. On the contrary, SIRAH parametrisation opts for a smaller role
of Lennard-Jones with respect to the Coulomb contribution, more consistently with
the atomistic description, especially regarding the Protein-Protein interaction. To re-
capitulate, protein electrostatics have an increasing contribution in MARTINI, Polar
MARTINI, SIRAH and atomistic respectively, both in absolute terms and with respect
to the Lennard-Jones contribution.
This might partially explain the differences in sizes observed across the models: for
example the Protein-Protein Coulomb energy is more negative in SIRAH. However,
with a smaller dielectric constant with respect to MARTINI, these contributions are
less screened, thus the many positive amino acids composing the capsule (giving a
positive net charge) can repel each other more effectively.
Comparing the two MARTINI models instead, Polar MARTINI has a greater Protein-
Protein Coulomb component with respect to standard MARTINI (in absolute value,
which means a more negative contribution). From this can be deduced that the slightly
more expanded structure observed in Polar MARTINI is likely due to a different balance
of electostatic versus Lennard-Jones, rather than to the more favourable solvation due
to the polar water model. Indeed, the balance between Protein-Protein and Protein-
Water components (Figure 3.16(b)) is in the same range for all the three coarse-grained
force fields, and it is slightly higher than the atomistic value for Coulomb, while for
Lennard-Jones it is lower by about 15-fold.
An interesting follow up on this topic would be investigating whether a tuning of
the dielectric constant used in the two MARTINI models can produce more consistent
results between them. However, the choice of the constant was optimised to reproduce
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at best the properties of bulk water and solvation free energies of ions for both cases.
This then raises the question whether the protein parametrisation performs equally
good in conjunction with both model, or whether one reproduces better the atomistic
Protein-Water interactions.
3.4.3 Bilayer versus monolayer: coarse-grained simulations
To prove also at the capsule level that the bilayer structure is indeed essential to grant
a structure which does not disassemble or changes shape, we performed simulations
of a monolayer capsule (specifically taking the external layer of the capsule already
simulated - Figure 3.1, E) in the three coarse-grained force fields employed so far
(Supplementary Movies SI M2 and SI M3 show SIRAH and Polar MARTINI runs for
the monolayer as well - Replica 1).
(a)
(b)
Figure 3.17: (a) RMSD of the monolayer and bilayer structures for SIRAH and Polar
MARTINI force fields, with respect to the initial geometrical configuration (external
layer of Figure 3.1, E). (b) RDF of Protein masses around their center of mass. For
each label of the legend, the bar has length of the respective RDF FWHM (thickness
estimate). Results are shown for Replica 1 of each simulation set-up.
The RMSD with respect to the initially built structure (the geometrically regular
polyhedra as in Figure 3.1, E) shows that the monolayer undergoes a larger confor-
mational change than the bilayer in the SIRAH force field and the effect is even more
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pronounced for the Polar MARTINI (Figure 3.17(a)). As a note, we take as reference
structure the regular geometry and not the first frame of the production as major re-
arrangements happen for the monolayer already in the equilibration phase, and those
are different for each force field. This larger change of the monolayer is due to a larger
contraction of the structure, which collapses more toward its center (Figure 3.17(b)).
The SASA of each residue type computed on the initial configuration is slightly
higher for the monolayer than the bilayer as expected, but this difference partially levels
out during the simulations, due to the rearrangements mentioned above (Figure 3.18).
Therefore, coarse-grained representations suggest that the larger deformation observed
in the monolayer is due mostly to the decrease in structural robustness when only one
layer is present, and only in minor measure to the hydrophobic effect. However the
evidence collected through atomistic simulations of assembly of a few capzip molecules
suggests the opposite - even if they can tackle a shorter time scale. The atomistic
simulation of a monolayer would be a useful piece of information to strengthen the
conclusion derived, but was not run in the interest of time.
The discrepancy between coarse-grained and atomistic conclusions can be solved
accepting both mechanisms (structural robustness and hydrophobic effect). Indeed,
it is clear that coarse-grained descriptions have their weakest point in the ability of
reproducing structural solvation, while they provide useful mechanical information.
Based on this, we deemed that the capsules observed experimentally must have a
non-monolayer structure: a single layer would not provide enough structural stability
and, moreover, it is not compatible with the thickness observed in the TEM images
collected experimentally (Figure 1.10(b)).
Overall, the multiscale investigation of this system provided information on how it
is structured, but also a useful comparison between force fields, proving how the same
system can be described in different ways from different models. This can be useful
especially for the (comparatively) new SIRAH force field, which has been less assessed
and less widely used than the MARTINI description.
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(a) (b)
Figure 3.18: Solvent Accessible Surface Area (SASA) per molecule, divided by residue
types for simulations of the bilayer and monolayer structure. Results are shown for
Replica 1 of each simulation set-up. (a) SASA computed from the initial configuration;
(b) from the average over the production run.
3.4.4 Backmapped simulations
Two of the final configurations obtained from standard MARTINI simulations were
backmapped to atomistic resolution, and simulated for additional 200 ns. The struc-
tures expanded roughly up to the sizes obtained in direct atomistic simulations (Figure
3.19(a)). They present however some unpaired arms and slightly deformed shapes, so
that the RDF profiles of their masses around the origin results in a broader curve with
respect to the original atomistic simulations, albeit they are centred at the same values
(Figure 3.19(b)).
The pattern of contacts per residue, computed on the last 100 ns of simulations, con-
tains features of both the atomistic and MARTINI profiles (Figure 3.20). In particular,
at the side chain level, is recovered the interaction between Arginine and Tryptophan
residues. Also for mixed backbone-side chain contacts the role of Tryoptophan with
respect to the other residues is restored. For backbone contacts instead, the pattern re-
sembles more the one from MARTINI. However, the number of total contacts is slightly
lower, probably due to the rapid expansion which follows the backmapping procedure.
This movement happens to relieve the unfavourable conformation deriving from the
conversion between resolutions.
The expansion of the structure suggests that the atomistic simulations analysed
before have indeed reached (or are reaching) an equilibrium: on one side, the atomistic
radius of gyration in Figure 3.9(a) has not reached a plateau and could possibly decrease
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(a) (b)
Figure 3.19: (a) Radius of gyration (computed on the protein backbone) and (b) RDF
of protein masses around their centre for atomistic simulations (Replica 1) and back-
mapped atomistic from final configurations of Replica 1 and 2 of standard MARTINI
runs. The RDF has been averaged over the last 50 ns of the original simulation, or
100 ns of the backmapped simulations. For each label of the legend in (b), the bar has
length of the respective FWHM of the Gaussian function fitting the data (thickness
estimate).
Figure 3.20: Number of contacts per residue type in each arm of capzip for an atomistic
simulation backmapped from standard MARTINI (Replica 1): each bar shows the
average number for the residue on the x-axis; its color is split by the identity of the
partner residue (color coded as in the x-axis legend). For mixed contacts the residue
on the x-axis contributes with its backbone. Results are shown for backmapped replica
1. Only contacts existing more than 50% of the simulation time are considered.
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more, on the other, when the structure is contracted (as it is after the backmapping)
it expands back to the larger size observed in Figure 3.9(a). This suggest that the
equilibrium value for an atomistic model lays between what found with an atomistic
and a MARTINI coarse grain approach.
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3.5 Results: peptide-membrane interactions
We now discuss simulations of capzip in contact with a membrane. First we focus
on atomistic simulations of the pentagonal peptidic subunit in contact with a model
bacterial or mammalian membrane, both under standard simulations conditions and
with an applied external electric field. In this, we elucidate the local effect that the
peptide has on the local lipid organisation. We then analyse the process of membrane
binding which is observed in coarse-grained simulations, comparing the MARTINI and
Polar MARTINI force fields for the simulation without an external electric field, and
necessarily resorting to Polar MARTINI for the ones involving it.
3.5.1 Atomistic simulations of the bacterial model membrane
Preliminary simulations were run on bacterial membranes alone (two lipid bilayers with
512 and 740 lipids respectively), to equilibrate them and compute their characteristics
in absence of the peptide. For the bacterial model chosen (DLPC/DLPG 3:1), we
obtained an ApL of 0.580(5) nm2 for the 512-lipid bilayer (simulated with GROMOS
54A7 force field), and 0.569(4) nm2 for the 740 one (GROMOS 54A8) as shown in Figure
3.21(a), lines 1 and 5. No experimental values are available for this lipid mixture to
compare the computational results.
The difference is small but statistically significant (the two measures are not com-
patible within the error). There are three differences between the two sets of sim-
ulations, and each of them can be responsible for the discrepancy. First, the force
field (GROMOS 54A7 versus 54A8, see Chapter 4 for a thorough comparison), then
the long range electrostatic treatment (RF versus PME), and finally the size of the
system (512 versus 740 lipids). Regarding the first, extensive tests on phosphocholine
lipids (see Chapter 4) suggest that generally 54A8 gives larger ApL values than the
ones computed with 54A7. Regarding the second, a control simulation on the 512-lipid
bilayer was run swapping the RF long range electrostatic treatment with PME (and
maintaining the remaining set-up). It produced an ApL of 0.586(5), slightly larger that
the one obtained with RF, but compatible with its value. Therefore we attribute the
discrepancy to the different sizes of the systems. Later in this section other cases are
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reported in which the size has a great influence on the simulation outcome.
Regarding the diffusion coefficient, we report in Figure 3.21(b) both the pure and
global values (computed as explained in Section 3.3 and Figure 3.7). Considering the
pure diffusion (squares in Figure 3.21(b)), the larger membrane has a smaller coefficient
with respect to the 512-lipid bilayer (line 1 and 5 of the Figure above). However,
considering the global one (triangles) we observe the opposite. In general, differences
are expected between the two systems, because of their different size: it is well known
that periodic boundary conditions affect the computed diffusion coefficient D [Camley
et al., 2015; Venable et al., 2017]. Previous studies found that, for atomistic simulations
of the size employed here, D is systematically underestimated [Camley et al., 2015]:
increasing the size would increase the coefficient, toward its real value (which is obtained
for an infinite box). This is consistent with our global diffusion results, but not the
pure ones. Unfortunately, it is not clear whether, in the publications mentioned, they
refer to what is here defined as pure or global diffusion.
To exclude that the difference between the two systems is given by the force field
chosen, we refer the reader to the next chapter, where, for simulations of monolipid
bilayers, the 54A7 or 54A8 force fields gave very similar values of pure diffusion, keeping
all the other simulations conditions identical (of the order of 0.1 µm2/s). Also in those
simulations we observed drift of one leaflet with respect to the other, which would
produce discrepancy between the values of pure and global D. The drift appeared in
some of the simulations only, and not in a consistent manner: it did not happen for a
lipid in particular, nor for a specific set of parameters. This suggests that small changes
in the the initial conditions can lead to very different values of the drift (if any exist).
However, once it is started, such motion seems to persist throughout the simulation
length, consistently with the inertia gained by the leaflet.
Interaction of the peptide with the 512-lipid model bacterial membrane
For the small bilayer, the presence of the pentagonal peptide subunit (made of ten
antimicrobial molecules, and bearing a +60 e total charge) made the ApL decrease
by 9% with respect to the value of the membrane itself (Figure 3.21(a), line 3 versus
1). A similar effect was observed applying an electric field of 70 mV/nm intensity or
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combining the peptide with a 20 mV/nm field, comparable with physiological values
(Figure 3.21(a), lines 2 and 4). Given the high net charge of capzip, the molecule itself
produces an electric field, thus the perturbation on the membrane is similar to the one
obtained when the field is externally applied.
The fact that both the peptide and/or the electric field lead to reduction of ApL
of a similar amount suggests that the membrane is approaching the maximum packing
allowed. Consistently, the diffusion coefficients had a 6-fold reduction for both species
of lipids (Figure 3.21(b)). Pure and global diffusion are very similar, as there is little
translation between the leaflets. At the same time, the order parameter SavgCD increased
slightly (Figure 3.21(c)). The variability on SavgCD is high, showing that some regions
reached a value larger than 0.3, which is often associated to transition to the gel phase,
characterised by highly order lipid chains [Pluhackova et al., 2016]. To investigate this,
for the simulation in presence of capzip, the hexagonal order parameter S6 is computed
for the bottom leaflet of the membrane (the one not hosting the pentagonal subunit, if
present). This shows a few lipids in the gel phase, i.e. S6 ≥ 0.72 (Figure 3.22): despite
there is no formation of ordered clusters, the shrinking of the membrane due to the
presence of capzip increases the lateral order (and the thickness of the membrane).
Indeed no lipid reaches the S6 gel threshold in the simulations of a pure membrane
(data not shown).
Interaction of the peptide with the 740-lipid model bacterial membrane
When we simulated the 740-lipid bilayer with an externally applied electric field and/or
in presence of the peptide, the ApL and tail order parameter SavgCD remained equal,
within the error, to the values obtained from simulations of the membrane alone.
The global diffusion coefficient D was still significantly affected, being reduced be-
tween 2.5 and 5 times (Figure 3.21, lines 5 to 8), but not the pure diffusion. The
simulation of the 740-lipid bacterial membrane alone is the only case, among all the
simulations results shown in Figure 3.21(b), in which pure and global D differ substan-
tially. However, as commented above, the leaflet translation seems to be dependent on
the initial conditions, thus we can not be certain that this translation is a consistently
reproducible effect.
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Figure 3.22: Hexagonal order parameter S6 for the bottom leaflet lipid acyl chains,
computed on the last frame of a simulation of a 512-lipid bacterial bilayer with 10
peptide molecules (line 3 in 3.21). Chains plotted by the average xy position of their
carbon atoms, and colour coded by the S6 value; chains of the periodic images shown
faded out; boundaries of the simulation box in solid black lines.
While, for the small bilayer, perturbations reduced the diffusion and the ApL to-
gether, the results on the larger membrane show that neither ApL nor pure diffusion
are affected from the peptide/electric field. However, given the decrease in global dif-
fusion, an the fact that the peptide is likely to influence the movement of the lipids
nearby itself, we computed the diffusion coefficient for subsets of lipids based on their
distance from the peptide at the initial frame of the production run (Table 3.2). On
this occasion, the trajectory was centred around the peptide COM, to understand the
lipid movement with respect to it. The lipids closer to the protein resulted indeed
the most slowed down in their motion. DLPG is slightly more mobile than DLPC, as
observed in all the 740-lipid bilayer simulations (Figure 3.21(b)).
The local slowing down of lipids is due to electrostatic and hydrogen bond interac-
tions between the lipids and the peptide. We computed the latter, monitoring the ones
which persisted more than 50% of the time, not necessarily i n a continuous fashion
(Table 3.3). Moreover, we singled out the ones involving Arginine and Tryptophan
residues. Arginine promotes many persistent bonds, and the number of them is equally
divided between DLPC and DLPG residues, despite there are less DLPG residues over-
all. Tryptophan promotes fewer persistent bonds; and the remaining ones that exist
for more than 50% of the time involve all Threonine residues. Thus, hydrogen bonds,
together with the electrostatic attraction between positive residues of the peptide and
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Local diffusion for DLPC/DLPG with capzip
DLPC DLPG
Lip. Pept. Region Nr. D (µm2/s) Nr. D (µm2/s)
10 737 d < 1 93 0.283(1) 38 0.272(2)
10 737 d < 2 152 0.325(2) 52 0.353(3)
10 737 d < 3 239 0.402(2) 70 0.393(3)
10 737 d > 3 329 0.442(3) 98 0.650(4)
10 737 All 568 0.486(3) 169 0.541(3)
0 740 All (global) 570 1.75(3) 170 2.02(2)
0 740 All (pure) 570 0.383(1) 170 0.487(3)
Table 3.2: Local diffusion for the DLPC/DLPC bilayer in presence of capzip. Pept.:
number of peptides; Lip.: number of lipids. The values are computed for groups of
lipids which, at the initial time, are at a distance d smaller than 1 nm, 2 nm or 3
nm from the peptide or larger than 3 nm (Regions). D is computed centring the
trajectory around the Protein COM. The pure and global diffusion coefficients for the
pure membrane are given for comparison. Error from linear fit in parenthesis.
Capzip - DLPC/DLPG lipids hydrogen bonds
E = 0 mV/nm E = 20 mV/nm
Total τ ≥ 50% Total τ ≥ 50%
R W R W R W R W
DLPC 668 73 20 7 798 90 18 6
DLPG 928 114 12 3 980 104 16 3
All 2041 50 2238 54
Table 3.3: Number of hydrogen bonds between the Arginine (R) or Tryptophan (W)
residues of the pentagonal subunit (10 capzip molecules) and DLPC or DLPG lipids
(740-lipid bacterial bilayer). Results shown for simulations without electric field (left)
or a 20 mV/nm field (right). The table displays both the total number of observed
hydrogen bonds (Total) and the ones present for more than 50% of the simulated time,
not necessarily in a continuous fashion (τ ≥ 50). Furthermore, the corresponding
figures for all the bonds occurring between any residue of the peptide and any lipid is
displayed (All).
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(a) (b)
Figure 3.23: Insertion of each amino acid of the pentagonal subunit within a bacterial
(a) or mammal (b) model membrane. The x-axis shows the amino acids in the capzip
sequence, with · indicating the RKGB central residue (19 overall). The boxes shows
the range on the 10 molecules forming the pentagonal subunit.
negatively charged DLPG lipids, slow down the dynamics of the lipids close to the pep-
tide, which do not diffuse away. The presence of a less mobile patch of lipids influences
the diffusion of the ones nearby as well, decreasing it.
Regarding the position of the amino acid within the lipid membrane, Figure 3.23(a)
shows a plot of the average insertion during the last 100 ns of the simulation. This
is computed taking into account for each amino acid the atom with the lowest z co-
ordinate, which is compared with the maximum z coordinates of the lipids around it.
In this way, the local height of the membrane is taken into account. The results show
a deeper insertion of Arginine residues on average, while Tryptophan inserts less, and
some of them are placed at the interface with solution. This will be important for the
initiation of pores in simulations with an external electric field (see the next paragraph).
We think that this reduced “fluidity” in terms of lateral diffusion is an important
perturbation of the membrane structure, as it diminishes its ability to accommodate
external stimuli, such as water penetration. With coarse-grained simulations (see Sec-
tion 3.5.3) it will be evident that on the long time scale, these interactions are also able
to recruit anionic lipids around the peptide, creating a local imbalance in the membrane
composition.
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(a) (b) (c)
Figure 3.24: (a) Bacterial membrane deformation due to an electric field applied to
the membrane (512 lipids, E = 130 mV/nm). (b) Pore formation due to the action
of the peptide and electric field of 130 mV/nm. (c) Pore precursor due to Arginine
insertion and water penetration. [VMD software, Humphrey et al. [1996]]
Electroporation results As it is not possible to witness the penetration of the
peptide through the membrane within the available simulation time, we opted to per-
form electroporation simulations. An electric field of increasing intensity was applied
along the negative z direction perpendicular to the membrane, with the peptide on the
positive z side, to model the field generated by the transmembrane potential.
The field was increased of 20 mV/nm every 200 ns (or 10 mV/nm when approaching
the poration threshold). The initial value of 20 mV/nm was chosen as it is an approx-
imation of the physiological value of the transmembrane potential (see discussion in
Section 3.2). This procedure showed that the critical value of 130 mV/nm triggered
poration in the presence of the peptide. This was confirmed by three replicas run with
a 130 mV/nm field from the initial unperturbed membrane configuration (poration af-
ter 20 ns, 75 ns and 71 ns respectively). Similarly, on the 740-lipid bilayer in presence
of capzip, the same field induced membrane disruption after 60 ns, 50 ns and 70 ns
respectively (Figure 3.24(b)). This value is significant at the time scale used, and it
is possible that for longer time scales one can witness poration at lower values of the
electric field.
As a control, a pure 512-lipid bacterial membrane was simulated under the same
conditions, in three replicas: in the 600 ns runs, we observed the appearance of curved
regions (Figure 3.24(a)) but no poration. The appearance of a curvature made it
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necessary to compute the area per lipid taking this into account, as explained in Section
3.3. The three replicas gave values of 0.520 nm2, 0.514 nm2 and 0.550 nm2. Their
discrepancy is due to the different level of curvature the membrane adopts during the
runs (as they can change at a fast pace, the values given above were computed over the
last 10 ns of the trajectory only). It is observed that once a curvature appears it can
be quickly enhanced by the electric field. Small casual variations in its initial onset can
bring to very different shapes of the membrane and thus of compression of the lipids
in it, giving different ApL values.
The electroporation threshold for the bacterial membrane alone was set at the higher
value of 140 mV/nm: out of three simulations run with such value of the electric field,
two resulted in disruption at 150 ns and 154 ns, while the third presented a curved but
still intact membrane after 200 ns. This shows that the effect of the field combined
with the presence of the peptide accelerates the disruption process. Because of that,
a slightly lower field value was sufficient to observe poration when the peptide was
present.
The simulations with high electric field performed on the 512-lipid bilayer resulted
all in curved geometries before the poration event (independently from the presence of
the peptide). However this does not happen with the larger membrane, for which the
poration was always initiated from a flat conformation (Figure 3.24(b)). To rule out
once more the hypothesis that the difference is due to the force field used (GROMOS
54A7 versus 54A8), we run an additional control simulation of the 512-lipid bilayer
with the 54A8 force field and the electric field set at the electroporation threshold of
140 mV/nm. The bilayer, which was not electroporated in the 200 ns run, developed a
curved shape similar to the outcome from the corresponding 54A7 simulations. Also,
the ApL values of the two simulations of the 512-lipid bilayer with peptide and a 140
mV/nm electric field, differing only for the force field (54A7 or 54A8), are quite similar:
0.554 versus 0.556 nm2, computed taking into account the curvature. However, from
the previous discussion it emerges that there is a high variability in the ApL computed
from highly curved configurations, so that the consistency of the two values might be
fortuitous. In any case, this analysis proves that the size of the bilayer has a large
influence in the outcome of the simulations.
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Arg Capzip - DLPC/DLPG lipids hydrogen bonds
[τ ≥ 50%]
E = 0 mV/nm E = 20 mV/nm
Total Pho COn All Pho COn
DLPC 20 6 14 18 10 8
DLPG 12 3 9 16 5 10
Table 3.4: Number of the hydrogen bonds between Arginine residues and lipids, exist-
ing for more than 50% of the time, in simulations of the 740-lipid bacterial bilayer with
the peptide and electric field equal to zero or 20 mV/nm. Total number is displayed
and the ones occurring with the Phosphate (Pho) moiety of the lipids or one of the
ester groups (COn).
Regardless the shape that the membrane assumes before disruption, the peptide
speeds up the membrane disruption. This is due to the charged Arginine residues
which insert into the membrane core interacting with the negatively charged phosphate
group of the lipids. They form hydrogen bonds with the ester groups, promoting
the penetration of water molecule (Figure 3.24(c) and Supplementary Movies SI M4).
The precursor of this mechanism can be seen also in the simulations without or with
low electric field (20 mV/nm): indeed, the vast majority of hydrogen bonds between
Arginine and lipids listed in Table 3.3 involves the oxygen of the ester or phosphate
group of the lipids, as shown in Table 3.4. This is also consistent with the deeper
insertion observed for Arginine residues with respect to other ones (Figure 3.23(a)).
The positive charge of Arginine residues makes its behaviour within the membrane
complex: Arginine residues buried in the membrane, can either bend their chain to
re-surface in solution (in a process called snorkelling [Liang et al., 2005; Ulmschneider
et al., 2017; Öjemalm et al., 2016]), or make interaction with the phosphate and car-
bonyl groups, as observed in our simulations. The second option has been observed
for Arginine rich antimicrobial or cell penetrating peptides through NMR experiments
which measured the distance between the nitrogen of Arginine and the Phosphorus of
lipids [Tang et al., 2007; Jobin et al., 2019] and it was confirmed by MD simulations
of the same or similar systems [Herce et al., 2009; Jobin et al., 2019], consistently with
what found in this work.
Finally, capzip causes a slight deformation on the shape of the membrane. This,
together with the Arginine insertion, allows pore formation at a value of the electric
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field lower than the one necessary for electroporation.
Therefore, the presence of capzip has two main effects: it decreases the membrane
fluidity (as measured by the reduction of the diffusion coefficient around the peptide),
and makes the bilayer more sensitive to electric field, favouring the formation of water
channels - two effects which are likely correlated, and which contribute to trigger its
membrane disrupting activity.
3.5.2 Atomistic simulations of the mammalian model membrane
After the investigation of a model bacterial membrane, we focussed on a mammalian
one, modelled as a DLPC membrane. We opted for a pure DLPC membrane to have a
mammaloan model as close as possible to the bacterial one (DLPC/DLPG), to reduce
the number of variables while testing the action of the peptide on these membranes.
Thus, the mammalian counterpart was obtained selecting only the zwitterionic lipid
species of the bacterial one. In turn, the bacterial model composition was selected
to be the same as in the Supported Lipid Bilayers experiments [Castelletto et al.,
2016]. Given the information accumulated in the previous investigation, we simulated
directly a large bilayer (748 lipids), as we deemed this size more appropriate to run the
subsequent simulations with the peptide. The force field employed is GROMOS 54A8
[Reif et al., 2012].
The properties of the stand alone membrane are computed as before and compared
with the experimental data. Indeed for mono-lipid membranes several experimental
results are available. The computed ApL is 0.592(3) nm2, while the experimental
range at 303 K of temperature is 0.608-0.632 nm2 (see Table 1 in Poger et al. [2016]).
To motivate the discrepancies, two factors must be considered. First, these experiments
are performed on a variety of lipid geometries, from vesicle to Supported Lipid Bilayers
(resting on a solid surface), justifying the broad range of values. Second, the membrane
is simulated in presence of a 150 mM salt concentration, while the experiments do not
adopt it. Several computational studies found a reduction of area per lipid when salt
concentration is introduced [Böckmann et al., 2003; Jarerattanachat et al., 2013; Reif
et al., 2017]. This is consistent with the experimental evidence [Pabst et al., 2007],
however, Reif et al. [2017] reported that simulations often overestimate this variation.
3.5. Results: peptide-membrane interactions 134
Properties of DLPC - atomistic
Pept. Lip. C (mM) ApL (nm2) D (µm2/s)
– 748 150 0.592(3) 0.673(1) (global)
– 748 150 0.592(3) 0.495(1) (pure)
– 512 a 0 0.626(5) 0.541(1) (pure)
– Exp.b 0 0.608-0.632 3
10 748 150 0.592(4) see Table 3.6
Table 3.5: Area per lipid and diffusion coefficient (global or pure) from atomistic
simulations of a DLPC bilayers. Pept.: number of peptides; Lip.: number of lipids.
a Run with RF long range electrostatics and 1.4 nm cut off. b Experimental values:
area per lipid from Table 1 of Poger et al. [2016], diffusion coefficients from Lindblom
and Orädd [2009].
The fact that salt is responsible for the reduction in ApL is supported by the results
from a simulation of a 512-lipid DLPC bilayer without salt, which gives ApL of 0.626(5)
nm2, compatible with the experimental values (see Table 3.5 for a summary. To be
noticed though that we are comparing two different sizes). Analogously, simulations of
the 512-lipid bacterial model membrane without salt gave ApL of 0.596(5) nm2, which
is 3% higher than the values found with a 150 mM concentration of NaCl (0.579(5)
nm2). Moreover simulations performed without salt (see Chapter 4 show a better
agreement with the experimental values. Therefore, we conclude that the effect of
the salt concentration is responsible for the smaller ApL observed for the large DLPC
membrane simulated with 150 mM NaCl with respect to the experimental values.
The ApL of the DLPC bilayer is larger than the one found for the model bacterial
membrane, likely because the presence of DLPG in the latter diminishes the repulsion
between the positively charged Choline heads of DLPC. Accordingly, the pure lateral
diffusion (0.495(1) µm2/s) is slightly higher than with what found for the mixed mem-
brane (0.383(1) µm2/s for DLPC and 0.487(3) µm2/s for DLPC). Simulations of a
512-lipid DLPC bilayer without salt (see Figure 8 in Chapter 4) gave a higher diffusion
value with respect to the 150 mM NaCl simulation, and again we deemed the presence
of the salt responsible for this.
The presence of the peptide does not affect the ApL of the DLPC bilayer, as it
was observed for the bacterial counterpart (on the same system size). Computing
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Diffusion for DLPC with capzip
Pept. Lip. Region Nr. D (µm2/s)
10 748 d < 1 100 0.495(3)
10 748 d < 2 180 0.584(3)
10 748 d < 3 323 0.603(5)
10 748 d > 3 412 0.993(5)
10 748 All 735 0.821(2)
0 748 All (BCOM ) 748 0.673(1)
0 748 All (LCOM ) 748 0.495(1)
Table 3.6: Diffusion coefficients of lipids, in a mammalian model membrane. Pept.:
number of peptides; Lip.: number of lipids; Region: the values are computed for
groups of lipids which, at the initial time, were within 1 nm, 2 nm, 3 nm from the
peptide or further away. D is computed centring the trajectory around the Protein
COM, when this is present. The pure and global coefficients are given for the pure
membrane. Error from linear fit in parenthesis.
the diffusion centring the trajectory with respect to the peptide, we observe a larger
diffusion coefficient with respect to the one computed for the membrane alone, likely
because of the movement of one leaflet with respect to the other. Moreover, the lipids
closer to the peptide are still slowed down in their movement as observed in the bacterial
membrane (Table 3.6).
Analysing the number of hydrogen bonds formed with the peptide, there are 590
bonds, of which 19 present more than 50% of the time. Of them, 11 involve Arginine
residues coordinated with ester or phosphate groups. These figures are smaller than
the ones obtained for the bacterial membrane. In particular, the absence of the charged
lipids makes the protein-membrane interaction less favourable. This is confirmed by
the measure of the amino acid insertion (Figure 3.23(b)) which are on average less
inserted than into the bacterial membrane.
The investigation performed on the bacterial model membrane sets to 130 mV/nm
the threshold electric field needed to observe poration at the atomistic level on such
membrane (with the GROMOS force field). Therefore, we want to reproduce this
condition on a DLPC model membrane and see whether the influence of capzip is
smaller on the DLPC membrane with respect to the DLPC/DLPG. However, for the
3.5. Results: peptide-membrane interactions 136
DLPC membrane this value was sufficient to cause poration both with and without
peptide. Despite the absence of lipids with a net charge, which are expected to interact
more strongly with the electric field, this membrane seems more sensitive to such
external perturbation. We think this is due to larger ApL: indeed, being the lipids less
packed, water penetration is easier. This, combined with the electric field, generates
more easily water channels which promote pore formation.
In the case of the mammalian model membrane, we observed that, once the mem-
brane starts disrupting, the peptide detaches from it, while it remained firmly attached
in the simulations with the bacterial one, following its deformations. This lower propen-
sity for binding on the mammalian case will be proven also by coarse-grained simula-
tions and is consistent with the previous analysis on hydrogen bonds propensity and
amino acids insertion. Moreover it confirms that the poration is induced because of the
high electric field rather than the presence of the peptide. We do not pursue the inves-
tigation of the electroporation threshold for the DLPC membrane, as we focussed here
only on the action of the peptide on it. Finally, in interpreting these results, it must be
considered that the transmembrane potential of a mammal cell is lower than the one
present in the bacterial membrane [Yeaman and Yount, 2003; Wilson et al., 2011], so
that their membranes usually need to withstand milder electric field conditions than
bacterial ones.
3.5.3 CG simulations of the buckyball on model membranes
Standard MARTINI simulations Coarse-grained simulations allow to model the
behaviour of the full capsule interacting with the membrane. At first, simulations with
the standard MARTINI model were run, as they have higher computational speed with
respect to the Polar MARTINI model. To be noticed that the full system, comprising
a 2880 lipids bilayer and the capsule, measures approximately 30 nm along each side
of the simulation box.
The coarse-grained simulations of the full buckyball bilayer on a DLPC/DLPG
membrane (3:1 ratio) confirms the binding of the peptide on the latter, driven by charge-
charge recognition: in both the replicas run, the peptide approaches the membrane after
about 2 µs, remaining bound for the remaining of the 10 µs simulated. Post-binding,
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the capsule diffuses on the membrane and produces an increasingly high curvature
on it, in a process which tends to maximize the contact area (see Figure 3.5(b) and
Supplementary Movies SI M5). No poration is observed, probably due to the force
field characteristics which stabilise the structure of both the membrane and the peptide
assembly. Additionally, longer time scales might be needed to observe it. Later in this
section, we will analyse simulations performed with an externally applied electric field,
in line with what done in the atomistic case, which speeds up the process and allow to
observe membrane disruption.
The area per lipid was computed taking into account the curvature (as explained
in Section 3.3 and in Braun et al. [2011]), and does not change significantly in presence
of the capsule. When analysing the diffusion coefficient, the values obtained for pure
membranes (or before the binding) have been computed removing the bilayer centre of
mass movement, while the ones with the capsule bound to the membrane by centring the
trajectory around it (and considering the portion of the trajectory after the binding
only). The MARTINI diffusion coefficients are about 60 times larger than the ones
obtained atomistically (Table 3.7), due to the coarse-grained parametrisation. The
values are consistent with results obtained on a variety of other systems tested by
Venable et al. [2017] in a study of diffusion for MARTINI simulations.
The diffusion coefficients obtained for simulations of the pure membrane and for
simulations with the buckyball bilayer before its binding (lines 1 and 5 in Table 3.7, top)
are similar for the DLPC/DLPG membrane and shows that the two lipids diffuse at
the same pace. The lipids diffusion is instead decreased after binding of the buckyball
bilayer, by 5% for DLPC and by 15% for DLPG (line 6 of Table 3.7, top). The larger
effect on DLPG is due to the attraction between the peptide and this negatively charged
lipid: computing the RDF of the phosphate beads (PO4) of DLPC and DLPG around
the protein, a much stronger signal comes from DLPG beads rather than DLPC ones
(Figure 3.25(a)), showing they are more attracted toward the peptide.
The mechanism above results in the slower diffusion of the DLPG residues nearby
the capsule, as already predicted at the atomistic level. Moreover, the coarse-grained
simulations allow to see the recruitment of negatively charged lipids nearby the cap-
sule: Figure 3.25(b) shows a lateral density profile of the two lipid species across the
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Properties of DLPC/DLPG - MARTINI
Pept. Lip. C E FF ApL DDLPC DDLPG
(mM) (mV/nm) (nm2) (µm2/s) (µm2/s)
1 – 2880 0 – MA 0.581(3) 75.84(7) 76.64(5)
2 – 2880 150 – MA P 0.611(1) 79.4(4) 79.0(5)
3 – 2880 150 20 MA P 0.614(1) 74.64(5) 73.67(2)
4 – 2880 150 40 MA P 0.619(2) 70.31(4) 70.45(6)
5 120 (BB)b 2880 0 – MA 0.582(1) 74.28(1) 73.34(2)
6 120 (BB)a 2880 0 – MA 0.581(2) 70.51(1) 62.59(2)
7 120 (BB)a 2880 150 – MA P 0.621(2) 65.82(6) 68.94(9)
8 120 (BB)a 2880 150 20 MA P 0.616(2) 70.29(7) 61.54(10)
9 120 (BB)a 2880 150 40 MA P Poration
Properties of DLPC - MARTINI
Pept. Lip. C E FF ApL DDLPC
(mM) (mV/nm) (nm2) (µm2/s)
1 – 2888 0 – MA 0.590(2) 83.5(3)
2 – 2888 150 – MA P 0.608(2) 80.5(4)
3 – 2888 150 20 MA P 0.610(1) 78.3(1)
4 – 2888 150 40 MA P 0.614(1) 76.90(3)
5 120 (BB) 2888 0 – MA 0.590(1) 81.07(3)
6 120 (BB) 2888 150 – MA P 0.608(1) 70.52(2)
7 120 (BB) 2888 150 20 MA P 0.611(1) 75.28(6)
8 120 (BB) 2888 150 40 MA P 0.616(1) 77.88(4)
Table 3.7: Properties of DLPC/DLPG (top) and DLPC membrane (bottom) in MAR-
TINI simulations with and without capzip. Pept.: number of peptides (BB - bucky-
ball bilayer). Lip.: number of lipids; FF: force field (MA - MARTINI; MA P - Polar
MARTINI). D is computed removing the centre of mass movement of the bilayer for
simulations without the capsule, and movement of the protein for simulations where
the peptide is bound to the membrane. For DLPC/DLPG, the buckyball bilayer binds
to the membrane: values marked with b are computed before its binding, with a after
the binding. For DLPC it never binds and the values are computed for the whole
simulation length (discarding the first 100 ns).
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(a) (b)
Figure 3.25: (a) RDF of phosphate bead (named PO4 in both MARTINI models) of
DLPC and DLPG around the Protein. (b) Mass density of DLPC and DLPC in a
DLPC/DLPG membrane along the x-axis, computed for simulations of the membrane
with the buckyball bound to it. Superimposed is a picture of the corresponding
configuration.
simulation box. Spanning the x axis, the DLPG density increases around the position
of the capsule, at the expenses of the DLPC one. The formation of a DLPG patch
enhances the slowing effect on the diffusion of this species, while DLPC, pushed away
from the capsule location, is less perturbed.
To conclude the investigation performed with standard MARTINI, we simulated
the capsule together with a pure DLPC membrane. The capsule does not bind to
the latter in the 10 µs simulated (Supplementary Movies SI M6): it comes close to it
multiple times, keeping an average distance of 3 nm and a minimum of 1 nm (Sup-
plementary Figure 3.41). This, together with what already observed in the atomistic
simulations, suggests once more that the interaction with non charged lipids is not
leading to attachment of the buckyball to the membrane.
Polar MARTINI simulations Polar MARTINI simulations focussed on in silico
experiments with an external electric field, to set a parallel with the analogous investi-
gation performed at the atomistic level. The addition of an external electric field is not
possible in standard MARTINI simulations because standard water does not provide
a long range electrostatic screening. As such, the electric field effect would be over-
estimated. Together with the simulations of the membrane with the capsule, we run
control simulations of the pure membrane with the selected values of the external field,
3.5. Results: peptide-membrane interactions 140
to exclude the possibility of electroporation.
Simulations on the membranes alone (both the bacterial and mammalian model)
showed an increased ApL with respect to the standard MARTINI simulations (lines
1-2 in Tables 3.7, top and bottom). This is the opposite of what observed in the
test case run in the original work that parametrised Polar water [Yesylevskyy et al.,
2010], possibly due to the different size and composition of the test membrane used.
Additionally, the two simulations are run with different values of the salt concentration
(MARTINI has only counter ions, Polar MARTINI has 150 mM NaCl): in the atomistic
case this discrepancy made the ApL decrease, which is again inconsistent with what
observed here and can be attributed to the parametrisation of ions in the coarse-grained
model (e.g. their van der Waals radius includes the first hydration shell, thus they will
penetrate less easily into the lipid head region). Regarding the diffusion coefficient it
decreases from MARTINI to Polar MARTINI, despite an increase in ApL, and this is
likely due to stronger interactions between lipids (especially the charged DLPG). This
is due to the Coulomb interaction, which is less screened and thus stronger in the Polar
MARTINI model.
When an electric field is applied in Polar MARTINI simulations, there is a slight
increase of ApL for higher values of it, but the diffusion decreases slightly (lines 2-4 in
Tables 3.7, top and bottom). In atomistic simulations the field decreased the ApL for
small systems and had negligible effect for larger ones; while the diffusion was reduced,
as in the Polar MARTINI case.
To simulate the binding of the buckyball bilayer, we first focussed on the bacterial
membrane. We run one simulation without electric field, to test the interaction be-
tween the two with the new parametrisation. The binding happens much faster than
what observed in the standard MARTINI simulations (within the first 50 ns), and the
membrane starts to be deformed by the capsule already after 100 ns (Figure 3.26(a)).
For this reason, Table 3.7 does not report a value of the diffusion before binding.
We did not observe poration on the time scale of the simulation (500 ns): a longer
simulation might allow to observe membrane disruption but, as mentioned before, we
preferred to focus on the action of the electric field. As such, we simulated the binding
under the action of a 20 mV/nm electric field. The curvature of the membrane is slightly
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E = 0 mV/nm
(a)
  
E = 20 mV/nm
(b)
Figure 3.26: Final configuration (500 ns) of Polar MARTINI simulations of a buckyball
bilayer approaching and binding to a model bacterial membrane, spontaneously (a)
or under the effect of a 20 mV/nm electric field (b). Capsule in bond representation,
green external layer, yellow internal one. Lipids in line representation, phosphate
beads in gold van der Waals. [VMD software Humphrey et al. [1996]]
more pronounced than in the case without field, but again no disruption happens in the
500 ns simulated (Figure 3.26(b)). From the final configuration of this run we doubled
the electric field, which was sufficient to observe poration within 200 ns. Remarkably,
a value of 40 mV/nm is within the physiological range of the transmembrane potential
(which is around 35 mV/nm for the bacterial inner membrane, and 20 mV/nm across
a mammalian membrane. See discussion in Section 3.2).
As in membrane simulations the pressure coupling is performed semi isotropically,
once a pore is formed, the box undergoes a large and unphysical deformation if the
pore keeps expanding. The analysis of the events happening after poration are thus
affected by this artefact. To obviate to that, we took a frame at the early stages of pore
formation (1 ns after the first formation of a water channel) and continued the run,
with the same electric field, with isotropic pressure coupling. This allowed to observe
the capsule penetrating the membrane in the first 10 ns from the beginning of this
run (Figure 3.27 and Supplementary Movies SI M7): the lipids do not seal around the
capsule, allowing the passage of water and ions, which is consistent with what found in
the atomistic simulations. Moreover, in the passage, the capsule deforms and partially
opens. After this, the membrane is completely disrupted and the lipids rearranged
into fibers ad micelles to shield their tails from the solvent, while some of them remain
attached to the capsule (Supplementary Movie SI M7).
The fact that we observed poration at a much lower value of the electric field than
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Figure 3.27: Bacterial membrane poration due to the action of the capzip buckyball
bilayer and an external electric field of 40 mV/nm (Polar MARTINI simulations).
∆t indicates the time from the beginning of the simulation performed with isotropic
pressure coupling (started 1 ns after the formation of a water channel spanning the
membrane). Capsule in bond representation, green external layer, yellow internal one.
Lipids in surface representation. [VMD software Humphrey et al. [1996]]
what found with the atomistic model can be explained by several characteristic of
the coarse-grained parametrisation: first, it favours a more dynamical rearrangement
between lipids (see the discussion on diffusion in the following); second, it is known for
smoothing the energy barriers and thus speeding up the course of events: the effective
time sampled in MARTINI simulations is 3 to 6 times larger than the one actually
simulated [Marrink et al., 2004]. Moreover, in these simulations the full capsule with
120 molecules is present, interacting with the electric field more strongly than the
pentagonal subunit used in the atomistic simulations, which hosted 10 molecules only.
As a control, the same simulations with external electric field were run with a DLPC
membrane: for none of the values tested (0, 20 and 40 mV/nm) the capsule attached
to the membrane, as already saw in standard MARTINI simulations.
Regarding diffusion, we retrieved the slowing down of lipids when the buckyball
bilayer is bound to the bacterial model membrane. DLPG is more slowed down with
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respect to DLPC in simulations with no or 40 mV/nm electric field, while for the 20
mV/nm it is slightly faster. Instead, when considering the DLPC membrane simulated
in presence of a capsule (which does not bind to it), diffusion of lipids is increased
with the field. This is the opposite to what observed for simulations of the DLPC
membrane alone, showing that the buckyball bilayer has a long range interaction with
the membrane and modifies its dynamics, even without binding to it.
As a final comment, it must be noticed that the variability on the diffusion coefficient
might be higher than what suggested from the error derived from the fit. The MSD
computed on MARTINI membranes has a very precise linear dependence from time,
thanks to the length of the simulation and the extent of the system (the MSD is
averaged over many time frames and many lipids, see Figure 3.42). This gives a small
error on the fitted slope. However for the MARTINI simulation of the capsule on
DLPC/DLPG, we run a second replica and observed a discrepancy of about 2 µm2/s
between the diffusion coefficients, despite both have a very small error from the fit.
As such, the results presented in Table 3.7 must be interpreted carefully. However,
the differences between the DLPC and DLPG coefficients observed for the simulations
after binding of the buckyball bilayer to the membrane are large enough to remain
significant, confirming that the peptide has a stronger effect on negatively charged
lipids.
3.6 Outlook
The investigation performed proved the power of the multiscale simulations approach to
elucidate details of nanoscale systems which are otherwise inaccessible to experiments.
When investigating the assembly process of capzip molecules, the use of atomistic
simulations gave insight into the role of each amino acid of the sequence in the pairing
of many copies of the molecule. Coarse-grained simulations proved the stability of the
hypothetical structure on the long time scale. Overall, we were able to conclude that
the ability of capzip to form capsule lays not only in the scheme of opposite charges that
it hosts along its arms, but also in the presence of many hydrophobic residues, which
favour the assembly by hydrophobic effect. Thus, the proposed structure contains a
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bilayer arrangement of the molecules, which is demonstrated to be more stable than a
monolayer one, and is consistent with recent experimental findings showing multilayer
capsules [Kepiro et al., 2019].
Coarse-grain simulations were also able to clarify the interaction of capzip with
the membrane. Capzip has a propensity to bind to negatively charged membranes,
which are a simplified model for the bacterial inner membrane, but not to zwitterionic
lipids, which model a mammalian membrane. Moreover, on the bacterial membrane,
the buckyball recruits the negatively charged lipids in its proximity, reducing their
diffusion.
Atomistic simulations complemented these findings showing the details of such in-
teraction: on a bacterial membrane, capzip interacts with the lipids forming many
hydrogen bonds and inserting the Arginine side chains deep in the phosphate region
of the lipids. Consequently, the lipids around the peptide are slowed down in their
diffusion also on the time scale of atomistic simulations. When analogous simulations
were run for the mammalian model membrane, less hydrogen bonds were observed,
a smaller propensity for Arginine insertion, and a smaller reduction of the diffusion
coefficient.
Finally, simulations with an esternal electric field applied to the system showed
that the peptide bound to the bacterial membrane promotes poration at values of the
field which would not cause electroporation on the membrane alone. Simulations at
the atomistic resolution make clear that this process is initiated at the location of
Arginine insertions, while a coarse-grained picture allows to see the deformation and
partial opening of the buckyball passing through the membrane on longer time scales.
Analogous experiments on the mammalian model membrane showed that its value for
electroporation is lower than the one for the bacterial counterpart at the atomistic
level, regardless the presence of capzip.
The above results integrated the ones deriving from experiments giving a more
complete picture on the characteristics of capzip. However, it would be interesting
to pursue the investigation further. Specifically, to extend the investigation of the
assembly process from molecules dispersed in solution; to assess more extensively the
capzip interaction with a mammalian model membrane; and finally to simulate more
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complex systems, namely capzip in assembly with RNA to investigate its delivery
ability. A brief outlook on these aspects will be given in Chapter 5.
3.7 Supplementary material
We include here additional material, plus Figures and Tables referenced in the chapter
which can help the reader in interpreting the results.
3.7.1 Self-assembly simulations
Test simulations on the self-assembly properties of capzip were run with the standard
MARTINI model. Indeed, the analysis presented in this chapter is a careful investi-
gation of the determinants that can drive the assembly, but a vision of the process
happening is still lacking. In Chapter 1 we already highlighted that simulating an as-
sembly process requires a great amount of computational resources. For this reason,
we focus on the MARTINI model with standard water, and we explore concentrations
of the order of mM, which are much higher than the ones employed in experiments
(around µM).
Results from 1.25 mM, 2.50 mM and 10 mM runs showed the formation of increas-
ingly larger and interconnected clusters when raising the concentration. Respectively,
the molecules aggregated into 7, 4 and 2 clusters within the first 6, 4 and 2.5 µs of the
simulations (Figure 3.28). It is not excluded that longer simulation would result in all
the clusters joined together.
The two properties we want to assess from these simulations are the contacts be-
tween the molecules, classified by amino acid type, and the SASA of each residue type,
to be compared with the results from the capsule model. However, from the previous
simulations we also know that the MARTINI parametrisation promotes a very tight
assembly of the molecules once they get in proximity, and that this is partially re-
verted back when backmapping a structure to an atomistic description. Therefore, the
results from self-assembly simulations must be interpreted with the caveat that the
protein-protein interactions might be overestimated.
The backbone contacts (Figure 3.29) show between 3 and 4 contacts per residue,
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Figure 3.28: Final configurations obtained from 10 µs standard MARTINI simulations
of the self-assembly of capzip molecules, from random initial configuration, at different
concentrations. Boundaries of the simuation box in blue; different clusters are circled
in red (the remaining ones are periodic copies of the ones highlighted).
Figure 3.29: Number of contacts per residue type in each arm of capzip for a MARTINI
self-assembly simulations at different initial concentrations: each bar shows the average
number for the residue on the x-axis; its color is split by the identity of the partner
residue (color coded as in the x-axis legend). For mixed contacts the residue on the
x-axis contributes with its backbone. Only contacts existing more than 50% of the
simulation time are considered.
Figure 3.30: Solvent Accessible Surface Area (SASA) per molecule, divided by residue
types, for self-assembly simulations at different concentrations.
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which is about three times higher than the figure obtained for the ordered capsule
structure (Figure 3.12), in line with a densely packed assembly. Furthermore, there is
a slight increase with the concentration.
The pattern of contacts suggests that Threonine interact with most partners. In-
terestingly, the contacts are distributed in a way which resemble more the atomistic
pattern found for the capsule rather than the MARTINI one. In general, this confirms
the role of the hydrophobic residues in keeping the assembly compact, but also suggests
aggregation of molecules when a high concentration is simulated.
Regarding SASA values (Figure 3.30), they confirm what found also in the capsule
conformation, with Arginine being exposed and Tryptophan buried. The SASA is
decreasing with the concentration, as for low concentration several clusters are formed
and float in solution separately (up to the time scale simulated), while for higher
concentrations the molecules can merge in fewer larger clusters, which have less exposed
surface. Interestingly, the decrease in SASA and increase in contacts does not scale
linearly with the concentration, as expected when the systems reach saturation and
the clusters cannot favourably accommodate more molecules. However, as only three
concentrations were simulated here, the data are not enough to extract a more precise
dependence between these properties.
Again, when interpreting these results, one must remember that a backmapping to
an atomistic resolution would produce more expanded structures, as it was observed for
the capsule. However, also at the experimental level, high concentrations (of the order
of mM as the ones simulated here) resulted in aggregation, i.e. the appearance of amor-
phous aggregates rather than geometrical capsules (data not shown). The MARTINI
simulations are likely capturing this behaviour, and one would need a long simulation
of a diluted solution to observe an ordered assembly. As it is almost impossible to
simulate the micromolar regime used in experiments, the simulations of pre-assembled
structures, as the ones presented previously in this chapter, are, so far, the only ones
able to explore the relevant range of concentrations.
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3.7.2 On the long range electrostatic cut off in lipid simulations
In a few paragraphs of this chapter we compare the simulations run here with the ones
from the parametrisation work in the next chapter. As the reader will see, these are
run on 512-lipid bilayers, with a simulation set up very similar to the one employed
here.
However, the long range electrostatic are treated with a Reaction Field scheme and
cut off radius of 1.4 nm. This choice was performed for consistency with previous
parametrisation work.DLPC Instead, the simulations run in the present chapter are
run either with the Reaction Field and a cut off of 1.2 nm (512-lipid bilayers) or with
a Particle Mesh Ewald treatment, and the same cut off (740-lipid bilayers).
Although briefly mentioned in the body of the chapter, we want to reiterate that
these discrepancies might affect the simulations, but in measure smaller than the pep-
tide or the electric field, which effect we wanted to assess.
Indeed, extensive literature on the effects of long range electrostatic treatment sug-
gests that electrostatics have an influence on the ApL up to 0.010-0.015 nm2 only. This
is confirmed for the change in the cutDLPC off treatment (single or double) [Silva et al.,
2018; Reißer et al., 2017], and the switch from PME to RF [Poger and Mark [2012];
Table 1 in Chapter 4]. The only conditions which severely affects the ApL seems the
complete neglect of the long range electrostatic, choosing a plain cut off scheme [Patra
et al., 2003].
Regarding the different cut off values, we did not find previous work testing the
difference. The effect of the cut off is to discriminate which regions are treated in the
exact way (nearby the atom for which the electrostatic force acting on it needs to be
computed) and which instead through the long range approximation of choice (far away
ones). As these approximations seem consistent among them and robust, we foresee
that a small shift in the cut off length does not have a high impact on the simulation
outcome.
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3.7.3 Buckyball simulations: results from Replica 2
In the following pages we include the results obtained from Replica 2 of the buckyball
bilayer and monolayer simulations (analogous to Figures 3.9-3.14 and 3.16-3.18).
3.7. Supplementary material 150
(a) (b)
(c)
Figure 3.31: (a) Rg and (b) RMSD computed on the Protein backbone. Results are
displayed for simulations performed in GROMOS (100 ns), SIRAH, MARTINI and
MARTINI with polar water (all 1 µs). Inset: zoom on the GROMOS values. (c) RDF
of Protein masses around their center of mass, computed on both layers, displayed
for the same simulation set up as in (a,b). For each label of the legend, the bar has
length of the respective FWHM of the Gaussian function fitting the data (thickness
estimate). Results for Replica 2 of each simulation set-up.
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Figure 3.32: Distribution of the correlation of motion between different molecules in
the buckyball simulations. Black band: median of the distribution; box: first and
third quartiles; whiskers: maximum and minimum, outliers excluded (hollow dots).
Results for Replica 2 of each simulation set-up.
DLPC
Figure 3.33: Number of paired arms within the same layer and between layers. Cut
off distance between arms center of mass equal to 1.2 nm. Only contacts existing more
than 90% of the simulation time are counted. Results for Replica 2 of each simulation
set-up.
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Figure 3.34: Number of contacts per residue type in each arm of capzip: each bar shows
the average number for the residue on the x-axis; its color is split by the identity of
the partner residue (color coded as in the x-axis legend). For mixed contacts the
residue on the x-axis contributes with its backbone. The parametrisation is reported
along the y-axis. Only contacts existing more than 50% of the simulation time are
considered. Results for Replica 2 of each simulation set-up.
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Figure 3.35: Average number of hydrogen bonds per residue occurring between amino
acids, including the central scaffold RKGB, for a 100 ns atomistic simulation of the
buckyball in solution. For each bar, the residue on the x-axis is the acceptor, and the
bar is split by the identity of the donors. In the case of Backbone - Side chain and
Side chain - backbone, the first mentioned correspond to the acceptor (and thus the
residue on the x-axis). Results for Replica 2.
(a) (b)
Figure 3.36: (a) Solvent Accessible Surface Area (SASA) per molecule, divided by
residue types. (b) Normalised SASA over the reference SASA computed for each
amino acid type X as the value in a Gly-X-Gly tripeptide. Results for Replica 2 of
each simulation set-up.




Figure 3.37: (a) Protein-Protein and Protein-Water non-bonded interactions, nor-
malised per molecule. Values obtained as average on the second half of the trajectory
of Replica 2 for each set-up. (b) Ratio between the Protein-Protein and Protein-
Water interactions for each force field, for Coulomb and Lennard-Jones respectively;
or between Coulomb and Lennard/Jones, for Protein-Protein an Protein-Water inter-
actions separately (note the log scale on y). Values computed as for plot (a). Points
are misaligned along x to facilitate the reading.
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(a)
(b)
Figure 3.38: (a) RMSD of the monolayer and bilayer structures for SIRAH and Polar
MARTINI force field, with respect to the initial geometrical configuration (external
layer of Figure 3.1, E). (b) RDF of Protein masses around their center of mass. For
each label of the legend, the bar has length of the respective RDF FWHM (thickness
estimate). Results for Replica 2 of each simulation set-up.
(a) (b)
Figure 3.39: Solvent Accessible Surface Area (SASA) per molecule, divided by residue
types for simulations of the bilayer and monolayer structure. (a) SASA computed
from the initial configuration; (b) from the average over the production run. Results
for Replica 2 of each simulation set-up.
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3.7.4 Additional Figures and Table
Figure 3.40: Final configuration from a 100 ns simulation of the pentagonal subunit
in solution. Bonds and cartoon representation, coloured by name. [VMD software,
Humphrey et al. [1996]]
Figure 3.41: Minimal distance between the buckyball bilayer and a DLPC membrane
(using the pair of closest atoms) during a MARTINI simulation.
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Figure 3.42: Typical lipid lateral MSD profile computed on Polar MARTINI simula-
tions: MSD computed on the PO4 bead of DLPC for a 2880 lipids membrane, with
an externally applied electric field of 20 mV/nm.
DLPCTable of simulations of pure membranes (atomistic)
Lipids Box (nm) E (mV/nm) ES Time (ns) Rep.
United atom GROMOS (GR)
512 (b) 12 0, 70, 120 RF 400 1a
512 (b) 12 130 RF 600 3a
512 (b) 12 140 RF 150P , 154P , 200 3a
512 (b) 12 140 RF 200 1b
740 (b) 14 0, 20 PME 400 1b
748 (m) 14 0 PME 400 1b
748 (m) 14 130 PME 20P , 28P , 39P 3b
Coarse-grained Polar MARTINI (MA P)
2880 (b) 30 0, 20, 40 PME 500 1
2888 (m) 30 0, 20, 40 PME 500 1
Coarse-grained MARTINI (MA)
720 (b) 30 0 RF 1000 1
722 (m) 30 0 RF 1000 1
Table 3.8: Table of control atomistic simulations of membranes. All run at 150 mM
concentration of NaCl. Lipids: number of lipids, (b) bacterial model (DLPC/DLPG
3:1) and (m) mammalian model (DLPC). Long-range electrostatic (ES): RF Reaction
Field [Tironi et al., 1995], PME Particle Mesh Ewald [Essmann et al., 1995]. For the
GROMOS force field (FF): a version 54a7 [Schmid et al., 2011], b 54a8 [Reif et al.,
2012]; coarse-grained MARTINI [Marrink et al., 2007; Monticelli et al., 2008], coarse-
grained MARTINI with polar water [Yesylevskyy et al., 2010]. Superscript P in the




imulations of lipids can be a challenging task, especially when the membrane
simulated has not been tested experimentally, and thus no comparison can be
performed on standard properties such as the area per lipid. Moreover, the param-
eters describing each lipid species must be carefully chosen, to aim at an accurate
reproduction of the natural properties of the membrane.
The work performed in Chapter 3 involved the simulation of a mixed membrane
which, to our knowledge, has not been experimentally tested. Additionally, one of the
lipids involved (DLPG) had not been parametrised before for the GROMOS force field.
The procedure of DLPG parametrisation brought to our attention the discrepancy
existing between the GROMOS parametrisation of protein and the one employed for
lipids, as the two of them are obtained through different procedures: fit to hydration
properties for proteins, and quantum mechanics computations for lipids.
The set of lipid parameters derived originally from Chiu et al. [1995] and updated
multiple times up to the work of Poger et al. [2010], is still regarded as a standard for
phosphocholines, and thus used to validate the most recent parametrisation of the force
field (GROMOS 54a8 [Reif et al., 2012]). However, it does not take into account recent
evolutions of the force field, aimed at reparametrising some constitutive moieties which
happen to be also part of lipids. For this reason, we performed a reparametrisation
of the lipid head group which includes these new descriptions, aiming at an improved
consistency with the rest of the force field and monitoring whether they would also
improve the agreement with the experimental quantities.
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The resulting parametrisation was successful in reproducing key properties such as
the area per lipid, and proposed a different interaction with a test peptide with respect
to the one outlined by the previous parameter set. Specifically, the new parameters
promote a weaker protein-membrane interaction allowing simulations to be less biased
from the initial conditions chosen. This is of crucial importance for all simulations in
general, and in particular when the sampling is reduced due to computational resources
issues.
This chapter consists of the paper “Lipid Head Group Parameterization for GRO-
MOS 54A8: A Consistent Approach with Protein Force Field Description”, published
in the Journal of Chemical Theory and Computation, together with its Supporting
Information. The project was conceived by Prof. Franca Fraternali, Dr. Christian Mar-
greitter and myself. I carried out all the work, under their guidance; specifically I
implemented the new parameter sets, performed and analysed the simulations and se-
lected the best performing parameters to be released. References for the paper and
its supplementary material are included separately after each of them (with a numeric
notation). All references feature in the bibliography of this thesis as well.
Lipid Head Group Parameterization for GROMOS 54A8: A Consistent
Approach with Protein Force Field Description
Irene Marzuoli, Christian Margreitter, and Franca Fraternali*
Randall Centre for Cell and Molecular Biology, King’s College London, London SE1 1UL, U.K.
*S Supporting Information
ABSTRACT: Membranes are a crucial component of both
bacterial and mammalian cells, being involved in signaling,
transport, and compartmentalization. This versatility requires
a variety of lipid species to tailor the membrane’s behavior as
needed, increasing the complexity of the system. Molecular
dynamics simulations have been successfully applied to study
model membranes and their interactions with proteins,
elucidating some crucial mechanisms at the atomistic detail
and thus complementing experimental techniques. An
accurate description of the functional interplay of the diverse membrane components crucially depends on the selected
parameters that define the adopted force field. A coherent parameterization for lipids and proteins is therefore needed. In this
work, we propose and validate new lipid head group parameters for the GROMOS 54A8 force field, making use of recently
published parametrizations for key chemical moieties present in lipids. We make use additionally of a new canonical set of
partial charges for lipids, chosen to be consistent with the parameterization of soluble molecules such as proteins. We test the
derived parameters on five phosphocholine model bilayers, composed of lipid patches four times larger than the ones used in
previous studies, and run 500 ns long simulations of each system. Reproduction of experimental data like area per lipid and
deuterium order parameters is good and comparable with previous parameterizations, as well as the description of liquid crystal
to gel-phase transition. On the other hand, the orientational behavior of the head groups is more realistic for this new parameter
set, and this can be crucial in the description of interactions with other polar molecules. For that reason, we tested the
interaction of the antimicrobial peptide lactoferricin with two model membranes showing that the new parameters lead to a
weaker peptide−membrane binding and give a more realistic outcome in comparing binding to antimicrobial versus mammal
membranes.
1. INTRODUCTION
Cellular membranes are key promoters and regulators of many
biological processes due to their crucial role in segregating the
external world from the organism. Small molecule transport,
drug permeation, intracellular signaling, and antibody response
are all regulated by the cell membrane or by membrane-related
components.1−8 To fully comprehend and ultimately influence
the bespoke processes, it is paramount to understand
membranes and their constituting lipids in atomistic detail.
However, due to the complexity of those systems, researchers
have resorted to the use of simplified model membranes, which
can be synthesized and characterized in vitro. This enables the
individual contributions of the components involved to be
disentangled. Indeed, for the cellular membrane to be able to
perform different functions, its composition is necessarily
complex. Lipids are one of the main components and can be
present in up to hundreds of different species.9 In addition,
many transmembrane proteins tessellate the cell surface,
promoting signaling pathways and influencing the membrane’s
structural and mechanical properties.10,11 Phospholipid bilayers
and micelles have been investigated, in particular, as these
lipids represent the main components of the eukaryotic and the
inner bacterial membranes. Both have been modeled selecting
specific phospholipids to emulate the appropriate surface
charge or to reproduce the human cell membrane fluidity by
introducing, for example, cholesterol.12,13 As these simplified
membranes retain the core characteristics of their different
biological templates,14 they can be used to test the membrane
interaction with proteins, peptides, antimicrobial molecules, or
drugs.
Experiments can provide global properties of membranes
and, despite the great accuracy of techniques like NMR and X-
ray scattering in measuring the average position of atoms in
rigid structures, they face challenges when characterizing the
biologically relevant fluid phase, as opposed to the gel one that
emerges at lower temperatures.15−18 Alongside experimental
characterization, molecular dynamic (MD) simulations have
played a central role in the investigation of the behavior of
lipids, due to the atomistic spatial resolution they provide.
Therefore, MD simulations complement our understanding of
membranes’ behavior and are also important for the study of
lipid systems in combination with proteins, providing detailed
insights into the mechanisms of their interactions. In the past,
Received: May 25, 2019
Published: August 21, 2019
Article
pubs.acs.org/JCTCCite This: J. Chem. Theory Comput. 2019, 15, 5175−5193
© 2019 American Chemical Society 5175 DOI: 10.1021/acs.jctc.9b00509

































































































MD simulations have been successfully employed to reproduce
typical phenomena in membranes, such as lipids’ flip-flop,19,20
vesicle formation,21,22 aggregation into bilayers,23−25 and
stress-induced26−29 and peptide-induced pore formations.30−32
Moreover, the implementation of more realistic models of
bacterial membranes, by including a more diverse set of
components into the simulated systems, has been pursued33,34
to test specific interactions with antimicrobial peptides and
understand their selectivity.35,36
The reliability of such simulations depends on the accurate
parameterizations of lipids and proteins, which need to be
validated against experimental data. Moreover, the two
descriptions must be consistently integrated into the force
fields used, i.e., be derived with the same parameterization
procedure. Different approaches to the problem are possible,
which resulted in the development of multiple force fields
suitable for simulations of biomolecules: for example, the
CHARMM37−39 and AMBER40 force fields are parameterized
from quantum mechanics calculations, while GROMOS9641 is
calibrated to match global properties like the hydration free
energy of chemical moieties. All of them have been constantly
updated to meet the new experimental values available and
more faithfully reproduce the different species involved.
However, it is a very difficult task to parameterize the
constituents of a complex system so that all parameters are
consistent with the rest of the force field and reproduce both
the single-molecule observables and the collective behavior. In
the present work, we consider the parameterization of
phospholipids in the context of the GROMOS96 force
field,41 addressing some of the inconsistencies in the lipid
head group parameters commonly used so far, particularly in
consideration that these contribute to the description of
recognition processes at the interface.
In the past, lipid simulations using the GROMOS96 force
field suffered from difficulties involved in transferring the pre-
existing parameters, calibrated mainly for peptides in an
aqueous environment, to the amphiphilic environment of the
lipid assembly. This resulted in the failure to reproduce the
membranes’ behavior properly42−44 and therefore a series of
modifications were adopted, particularly in the choice of lipid-
specific Lennard-Jones interactions44−46 and partial charges.42
In the light of recent reparameterizations of a set of choline
moieties47 and of phosphate-containing species,48 we under-
take the task of updating the parameters used for lipids, in
particular, phosphocholines, as they contain both these
chemical moieties. Within this work, we show that it is
possible to integrate the recently computed partial charges
within simulations while maintaining good agreement with the
available experimental data. We also test the transferability of
the new phosphate charges onto lipids without a choline head
group, namely, phosphoethanolamine (POPE) and phospha-
tidylglycerol (POPG).
Most importantly, the new description of phosphocholine is
consistent with the GROMOS96 parameterization philosophy,
based on the decomposition of large molecules into smaller
compounds and subsequently fitting their parameters to
experimental hydration free energies. Together with adjust-
ments to specific van der Waals potentials, we believe that the
parameters presented here will contribute to improving the
accuracy of the description of membrane−solvent and
membrane−protein interactions. To this aim, we compared
the available parameters with the one proposed in this work,
simulating the interaction of an antimicrobial peptide with two
model membranes, highlighting the differences in the
mechanisms observed, and comparing them with the available
experimental evidence.
2. METHODS
2.1. Background to Lipid Force Fields. The most recent
iteration of the lipids’ parameters commonly used in
simulations with the GROMOS force field is the one by
Poger and Mark.44 They employed partial charges derived
quantum-mechanically by Chiu et al.,42 combined with a
modified repulsion between the choline methyl groups and the
OM oxygen atoms in the phosphate with respect to the
standard choline−OM one.
The original set of Chiu charges42 was derived from ab initio
Hartree−Fock self-consistent field calculations52 and Mulliken
population analysis.53 Slight modifications were applied to
make each individual charge group sum up to an integer value,
following the GROMOS96 philosophy. Despite the resulting
charges that differ substantially from the ones used for the
same chemical groups in different chemical contexts, the
GROMOS community employed this set as it gave results in
closer agreement with the available experimental data.
The refinement of van der Waals parameters for aliphatic
alkanes, together with the bond, bond angle, and torsional
parameters for the ester groups,49,50 prompted the reparamete-
rization of the lipids’ head group description: in particular,
Chandrasekhar et al.45 recomputed the head group torsional
parameters from ab initio quantum-mechanical torsional
profiles of each of the fragments composing the head group
(Figure 1).
The modifications above were included in the 53A6 version
of the GROMOS force field. However, an additional change
was necessary to match the experimental results. Therefore,
Poger and Mark44 introduced a change in the CH3 choline and
OM repulsion. The C12 parameter (related to the Pauli
repulsion) between the newly introduced atom-type CH3p (to
Figure 1. Evolution of the lipid parameters in the GROMOS force
field. ReferencesChiu1995: ref 42; Chandrasekhar2001, 2002,
2003: refs 45, 49, 50; Poger2010: ref 44; Kukol2009: ref 46;
Schmid2011: ref 51; Reif2012: ref 47; Margreitter2017: ref 48.
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represent the united methyl atoms in the choline head group of
lipids) and the oxygen-type OM, present in the phosphate
group, was increased by a factor of 3.5. This modification was
optimized and tested against experimental values, increases the
spacing between individual lipids, and thus leads to the
appropriate area per lipid (ApL).51,54 The new atom-type
CH3p has all of the characteristics of CH3, except for the
bespoke parameter, i.e., the Lennard-Jones interactions
involving OM. These Poger−Chiu parameters have been
successful in reproducing membrane behavior and were used in
many MD applications.55−57
Later, Reif et al.47 enhanced the methyl−methyl repulsion
for both CH3 and CH3p in the 54A8 parameter set, which
allowed for a decrease in the large repulsion value between
CH3p and OM previously introduced44 while still reproducing
experimental values. The 54A8 parameter set contains two
additional, nonlipid-specific, modifications important for this
work: the choline Lennard-Jones parameters and partial
charges, and the phosphate partial charges. The C12
Lennard-Jones repulsion term for the NL nitrogen atom type
(present in the choline moiety) was increased to successfully
prevent oversolvation.47,54 To the same end, the +1 e total
charge was evenly distributed over all five atoms, which
resulted in a better approximation of the experimentally
obtained hydration free energy in comparison to the 54A7
parameter set. Similarly, Margreitter et al.48 calibrated the
partial charges of four phosphate species and enhanced the
reproduction of experimental data. The relevant phosphate-
containing species for this work is dimethyl-phosphate, a
compound not directly present in force field versions prior to
54A8.
Another approach to lipid parameterization was proposed by
Kukol,46 namely, the use of the already available CH0 atom
type for the ester carbons in place of the standard C atom type,
in conjunction with the Chiu charges. This atom type,
designed to describe a bare sp3 carbon bound to four heavy
atoms, has a repulsion energy term 10−40 times larger than a
bare carbon bound to other atom types, enforcing a greater
spacing between lipid molecules and thereby increasing the
ApL. As this modification is also applicable in the absence of a
choline head group and does not require the introduction of
another atom type, this method can be used to parameterize
POPE and POPG.
2.2. Parameterization Strategy. In an effort to enhance
the consistency of the force field, we integrated the new partial
charges for the choline and phosphate moieties [Reif−
Margreitter (RM) charge set] into the lipid building blocks
of GROMOS 54A8 so that the entire phosphocholine head
group now follows the common GROMOS-like modeling
approach (Figure 2). Only the partial charges of the ester
groups remain as described in the Chiu set, a deviation from
the canonical parameterization strategy necessary to match the
experimental area per lipid values: Chandrasekhar et al.
showed in ref 59 that the replacement of the ester charges
with the standard ones for the ester moiety (parameterized to
reproduce the experimental free energies of hydration of a
series of alkane esters60) resulted in a much smaller area per
lipid, not compatible with the experimental values.
Figure 2. Partial charges for the phosphocholine head groups and the glycerol and ester moieties in the Chiu42 scheme (left) and the one tested in
the current work (right). Red font denotes values that have been changed between the two. Atoms belonging to the same charge groups are
enclosed by the same dashed polygon.
Table 1. Table of Simulations for Phosphocholine Bilayersa
simulations of phosphocholine lipids
sim chargesb FF CH3p−OM C12c (kJ mol−1 nm12) CH3p−CH3p C12d (kJ mol−1 nm12)
1 Chiu 54A7 1.58 × 10−5 2.66 × 10−5
2 Chiu 54A8 6.93 × 10−6 6.48 × 10−5
3 RM 54A8_v1 1.10 × 10−5 6.48 × 10−5
4 RM 54A8_v2 1.58 × 10−5 6.48 × 10−5
5 RM 54A8_v3 4.50 × 10−5 6.48 × 10−5
aAll are run for 500 ns and systems consisting of 512 lipid molecules (256 per layer), using a particle mesh Ewald (PME) long-range electrostatic
scheme. bCharge set: Chiu from Ref 42, Reif−Margreitter (RM) as illustrated in the present work. cAs a reference, the standard C12 parameter in
54A7/54A8 for CH3−OM is 4.44 × 10−6 kJ mol−1 nm12. dThe CH3−CH3 C12 parameters are 2.66 × 10−5 for each parameter set.
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The introduction of the new head group charges required a
refinement of the CH3p−OM Lennard-Jones repulsion, as the
54A8 value was set considering the original Chiu charges.
Ideally, one would always try to keep the force field terms as
much transferable as possible. Nevertheless, the complexity
and anisotropic nature of some biological environments can be
difficult to parametrize with single chemical groups, as the
same chemical group can behave differently according to the
context it is inserted in. Lipid systems are one of such
examples, and to maintain the correct physical behavior of the
system, we used specific C12 parameters for the CH3p−OM
repulsion in phosphocholine lipid atoms. This allows for a
more balanced description of the physicochemical properties
of the lipid bilayer and a better match with the available
experimental observables.
Aiming at this, and to disentangle the effect of charge
parameterization versus the CH3p−OM repulsion, we tested
three different values of such Lennard-Jones parameter with
the new charges while control simulations were run using the
Chiu partial charges and the GROMOS 54A7 or 54A8
parameter set for each lipid (Table 1). The phosphocholines
tested are 1,2-lauroyl-sn-glycero-3-phosphocholine (DLPC),
1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1,2-
dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-dipalmito-
yl-sn-glycero-3-phosphocholine (DPPC), and 2-oleoyl-1-pal-
mitoyl-sn-glycero-3-phosphocholine (POPC), which have
different tail lengths and numbers of unsaturated bonds as in
previous works44,61 (Table 2).
To prove the transferability of the new phosphate charges to
other lipid species, which do not contain a choline head group
(and thus an enhanced repulsion, which has an impact on the
ApL), test simulations of a phosphoethanolamine (POPE) and
a phosphoglycerol (POPG, Table 2) bilayer have been
performed. These lipids have amine and glycerol head groups,
respectively. The parameterization of both takes advantage of
the Kukol approach46 employing a CH0 atom for the ester
moieties to enhance the repulsion between lipids. For POPE
and POPG, simulations were run with the standard parameters
from ref 33 (denoted as Piggot−Chiu in the present work) or
with the updated phosphate partial charges (Supporting
Information (SI) Table 2).
The evolution of simulation techniques seen in the recent
years suggested two other changes in the simulation setup:
first, the original set of parameters was designed to be used
with a twin-range cutoff scheme and a reaction field long-range
electrostatic contribution,62 but the twin-range cutoff is no
longer supported in the latest versions of the GROMACS
software used for the present work.63 Additionally, the PME
algorithm64 for long-range electrostatic treatment is currently
the predominant method used for protein dynamics. In the
context of unifying the two fields of protein and lipid
simulations, we therefore opted for a PME long-range
treatment, running a control simulation (on the DPPC bilayer)
with a reaction field scheme to assess the impact of such a
change (SI Table 1).
The other change we adopted in comparison to the earlier
work was a larger system size. Due to computational
limitations, the original parameterization was performed on a
128-lipid bilayer,44 but recent advances allow for larger systems
to be simulated and we therefore used membranes four times
as large (512 lipids). This larger size allows to track larger
undulations of the membrane, as the effect of periodic
boundary conditions (PBCs) is less restrictive. Again, a control
simulation on a 128 DPPC membrane has been run to test the
relevance and the effect of this change (SI Table 1).
Finally, the improvements reached with the adoption of the
new parameters are monitored through the comparison with
experimental values, but it is useful to have benchmarks
derived from other simulation experiments. For that purpose,
we compare some key properties with the values obtained by
the all-atom CHARMM36 force field.37,65 Despite a thorough
comparison is beyond the present work, it is relevant to
observe whether the changes introduced by the new
parameters are going in the direction of the outcomes
proposed by other descriptions.
2.3. Simulation Systems. Seven pure lipid bilayers have
been simulated, five of which contain phosphocholines, one
phosphoethanolamine (POPE), and one phosphoglycerol
(POPG), as described in Table 2. Every bilayer is formed by
512 lipids (256 per leaflet), generated by replicating an
equilibrated 128-lipid system from the literature two times in
the x and y directions (see Table 2).
Water molecules were added to reach a minimum distance
of 7.5 nm between periodic copies of the membrane along the
z-direction, with a ratio of 85−120 H2O per lipid. This
distance is larger than the one used in the previous
parameterization publications because we observed an
enhanced undulatory behavior for larger membranes and
therefore a higher distance is necessary to avoid interactions
between periodic replicas in the z-direction.
2.4. Simulation Parameters. All simulations were run
using the GROMACS software version 2016.3,63,72,73 under
periodic boundary conditions in a rectangular box. The
temperature was maintained by coupling the membrane and
the solvent independently to an external bath using the
Berendsen thermostat74 with a coupling time τT of 0.1 ps, at
the reference temperatures indicated in Table 2, which are
above the gel−liquid phase transition temperature for each
lipid. The pressure was kept at 1 bar with a semi-isotropic
coupling using a Berendsen barostat,74 applying isothermal
Table 2. Details of the Systems Simulated: Lipid Name, Tail
Composition, Initial ApL (and Reference from Which the
Initial Coordinates Are Taken), Simulation Temperature,
and Gel−Liquid Phase Experimental Transition
Temperature
lipid bilayer systems
lipida tailsb ApL0 (nm
2) TMD (K) TC (K)
DLPC 12:0/12:0 0.63244 303 276.466−69
DMPC 14:0/14:0 0.61661 303 296.966−69
DOPC 18:1c9/18:1c9 0.64961 303 255.766−69
POPC 16:0/18:1c9 0.63861 303 270.566−69
DPPC 16:0/16:0 0.63161 323 314.266−69
POPE 16:0/18:1c9 0.56833 313 299.370
POPG 16:0/18:1c9 0.60233 303 268.171
aDLPC: 1,2-lauroyl-sn-glycero-3-phosphocholine, DMPC: 1,2-dimyr-
istoyl-sn-glycero-3-phosphocholine, DOPC: 1,2-dioleoyl-sn-glycero-3-
phosphocholine, POPC: 2-oleoyl-1-palmitoyl-sn-glycero-3-phospho-
choline, DPPC: 1,2-dipalmitoyl-sn-glycero-3-phosphocholine, POPE:
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine, POPG: 1-
palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1′-rac-glycerol). bExample:
16:0/18:1c9 indicates that tail 1 has 16 carbons with no unsaturated
bonds and tail 2 has 18 carbons with one unsaturated bond between
carbons 9 and 10ester carbon counts as number 1.
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compressibility of 4.5 × 10−5 bar−1 and a coupling constant τP
of 0.5 ps. Covalent bond lengths of the lipids were constrained
using the LINCS algorithm.75 The geometry of the simple
point charge water molecules was constrained using
SETTLE.76 A 2 fs time step was used, with a Verlet integration
scheme. The PME64 long-range treatment was applied to the
electrostatic interactions beyond a 1.4 nm cutoff, and the
reaction field scheme62 control simulation was run with the
same cutoff radius. A plain cutoff was used for van der Waals
interactions, with a cutoff radius of 1.4 nm.
Each system was initially energy-minimized and then
simulated at 50 K for 10 ps. Subsequently, the temperature
was increased gradually over 500 ps until the final simulation
temperature. The system was then simulated for 500 ns. The
equilibration of the systems was monitored by examining the
time evolution of the potential energy and the area per lipid:
200 ns is found to be sufficient to reach equilibration for all of
the bilayers (SI Figure 2) so that the analysis has been
performed over the last 300 ns of the production run, with
frames stored every 100 ps. An overview of the simulations
performed is given in Table 1 and SI Tables 1 and 2.
2.5. Analysis. To calibrate the lipid parameters, we used
the observables listed below, as common practice in standard
parameterization procedures.61,77
2.5.1. Area per Lipid. For systems where the membrane is
aligned to the xy plane, the area per lipid (ApL) can be
computed from the product of the lateral dimensions of the
simulation box divided by the number of lipids in one leaflet.
As shown in SI Figure 2 for DPPC, after 100 ns of simulation,
the ApL oscillates around a value with fluctuations of the same
magnitude, indicating equilibration. To allow further time for
local rearrangements, we restrict our analyses to the last 300 ns
of the simulations.
The equilibration protocol was verified on the DPPC
bilayer, repeating the computation of the ApL on two
nonoverlapping time windows, specifically between 200 and
350 ns and between 350 and 500 ns. For all of the parameter
sets, the two windows gave compatible values of the ApL,
confirming the convergence of the simulations (SI Figure 3).
The above procedure is valid if the membrane is flat or has
minor undulations only. To test this and verify that deviations
from planarity are not influencing the results, the ApL was
recomputed for DPPC taking into account membrane
undulations according to the procedure outlined in ref 78.
The differences with the values computed from the simulation
box dimensions were between 0.20 and 0.46%, which is lower
than the error derived from the standard deviation across the
simulation for any of the area per lipid computed.
As such, our computations are of value in rating the results
against experimental outcomes and/or to compare parameter
sets, as a local measure would not significantly improve the
comparison.
2.5.2. Isothermal Area Compressibility Module. Following
the protocol in ref 61, we computed the isothermal area
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where kB is the Boltzmann constant, ⟨T⟩ and ⟨ApL⟩ are the
ensemble averages of the temperature and the area per lipid,
respectively, nL is the number of lipids in one leaflet, and σApL
2
is the variance of ApL.
2.5.3. Bilayer Thickness. From the electron density profiles,
the bilayer thickness can be evaluated in several ways and
compared to the values from X-ray scattering experiments: the
hydrophobic thickness (DHH) is measured as the distance
between the phosphorus peaks in the two layers, as these
atoms have the highest electron density, while the Luzzati
thickness (DB)
61 is defined as
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where bz is the z-dimension of the simulation box and ρW(z) is
the volume fraction of water (vs other components) along z









where nW(z) is the time-averaged number of water molecules
in a bin of width dz, VW is the specific volume of the water
model used (taken from ref 79), and dV is the time-averaged
volume of a slice.
2.5.4. Dipole Potential. The dipole potential along the z-
direction (perpendicular to the membrane plane) can be
computed from the charge density along z (ρ(z)) via a double
integration82
z z z z( )
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Several choices are possible for the two integration constants,83
and for the present work, they are selected to set the dipole
potential to zero in the middle of the bulk water region, at both
sides of the membrane.
2.5.5. Deuterium Order Parameter of Lipid Chains. The
deuterium order parameters SCD of the acyl chains for each
lipid bilayer were calculated and compared between the
different sets studied. SCD evaluates the average order of the
lipid tails by measuring the orientation with respect to the
bilayer normal of a carbon−hydrogen bond in a given position
along the chain for each lipid in the bilayer. Their spread is
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As the GROMOS force field employs a united-atom
representation, the tetrahedral positions of the hydrogens are
constructed based on the neighboring carbons’ posi-
tions.58,80,81
2.5.6. Hydration of Head Groups. To estimate and
compare the hydration of lipid molecules, we computed the
distribution of the distances between the oxygen of water and
the nearest lipid atom. For each individual chemical group, the
distance between the water oxygen and the nearest atom
within that group was calculated. A quantitative measure for
hydration was obtained by integrating the distribution up to
the first peak or second one (for phosphate and glycerol).
2.5.7. Orientation of Head Groups. We computed the
orientation of the lipids’ head groups as the distribution of the
angle between the P−N vector (joining the phosphorus atom
and the choline nitrogen) and the outward normal to the
membrane. The orientation of the sn-1 and -2 carbonyl dipoles
with respect to the bilayer normal has also been calculated.
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Table 3. Average Area per Lipid (in nm2) over the Last 300 ns of Simulations for Phosphocholine Bilayersa
ApL (nm2)
ID charges/FF DLPC DMPC DOPC POPC DPPC
1 Chiu/54A7 0.608(4) 0.591(4) 0.600(5) 0.604(4) 0.616(4)
2 Chiu/54A8 0.626(5) 0.612(4) 0.623(4) 0.623(4) 0.635(5)
3 RM/54A8_v1 0.631(4) 0.616(5) 0.625(6) 0.629(5) 0.638(5)
4 RM/54A8_v2 0.652(5) 0.643(6) 0.649(5) 0.650(5) 0.657(5)




experimentalb 0.608−0.632 0.589−0.660 0.674−0.725 0.643−0.683 0.570−0.717
CHARMM3637 0.644(4) 0.608(2) 0.690(3) 0.647(2) 0.629(3)
aThe number in parentheses is the standard deviation of the last digit. All simulations are run at 303 K, except for DPPC (run at 323 K). Analogous
values for POPE and POPG are reported in SI Tables 6 and 8. bWe report the maximum and minimum values of a review of experimental results
given in Table 1 of ref 77. Only values referring to the temperature simulated are considered.
Figure 3. Area per lipid obtained for the five sets of parameters and seven lipid species. Error bars are the standard deviation over the 300 ns
analyzed. Dashed lines indicate the range of experimental values from Table 1 in refs 77 and 33. For the plot reporting POPE and POPG values, the
black dashed lines refer to POPE and the blue one to POPG.
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2.5.8. Lateral Diffusion. For each simulation, we extracted
the trajectory of the phosphorus atom of every lipid in the top
and bottom leaflets separately, removing the collective motion
of the leaflet. These trajectories were used to compute the
mean-square displacement (MSD) for each lipid as a function
of time, discarding the first 200 ns of production. This figure
was averaged over all of the lipids in the leaflet and, for a given
interval of time, on all of the possible time windows of that
length-fitting within the simulation time analyzed. The
diffusion coefficient D was obtained from a linear fit of the
average MSD profile, following the Einstein equation84 in two
dimensions
x x Dt( ) 40
2⟨ − ⟩ = (6)
The fit was performed discarding the first 50 ns of the profile,
where the behavior is not linear, and the last 100 ns, where the
poorer statistics leads to more noisy data. Coefficients obtained
for the two leaflets were averaged to give the value reported.
2.5.9. Tilt Modulus. We computed the tilt modulus
following the theoretical framework explained in ref 85.
According to this, the angle θ a lipid forms with the local













where C is a normalization constant, kB is the Boltzmann
constant, T is the temperature, and κt
l is the tilt modulus. This
can be extracted from a fit of the distribution or, for
computational reasons, from a fit of ln(P(θ)(sin θ)−1). The
direction in which a lipid points is taken as the vector joining
the center of mass of the terminal atoms of the tails and the
center of mass of selected atoms in the head group.
Specifically, the last three carbons of each tail are taken as
the reference for the first group, and the phosphorus and the
carbon from which the two tails divert for the second. The
computation was performed using a dedicated python
module85 available on the openStructure platform.86
2.6. Phase Transition. The set of new parameters
performing best according to the previous observables was
tested for sensitivity to temperature variations. A DPPC bilayer
was chosen as the reference system and simulated at two
additional temperatures: 303 and 333 K (SI Table 1), the first
of which is below the experimentally determined liquid to gel-
phase transition temperature.66−69 As DPPC has also been
used to perform the other control simulations, we opted for
this model membrane for consistency reasons.
Besides the standard analysis described before, the local area
per lipid was computed using a Dirichlet tessellation87 of the
lipid tail positions projected onto the horizontal plane parallel
to the membrane (one leaflet at the time). The tessellation
divides the plane into polygons, each enclosing one tail
position. Every polygon comprises the locations on the plane,
which are closer to the position of the head enclosed by that
polygon than to any other head.
Moreover, to quantify whether and how many lipids
undergo face transition during the simulations, the regular
packing of each of their chains was quantified by the hexagonal
order parameter S6, as previously reported in the literature.
88
Specifically, a chain was represented by its position on the xy
plane (parallel to the membrane surface), computed as the
average x and y positions of its carbon atoms. For each chain j,
the set of neighboring chains was defined as the ones within a









with θjk being the angle between the vector connecting j and k
and the x axis (i is the imaginary unit). A chain is in the gel
phase if it has an hexagonal order parameter larger than 0.72.88
3. RESULTS AND DISCUSSION
In general, the parameters described in this work are shown to
reproduce the available experimental target values well while,
at the same time, are likely to allow for a better description of
lipid−protein interactions, since the head groups are updated
to the recent GROMOS force field.
3.1. Area per Lipid and Isothermal Area Compressi-
bility Module. We report in Table 3 and Figure 3 the values
of ApL for the simulation run. From such computations, it
emerges that the increase of the CH3p−OM repulsion has a
nonlinear effect on the area per lipid, as reported in ref 54. On
the contrary, the comparison between simulation ID1 and the
control ID0 for DPPC, which differ only in their partial
charges, shows an almost identical ApL value (SI Figure 4).
This suggests that the charge redistribution in the head group
affects the global structure of the bilayer and the ApL less
dramatically than the adopted value for the Lennard-Jones
repulsion.
The comparison with the control simulation using a smaller
membrane shows that larger systems allow for the evaluation of
the ApL with a smaller error, as local fluctuations are averaged
over a larger number of lipids. The standard deviation
computed for the 128 lipids system is compatible with those
reported in both the original61 and a more recent
publication,89 in which the same system size was used.
The ApL from the simulation with a reaction field treatment
for the long-range electrostatic term does not differ
significantly from the one obtained with a PME treatment,
being only slightly higher, which is in consistence with what
was found in ref 90.
Finally, the values found using the Chiu charge set and the
54A7 force field (ID1 in Table 1) are systematically lower than
those obtained in the original publications,44,61 despite
employing the same charge set and force field, while a better
agreement is shown with those obtained more recently by Reif
et al. for DPPC.54 We attribute this to the different versions of
GROMACS used, as the integration algorithm has recently
been updated, affecting the calculated properties. Moreover,
the double-cutoff scheme is no longer supported, preventing a
faithful reproduction of the simulation setup used in ref 61.
The variability caused by these changes has been extensively
investigated by Reißer et al.89 and reflects the observed
discrepancy between the present and previous results.
From the considerations above, we suggest parameter set
RM/54A8_v1 as the one that best reproduces all of the tested
lipids at once. For DOPC and POPC bilayers, however,
parameter set RM/54A8_v2 performs slightly better: it must
be noticed that these two species present unsaturated bonds
along the tails, whose influence might not be fully represented
by any of the parameter sets. Indeed, it has been suggested that
only a polarizable force field would be able to correctly capture
the dynamics of the hydrophobic region of the membranes,91
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taking in proper account the difference between saturated and
unsaturated bonds.
For POPE and POPG, we resorted to the modification
proposed by Kukol,46 i.e., the use of the CH0 atom type for the
ester carbons (see Section 2). For both lipids, a good
agreement with experimental ApL values could be achieved
using the new partial charge parameters (Figure 3).
Along the same lines, when comparing the results with the
ones obtained with the CHARMM36 force field in its original
publication,65 we find DOPC, presenting an unsaturated bond
in each tail, to be the most diverging. In particular,
CHARMM36 better captures the spacing between the lipids,
enhanced due to the presence of the double bond, and we
suspect that this is due to its all-atom description.
Results of the isothermal area compressibility calculations
confirm the finding of refs 61 and 65 that KA values obtained
from simulation are about 1.5−3 times larger than those
measured experimentally (SI Table 3). This holds for all
parameter sets tested. Set RM/54A8_v1 performs better than
Figure 4. Electron density profiles of the hydrated DLPC, DMPC, DOPC, DPPC, and POPC bilayers (total) and of their individual components
(Cho: choline, PO4: phosphate, gly + carb: glycerol and carbonyl groups, CH2: methylenes of the acyl chains, CH: CHdCH groups in the oleoyl
chains, CH3: terminal methyls of the acyl chains) for simulation ID3 (54A8_v1 force field, Reif−Margreitter charges).
Table 4. Bilayer Thickness for Phosphocholine Bilayers, Derived from the Electron Density Profiles (Example in Figure 4)
According to the Phosphate or Luzzati Methodsa
hydrophobic thickness DHH (nm)
ID charges/FF DLPC DMPC DOPC POPC DPPC
1 Chiu/54A7 2.83 3.59 3.05 3.30 4.30
3 RM/54A8_v1 2.72 3.48 2.89 3.22 4.06
experimentb 3.08 3.44−3.60 3.53−3.71 3.70 3.42−3.83
Luzzati thickness DB (nm)
ID charges/FF DLPC DMPC DOPC POPC DPPC
1 Chiu/54A7 3.11 3.54 4.13 4.00 3.93
3 RM/54A8_v1 3.04 3.48 3.94 3.88 3.75
experimentb 3.14 3.63−3.96 3.59−3.87 3.68 3.50−3.83
aAll simulations were run at 303 K, except for DPPC (323 K). bValues from ref 44 and Table 2 in ref 61.
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Chiu/54A7 for all of the lipids tested but DLPC, for which the
results are equivalent.
The overestimation of the compressibility is likely due to the
underestimation of ApL fluctuations during dynamic simu-
lations. The KA value computed for the small, 128 lipids,
DPPC bilayer patch is smaller than the one computed for the
512 lipid ones (342 and 499 mN m−1, respectively), as the
small patch exhibits higher fluctuations of the ApL (see Section
3.1). It is thus evident that the size of the system plays a pivotal
role in obtaining correct fluctuations and global properties.
3.2. Electron and Charge Density Profile. Across
simulations with different parameters, the electron density
qualitatively maintains the same profile for each phosphocho-
line lipid. In Figure 4, the density for parameter set 54A8_v1
and all of the lipids is displayed (SI Figures 10−13 show the
same plot for the other parameter sets), while in SI Figures 5−
9, panel (b), the total and the phosphate group electron
densities are shown for the five parameter sets tested, for one
lipid at the time. The peak broadness shows a direct
relationship with the packing density of the bilayer: larger
ApL values correspond to a shallower profile of the density,
due to fluctuations of the membrane along the z axis and to
deeper penetration of water molecules into the bilayer.
The bilayer thickness was evaluated from the electron
density profiles, as explained in Section 2. Our parameters are
overall in better agreement with the Luzzati estimate of the
thickness rather than the hydrophobic one, but altogether,
these measurements (phosphate and Luzzati thickness) do not
strongly discriminate between sets. In Table 4, the values for
the Chiu/54A7 and RM/54A8_v1 sets are shown (see SI
Table 4 for the complete results).
Further comparison of the dipole potential profiles, obtained
from the charge density, shows how the RM/54A8_v1 charge
set gives results closer to the ones obtained in all-atom
simulations82,92 (see SI Section 1 for a complete discussion).
3.3. Order Parameter of the Acyl Chains. For all of the
lipids and parameter sets, SCD is lower than 0.25, which
indicates that the tails are generally disordered and the
membrane has not transitioned to a gel-like state,93 even for
the simulation with the lowest ApL. Figure 5 and SI Figures
14−17 display the computed values for specific parameter sets,
and SI Figures 5−9, panel (c), show a cross-parameter
comparison for each lipid. Comparing these different sets,
simulations denoted by ID from 1 to 5 show a consistently
decreasing SCD, in line with the increased area per lipid and
decreased bilayer thickness. This indicates that when the lipid
molecules are constrained in space, their tails tend to be
stretched and ordered. The presence of unsaturated bonds in
the DOPC and POPC lipids is captured, by all parameter sets,
as a decrease in SCD at the positions related to those bonds.
The main difference due to the introduction of the new
charges is in the decreased order observed for the first and
second carbon bonds of the sn-1 tail, which show SCD values
smaller than the ones for the third carbon bond, while with the
Chiu charges, a constant increase is observed with decreasing
carbon index for tail sn-1.
Figure 5. Deuterium order parameter SCD profiles of the sn-1 (solid curves) and sn-2 (dashed curves) fatty acyl chains of hydrated DLPC, DMPC,
DOPC, DPPC, and POPC bilayers calculated from simulations ID1 (54A7 force field, Chiu charges) and ID3 (54A8_v1 force field, Reif−
Margreitter charges). The SCD values are averaged over all of the lipid sn-1 and -2 acyl chains in the systems (proS hydrogen only). Experimental
values Douliez1995 from ref 94 and Petrache2000 ones from ref 95.
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Overall, the RM/54A8_v1 set is within the range of
experimental values94,95 (Figure 5); in particular, it captures
the low order of the first sn-2 carbon atom (numbered 2) well,
while the Chiu/54A7 set presents closer values in the central
region of the tails. However, it must be noticed that variability
is found within the experimental data (see the different
experimental values reported in Figure 5). Therefore, without
aiming at a perfect fit to such a small pool of experimental data,
we consider set RM/54A8_v1 as sufficiently accurate in
representing the experimental findings, in particular, in better
reproducing the regions in the vicinity of the head group, while
the description of the hydrophobic core remains less accurate
and subject to improvement.
3.4. Hydration of Head Groups and Glycerol/Carbon-
yl Moieties. The hydration of functional groups of lipids is a
key characteristic for both their dynamics and potential
interactions with other molecules, such as proteins. From the
distribution of distances between water oxygens and the
nearest atom of various lipid groups, it emerges that the new
partial charges modify the hydration profile of the lipid head
group (Figure 6 shows the comparison between parameter sets
for DPPC and SI Figures 17−20 for the other lipid bilayers).
The choline major peak at 0.38 nm and the phosphate one
at 0.30 nm are higher and sharper when employing the RM
charges rather than the Chiu ones, reflecting an increased
average hydration of these two moieties. Additionally, for the
simulations run with the RM charges, the choline profile does
not display the first, low intensity, peak obtained with the Chiu
set at 0.28 nm: indeed, the charges of choline and the
modification of the C12 Lennard-Jones repulsion for the NL
atom type introduced in parameter set 54A8 were optimized to
successfully prevent oversolvation, repelling water from its
core.47,54 The profiles of the other components are partially
influenced, as well. For the RM charges, the second peak for
glycerol increases its value and the two ester peaks have more
similar values between them (Figure 6, panel (c), and SI
Figures 17−20), which is consistent with deeper water
penetration.
To quantify the observed differences, the hydration profiles
were integrated up to the first peak or the second one in the
case of phosphate and glycerol (SI Table 5). The results show
that the average number of water molecules around the choline
group is higher for the RM/54A8_v1 set than for the Chiu/
54A7 one by one water molecule. This seems to contrast with
the increased hydrophobicity of the newly parameterized
choline moiety; however, this might partially be explained by
the changed orientation of the head groups (see Section 3.5)
and by the new parameterization of phosphate,48 which
accounted for the hydrogen bond potential of the most
solvent-accessible atoms, leading to a better solvation of the
head group in comparison to the Chiu/54A7 and Chiu/54A8
sets.
The integration up to the second peak of the distribution of
distances between the water oxygens and any lipid head group
atom gives values between 12 and 17 water molecules per lipid,
which is in agreement with the experimental range of 10−
20.96−99 Again, parameter set RM/54A8_v1 results in more
hydrated head groups (about one water molecule more for
each lipid) with respect to Chiu/54A7. Notably, the average
number of water molecules increases, as expected, for the
simulations resulting in a larger ApL (RM/54A8_v2 and RM/
54A8_v3). The trends above are confirmed by solvent-
accessible surface area values, which are higher for the choline
head groups described by the RM charge set with respect to
the Chiu one, while the values are closer between parameter
sets for the phosphate and glycerol moieties, which are more
deeply buried (SI Figure 21).
The increased hydration might be of relevance when
simulating interactions with peptides and proteins. Moreover,
as shown in a recent comparison between different lipid force
fields,65 the Chiu/54A7 parameter set results in a slightly less
hydrated head group with respect to the CHARMM3637 and
Lipid14101 force fields; therefore, the new set of parameters
achieves values closer to them.
3.5. Orientation of the Head Groups and Carbonyl
Moieties. The orientation of the head groups, defined by the
angle of the P−N vector with the outward bilayer normal, is
similar for all of the lipids within the same parameter set (see
SI Figure 22, top row). This indicates that the nature of the
tails does not strongly affect the behavior of the head group,
which is to be expected. Comparing different sets for DPPC
(Figure 7 and SI Figure 23), it emerges that with the Chiu
charges, the distribution of P−N angles is bimodal, with
preferred values around 60 and 90°, while the new charges
restrict the motion to the 60° configuration. Recent
experimental data support a value around 60° (see refs 100
and 102), as opposed to 90° as reported previously.103
It is noteworthy that this property was not part of the
calibration process, i.e., the agreement with the experimental
Figure 6. Distribution of the distance between the water oxygen and
the nearest lipid head group atom for simulation DPPC. Cho: choline,
PO4: phosphate, Gly: glycerol, CO1 and CO2: carbonyl groups at the
sn-1 and sn-2 positions.
Figure 7. Distribution of the P−N, CO1, and CO2 angles with
respect to the outward normal to the bilayer.
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observables in ref 102 is most likely due to a more accurate
description of the solvation of the choline and phosphate
moieties. Simulations performed by Botan et al.104 confirm that
smaller angles with respect to the membrane normal are caused
by a higher level of head group hydration, which is in line with
conclusions from the previous section. This difference in the
predominant configuration of the lipids’ head group will most
probably influence the interaction with proteins or peptides
approaching the interfacial region, providing a different
binding recognition landscape.
The orientation of the sn-1 and sn-2 carbonyl dipoles with
respect to the bilayer normal is again similar across different
lipids (SI Figure 22, middle and bottom rows). The
introduction of the RM charges has a small effect on these
dipoles, as a result of the spatial rearrangement of the nearby
head group. The most probable value for CO1 is shifted from
110 to 120° (Chiu vs RM charges), while the one for CO2
from 135 to 150°.
3.6. Lipid Lateral Diffusion. To correctly reproduce the
membrane and its functions, its dynamical characteristics are as
important as its structural ones. To address this, lipid lateral
diffusion can be measured and compared against experimental
data. Lateral diffusion is influenced by the area per lipid, with a
tighter packing preventing larger displacements but is not
solely determined by it.
Lateral diffusion coefficients (D) measured from simulations
are shown in Figure 8. As anticipated, the set with largest ApL
(54A8_v3) presents the highest values; however, parameter set
54A8_v1 gives significantly higher diffusion coefficients than
those obtained with the Chiu/54A7 set, despite the values of
ApL being similar. SI Figure 24 depicts a comparison of the
diffusion coefficient of DPPC between ID0 and ID1, which
differ only in the partial charges of the head groups. It confirms
that the RM charges (ID0) allow for more mobility of the
lipids with respect to Chiu ones (ID1), independent from all
other modifications to the force field.
Regarding the simulation conditions, the use of a reaction
field scheme increases the mobility by 34%, whereas the size of
the patch decreases it by a small but significant amount (19%;
see SI Figure 24). It is known that periodic boundary
conditions affect the evaluation of lipid diffusion;105,106
therefore, the larger the system simulated, the more accurate
the reproduction of the experimental values. However, the
change in the D due to the electrostatic treatment and the
patch size, taken in absolute terms (i.e., a difference of about
0.4 and 0.2 μm2 s−1, respectively), are small in comparison with
the effect due to the adoption of the new parameters (between
2 and 6 μm2 s−1).
The comparison with experimental values is challenging due
to the fact that different experimental techniques report values,
which are an order of magnitude apart. Poger et al. gave an
overview of this variability for DPPC bilayers in Table 2 of ref
77 and observed that values span from 0.5 to 50 μm2 s−1. In
this view, the values obtained in the present work for DPPC
are well within the range, regardless of the parameter set
chosen. However, we report experimental values from ref 107
obtained through pulsed-field gradient nuclear magnetic
resonance as a guide. Additionally, we report the values
obtained with CHARMM36 in ref 65. The CHARMM36
benchmarks are present only for two of the phosphocholines
analyzed in this work and show that the values obtained with
this force field span a broader range. The consistently low
values of D computed with the different GROMOS parameter
sets in this work are in agreement with what was found in the
literature.108,109
3.7. Tilt Modulus. We report in Figure 9 the values of κt
l
obtained for each of the phosphocholines considered and each
parameter set tested. For comparison, we plot the experimental
values obtained by Nagle et al. in ref 110 and the results from
simulations using the CHARMM36 force field.111 Given that
the data show quite a large spread in their values depending on
the actual experimental setup used, for the comparison, we
selected values, which were all obtained under the same
conditions, for both the experiments and the computational
results.
The plot shows that the tilt modulus κt
l varies between 3 and
5 × 10−20 J nm−2. In simulations resulting in larger ApL (e.g.,
parameter set 54A8_v3), the lipids are in a less dense
environment and can better accommodate changes in their
orientations resulting in a lower tilt modulus (the tilt modulus
gives the energy necessary for tilting the lipids per unit area).
The comparison with the experimental values is very good
for DMPC and DPPC, while it is poorer for DLPC and very
poor for DOPC and POPC, which harbor unsaturated bonds
in the tails. Results from the CHARMM36 simulations show
more variability between different phosphocholines, but a
similar if not lower agreement with the experiment (for
example, for DOPC). In general, comparing the results
together, we think that we achieved a sufficiently qualitative
agreement with the previous computational literature.
The discrepancy with experiments (both for our results and
for the ones from ref 111) is likely due to computational
limitations: as the tilt is retrieved from an ensemble
Figure 8. Lateral diffusion coefficient of DLPC, DMPC, DOPC,
DPPC, and POPC bilayers for different parameter sets.
Figure 9. Tilt modulus κt
l computed from the distribution of lipid tilt
angles along the last 300 ns of the trajectories. The results are
compared with the experimental values from ref 110 and the ones
obtained (with the same procedure as employed here) from
CHARMM36 simulations in ref 111.
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distribution, larger and longer simulations are more likely to
give a better result. Moreover, as briefly mentioned at various
points in the manuscript, artifacts arising in the hydrophobic
regions of lipids (such as the suboptimal modeling of
unsaturated tails) will probably only be resolved using a
polarizable description.
3.8. Phase Transition Behavior. The previous analysis
points to parameter set 54A8_v1 as the one that best
reproduces the experimental properties for each of the lipids
simulated. Therefore, we test this set further to assess its ability
to reproduce the change in lipid behavior under different
temperature conditions. As mentioned in Section 2.6, we use
as test system the DPPC bilayer patch.
The comparison between simulations at 323 and 333 K
shows that the global area per lipid increases with temperature,
consistently with what was expected. Parameter set 54A8_v1
captures the increase in lipid spacing, with a slight under-
estimation of ApL at 333 K with respect to the experiments
(for 54A8_v1 and experiments, respectively: 0.624(6) vs
0.631(13) nm2 at 323 K and 0.634(5) vs 0.650(13) nm2 at 333
K). The experimental ApL is measured at a different
temperature with the same experimental setup.16
The simulation at 303 K shows the formation of a patch of
ordered lipids, suggesting that the parameters can reproduce
different phases: two nucleation sites for the gelification
process are observed in both the upper leaflet and lower leaflet,
in nonmatching positions, and the gel front extends over time.
To classify the phase a lipid belongs to, we computed the
hexagonal order parameter S6 for each chain from the last
frame of the simulation (time point 400 ns). Figure 10 shows
the position of the chains on the xy plane, for each leaflet
separately, color-coded by S6: the regions where S6 is larger
correspond to a densely packed area with a quasi-hexagonal
lattice. In particular, the center of the ordered patches has S6
values larger than 0.72 (last two colors of the scale), i.e., it can
be classified as a gel. Overall, 20% of chains have undergone
this transition within the time simulated.
Averaging over all of the lipids, S6 at 303 K is 0.45. As a
comparison, we computed this average quantity on the last
frame of the simulations performed at 323 and 333 K, finding
0.28 and 0.27, respectively (with only six and three chains
above the gel threshold of 0.72).
A hexagonal order can be obtained when the tails are well
ordered and parallel to each other, standing in a vertical
straight conformation (SI Figure 25 shows a detail of a well-
ordered gel patch). We thus compute the SCD order parameter
of the acyl chains averaging separately over the lipids for which
at least one chain has an S6 value larger than the 0.72 threshold
(168 lipids overall) and for the others. The last 100 ns of the
simulation time was used. These values are compared to the
average SCD from the simulations at 323 and 333 K. Figure 11
shows highly ordered tails for the membrane simulated below
the transition temperature, for both the gel and nongel lipids
(classified according to the S6 threshold). This suggests that
the full patch is undergoing a phase transition, but the
completion of the process is not seen due to the short
simulation time scale. As a comparison, tails at 323 and 333 K
are much more disordered, with a slight decrease in order with
increasing temperature.
Finally, we computed the local area per lipid chain from a
Dirichlet tessellation of the same set of points used to calculate
the hexagonal order parameter. The average values over the
gel-phase tails (multiplied by 2) give an ApL of 0.438 ± 0.038
nm2, while the remaining of the chains have widely spread
values, correlated to their S6 parameter, giving an average of
0.57 ± 0.18 nm2. The values found for the gel patches (at 303
K) are close to the experimental outcomes by Nagle et al. of
0.473 nm2 at 293 K112 and 0.479(2) at 297 K.113 The value
computed from simulations is smaller likely because it is
computed only over the tails perfectly packed in a hexagonal
lattice.
Altogether, these results prove that the newly developed
parameters can successfully reproduce the gel phase when a
lipid patch is simulated below the phase transition temper-
ature.
3.9. Transferability to POPE and POPG. As mentioned
above, the areas per lipid values of POPE and POPG
simulations, where the phosphate partial charges have been
replaced with the RM values and, in the case of POPE, the
amine partial charges have been updated according to the
54A8 force field, are in good agreement with the available
experimental data.
For POPE, a slightly enhanced hydration is obtained from
the update of the phosphate charges (from 5.7 to 6.4 water
Figure 10. Hexagonal order parameter S6 for lipid acyl chains
computed on the last frame of a DPPC bilayer simulation using
54A8_v1 parameters. Each point corresponds to the average position
of the carbon atoms of the respective chain on the xy plane. Thus,
every lipid is represented by two points in these plots. Solid black
lines denote the boundaries of the simulation box and chains of the
periodic images (used for the computation of S6 boundaries) are
shown faded out. Colors from red to blue denote an increasing S6
value: the last two indicate gel-phase lipids.
Figure 11. Order parameter for the acyl chain sn-2 for a DPPC bilayer
simulated at a different temperature. The average is performed
including both leaflets. For the simulation at 303 K, the lipids were
split in two groups according to their hexagonal order parameter S6
and the acyl chain order parameter SCD computed for each of them.
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molecules per lipid with experimental values between 4 and
7;114,115 see SI Table 7) with similar results in terms of
thickness DB (3.89 nm for Chiu and 3.92 for RM set, with an
experimental value of 4.13 nm;116 SI Table 6 and SI Figures 26
and 27). Overall, these results confirm the transferability of the
new phosphate charges to different types of phospholipids.
4. INTERACTION WITH PROTEINS
The adoption of the updated parameters enhances the
consistency with the GROMOS parameters for protein
simulations. To test how this affects the simulations of
peptides interacting with a membrane, we performed addi-
tional simulations of a small antimicrobial peptide on the
surface of two different model membranes.
The peptide selected is bovine lactoferricin (PDB code
1LFC). It has a length of 25 amino acids and adopts a β-
hairpin conformation in solution, with many aromatic
hydrophobic residues on one side and charged amino acids
distributed all over.117 This peptide is antimicrobial and
therefore found to preferentially bind bacterial membranes
Table 5. Binding Time of Lactoferricin (LFC) Peptide to the Model Membranes in Examinationa
binding time (ns)
DLPC/DLPG 3:1 POPC
OI OII OIII OIV OI OII OIII OIV
Chiu/54A8 0.5 3.8 6.3 2.8 13.9 21.9 (65.0) 13.9
RM/54A8_v1 2.8 75.2 62.0 9.6 1.0 NA NA NA
aNA denotes no binding observed in the time simulated (100 ns). For POPC/OIII simulated with parameter sets Chiu/54A8, the binding time is
in parentheses as LFC approaches the membrane but maintains a 0.4 nm distance (±0.02), which is higher than the threshold chosen to define a
binding event.
Figure 12. Final configurations of the simulations of LFC on a DLPC/DLPG 3:1 membrane, starting from four different initial orientations OI−
OIV. OII, OIII, and OIV are obtained from OI with an anticlockwise rotation of, respectively, 90, 180, and 270° along the main axis (x axis in the
top right panel). LFC is colored by residue type (blue charged, green hydrophilic, white hydrophobic); phosphorus atoms are shown in golden
beads. The terminal and hinge regions of 1LFC are indicated (TER, hinge), together with GLN7 as a red dot to help the visualization. The insets
shows a cartoon representation of the initial and final configurations, highlighting the positive patches as blue dots.
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One can model the bacterial membrane by a mixture of
zwitterionic and anionic lipids. The latter are characteristic of
the cell wall of both Gram-positive and -negative bacte-
ria.120,121 In this study, we selected the mixture DLPC/DLPG
with a 3:1 ratio that has been used to elucidate the
antimicrobial activity of lactoferricin-derived peptides.122 As
for the mammal membrane description, we used POPC as it
has been often used in molecular dynamics simulations with
this purpose.123−125 Despite being rather simple, these or
similar model membranes have often been used in experiments
to test, among others, the effects of antimicrobial peptides
upon binding.14
Molecular simulations can shed light on the differences in
the binding process of LFC to antimicrobial and mammal
model membranes. Our parameterization should then reflect a
sensible difference in the binding behavior for these two cases.
The exact binding mechanism of LFC to a membrane is not
fully understood, and a number of experimental papers have
hypothesized binding modes for the interactions of this peptide
with model membranes. A mutation study in LFC1−15 suggests
that Trp residues anchor the peptide to the membrane as the
antimicrobial activity of the peptide was retained only when
Trp was mutated in equally hydrophobic amino acids.126
However, the role of Trp seems to be different in other
antimicrobial peptides, where they reside at the lipid−water
interface and form hydrogen bonds with the moieties
nearby.127 As experiments on the full-length peptide (25
amino acids) have not yet been reported and the full sequence
contains additional charged and hydrophobic residues, it
remains unclear whether this additional region would change
the aforementioned binding mechanism. We therefore decided
to use molecular dynamics simulations to elucidate molecular
determinants in discriminating the binding of the peptide to
mammal and bacterial membranes.
In order to not be biased by the initial configuration adopted
in the simulation, we performed multiple simulations with
different initial orientations of the peptide relative to the
membrane. The hairpin main axis was aligned to the
membrane plane and the peptide rotated around this axis in
steps of 90°, leading to four different starting orientations
named OI, OII, OIII, and OIV (SI Figure 29). This allows
different segments of the sequence (and thus amino acids with
different chemical characteristics) to face the membrane in the
initial positioning. The initial minimum distance between the
peptide and the lipids was set to 2 nm. The simulation length
was 100 ns each, sufficient to see the binding process in all of
the control cases.
The simulations have been performed for the proposed RM/
54A8_v1 parameter set and the Chiu/54A8 one (control
cases) to compare with the most recent set available in
GROMOS and highlight the difference of the newly para-
meterized lipid head groups.
To quantify the outcome of the simulations, we monitored
the time at which the peptide binds (always irreversibly) to the
membrane as the time at which the minimum distance
between the peptide and the membrane is below 0.3 nm
(Table 5). The cutoff was chosen, analyzing the configurations
after LFC bound to the membrane, which resulted generally to
stabilize around a minimum distance of 0.25 nm. The
minimum distance was computed every 100 ps, and a running
average was applied with a 10 frame window. Additionally, the
insertion depth of each amino acid in the membrane has been
calculated as the difference between the z position of the
lowest atom of the amino acid and the average of the
maximum z coordinate of the five lipids closest to it.
Table 5 shows the different binding times for LFC against a
mixed DLPC/DLPG or pure POPC membrane patch. For the
mixed, anionic membrane, the new parameters favor a slower
and weaker binding process. Indeed, with parameter set Chiu/
54A8, the peptide is quickly sequestrated by the lipids due to
the opposite charge interaction. This favors an unspecific
binding, dependent on the sequence facing the membrane in
the initial configuration (Figure 12 and SI Movie 1). In Figure
13, the average insertion in the membrane after the binding is
plotted for each amino acid: Chiu/54A8 favors a deep
insertion of differently charged residues for different runs.
The RM/54A8_v1 simulations produce a less inserted
configuration of LFC and a more consistent protrusion of
the hinge region out of the membrane, i.e., the central stretch
of amino acids between Met and Leu (Figure 13), as three out
of the four simulations (all but OIII) show this behavior.
The angular orientation of the peptide around its axis has
been computed as the angle formed with the z axis by the
backbone carbon and nitrogen bonded via a hydrogen bond
(amino acids 7 with 19 and 9 with 17), confirming that the
new set of parameters allows for more freedom in the
reorientation of the initial configurations, while the previous
one tends to keep them close to the original configuration (SI
Figure 30). Additionally, the new set of parameters seems to
favor the reorientation of the peptide as to face the Trp
residues toward the membrane surface in three out of the four
simulations, in contrast with the results from the previous
parameterization. This preference for the interfacial region is a
known mechanism in the membrane binding of Trp- and Arg-
rich peptides.127
When simulating a pure POPC membrane (here considered
as a mammal membrane model), the resulting binding poses
obtained with the Chiu/54A8 and different initial conditions
are consistent among each other; in particular, the three amino
acids Lys12−Leu13−Gly14 located at the hinge of the hairpin
promote the insertion, while the terminal region stays exposed
in solution. Therefore, parameter set Chiu/54A8 discriminates
between the two membranes as it suggests a weaker binding to
the mammal one. However, with the parameter set RM/
Figure 13. Average insertion depth of each amino acid after binding
of the LFC peptide as per Table 5. The zero value is the top of the
membrane plane so that a negative depth means insertion into the
membrane. Some reference amino acids are displayed at the bottom.
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54A8_v1, three out of the four simulations result in no binding
at all, in agreement with experimental findings.118 The
remaining simulation (OI) shows a quick binding event,
promoted by the terminal regions as observed for three out of
four simulations with the DLPC/DLPG 3:1 membrane.
The results above highlight that the new parameters show a
membrane-binding process less dependent on the initial
conditions, allowing for a dynamical rearrangement of the
protein at the membrane interface. This comes at the expenses
of a longer sampling time needed to observe binding events for
most of the configurations chosen. Future work will focus on
systematic comparisons of available peptide−membrane
simulations with other parameterizations and on longer
simulated times.
The difference between the behavior on a model bacterial or
mammal membrane is more pronounced for the new
parameters, and this is consistent with the selective
antimicrobial action of the peptide and its low hemolytic
activity.118,119 Overall, we think that these new parameters
show promising characteristics for the simulation of mem-
brane−peptide interactions within the GROMOS force field,
particularly for the study of interfacial absorption.
5. CONCLUSIONS
In this work, we present a reparameterization of a range of
phospholipids in the context of the GROMOS force field,
taking advantage of recent optimizations reported for key
chemical groups in these molecules. The effect of the newly
adopted head group partial charges has been tested extensively
to ensure that they match experimentally observable character-
istics of lipid bilayers. In parallel, we tested the effect of the van
der Waals repulsion between the choline methyl groups and
the phosphate oxygens, as it was modified by Poger et al. to
reproduce the experimental area per lipid values while using
the partial charges derived by Chiu et al. A summary of the
updated parameters and simulation conditions is available in SI
Table 10.
The work proves that the new charges are suitable to
describe all of the phosphocholine bilayers tested, matching
the experimental values as successfully as the previous
parameter set. The major advantage of the Reif−Margreitter
set lies in the partial charges of the head group, which are
derived by applying the GROMOS parameterization philoso-
phy rather than quantum mechanics calculations, thereby
providing a description, which is more consistent with the
parameters adopted for other biomolecules such as proteins
within this force field. By using the updated partial charges for
the choline (more hydrophobic) and phosphate (more
hydrophilic) groups, the parameters also show a better
reproduction of the average head group orientation, which
was recently reassessed by experiments. The value of the
Lennard-Jones repulsion term found to best reproduce the
experimental values is the one in set 54A8_v1, which is set to a
value in between that of the 54A7 and 54A8 parameter sets.
In the Reif−Margreitter parameter set, only the partial
charges of the ester groups remain as described in the Chiu
charge set. Preliminary work has been started to test the
influence of the ester charges in combination with the new
ones for the head group but, in accordance to what was
previously found by Chandrasekhar et al. (ref 59), the
replacement of the ester charges with the standard ones for
the ester moiety resulted in values of area per lipid too low
with respect to the experimental findings. As mentioned
previously, it is possible that this discrepancy with the rest of
the force field can only be avoided by adopting a polarizable
force field.91 However, in the absence of further sophisticated
changes to the force field parameterization, we are confident
that the proposed parameters are a major step forward in the
description of lipid head groups and they should enable
improved modeling of the interaction of lipids with water and
other soluble molecules.
The new phosphate partial charges have been proved to
transfer well to other phospholipids not presenting a choline
head. For those lipids, the Kukol modification, which takes
advantage of a different atom type for the ester carbon, is
adopted to obtain the correct area per lipid.
Finally, the performance in reproducing some specific
peptide−membrane interactions was tested. In this respect,
the new parameter set shows significant differences with
respect to the latest Chiu/54A8 set: it better discriminates the
binding of an antimicrobial sequence on a bacterial versus a
mammal membrane. Additionally, it favors a weaker and more
dynamic binding, which is less biased from the initial
conditions of the simulations.
In conclusion, we believe that the new Reif−Margreitter
charge set together with the GROMOS 54A8_v1 parameter set
is a major improvement on the previous iteration of the
GROMOS lipid force field and should be particularly suited for
protein−membrane systems, such as studies including small
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1 Supplementary results: dipole potential
For the five phospholipids and the five different parameters tested, we computed the dipole
potential across the membrane, according to the procedure outlined in Section 2.5 of the
paper.
The results are outlined in Figure 1 and show a striking difference between the profiles
obtained with the Chiu partial charges set and the Reif-Margreitter one: in particular, while
the former suggests local maxima of the dipole potential in the head regions, the latter results
in a potential rising to its higher value in the center of the tails region.
Figure 1: Dipole potential for respectively: (left) a DPPC bilayer, simulated with the five
parameter sets explored in the manuscript; (center) the five different phospholipid considered
and parameter set Chiu/54a7; (right) the five different phospholipid considered and parameter
set RM/54a8_v1.
The results for the Chiu set of partial charges (and either the 54a7 or 54a8 GROMOS force
field) are compatible with what obtained previously by Gurtovenko et al. in Ref. [7] using
the same charges and the Berger force field (a slight modification of GROMOS tailored for
lipids simulations). On the contrary, the new results are qualitatively more similar to what
obtained with the all atom force field CHARMM36 in Ref. [4] and [23], as they both suggest
a peak of the potential in the lipid tail regions. However, with respect to the CHARMM36
profiles, the ones obtained by the RM/54a8_v1 parameters give a flatter trend in the center
4
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of the bilayer. Moreover, the peaks relative to the phosphate regions are shallower for the
RM/54a8_v1 simulations with respect to the CHARMM ones.
To discriminate between the two behaviours it is necessary a comparison with experimental
results. Few works compute the profile of the dipole potential along the bilayer normal,
focussing instead on measuring the difference between the dipole potential on the two sides of
the bilayer [20, 19, 13]. Never the less, Wang et al. [22] measured its profile for ester-DPhPC
lipid vesicles, suggesting a peak in the central region of the bilayer. This lipid is derived
from DPPC by adding an ester linkage: as such, its profile will not be identical to the one
produced by DPPC, but being the modification in the ester region only, we can assume that
the qualitative trend remains the same and thus can be used for the present comparison.
Additionally to experimental data, theoretical profiles obtained from ab initio calculations
and geometrical assumptions on the structure of lipids bilayers suggest indeed a plateau in
the tail region [3] - or at the very least do not support the presence of peaks in the head
regions, as showed when the Chiu charge set is used in the simulations.
For all the above reasons we once more consider the new set of parameter (RM/54a8_v1)
as a better compromise than the previous sets Chiu/54a7 or Chiu/54a8.
5
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Supplementary Movie 1: file LFC_54a8_v1_0.mp4
The movie displays the simulation of LFC on a bacterial membrane (composition DLPC:DLPG
with 3:1 ratio) for both parameter set Chiu/54a8 (left half) and RM/54a8_v1 (right half),
starting from orientation OII. The lipid choline and phosphate atoms are shown as van der
Waals beads, the protein as cyan cartoon and bonds coloured by residue type (blue positive,




Sim Charges a FF Long range ES b Nr lipids T (K)
0 RM 54A7 PME 512 323
RF Chiu 54A7 RF 512 323
Small Chiu 54A7 PME 128 323
303 RM 54A8_v1 PME 512 303
333 RM 54A8_v1 PME 512 333
Table 1: Table of additional control simulations, run on the DPPC bilayer. a Charge set:
Chiu from Ref [2], RM Reif-Margreitter as illustrated in the present work. b RF reaction field
[21], PME Particle Mesh Ewald summation [6].
Simulations of POPE
Sim Charges a FF Ester carbon type
1CH0 PC 54a8 CH0
CH0 RM 54a8 CH0
Table 2: Table of simulations for POPE. All are run for 500 ns and systems consisting of 512
lipid molecules (256 per layer), using a PME long range electrostatic scheme. a Charge set:










ID Charges/FF DLPC DMPC DOPC POPC DPPC
1 Chiu/54A7 553 477 607 515 499
2 Chiu/54a8 471 500 471 679 612
3 RM/54a8_v1 562 354 485 397 329
4 RM/54a8_v2 365 318 518 466 406
5 RM/54a8_v3 332 300 426 345 376
Experiment a 234(23) 188-265(18) 231(20) 180-330 248(20)
Table 3: Average isothermal area compressibility moduleKA over the last 300 ns of simulations
for phosphocholine bilayers. All simulations run at 303 K, except for DPPC (323 K). a Values
from Ref. [9] and Table 1 in Ref. [15], in parenthesis the standard error on the last digit is
shown.
Hydrophobic thickness DHH (nm)
ID Charges/FF DLPC DMPC DOPC POPC DPPC
1 Chiu/54A7 2.83 3.59 3.05 3.30 4.30
2 Chiu/54a8 2.78 3.52 2.90 3.14 4.21
3 RM/54a8_v1 2.72 3.48 2.89 3.22 4.06
4 RM/54a8_v2 2.61 3.33 2.82 3.08 4.06
5 RM/54a8_v3 2.38 3.13 2.65 2.86 3.77
Experiment a 3.08 3.44-3.60 3.53-3.71 3.70 3.42-3.83
Luzzati thickness DB (nm)
ID Charges/FF DLPC DMPC DOPC POPC DPPC
1 Chiu/54A7 3.11 3.54 4.13 4.00 3.93
2 Chiu/54a8 3.14 3.61 3.97 3.96 3.96
3 RM/54a8_v1 3.04 3.48 3.94 3.88 3.75
4 RM/54a8_v2 3.00 3.34 3.87 3.77 3.74
5 RM/54a8_v3 2.80 3.21 3.62 3.57 3.50
Experiment a 3.14 3.63-3.96 3.59-3.87 3.68 3.50-3.83
Table 4: Bilayer thickness, according to the Phosphate or Luzzati methods, derived from the
electron density profiles of phosphocholine bilayers. All simulations run at 303 K, except for
DPPC (323 K). a Values from Ref. [16] and Table 1 in Ref. [15]
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Nr water molecules per group
Group ID DLPC DMPC DOPC DPPC POPC
All 1 3.9 (13.2) 3.8 (12.9) 3.9 (13.3) 3.7 (12.7) 3.8 (13.1)
2 3.6 (12.7) 3.5 (12.4) 3.6 (12.9) 3.4 (12.3) 3.6 (12.6)
3 4.3 (14.1) 4.3 (13.8) 4.4 (14.3) 4.2 (13.7) 4.3 (14.1)
4 4.6 (15.1) 4.6 (15.0) 4.6 (15.1) 4.5 (14.7) 4.6 (15.1)
5 5.1 (16.9) 5.1 (16.8) 5.0 (16.9) 4.9 (16.6) 5.1 (16.8)
Cho 1 13.1 12.8 13.3 12.6 13.1
2 12.6 12.3 12.7 12.2 12.5
3 14.3 14.1 14.5 13.9 14.3
4 15.3 15.2 15.4 14.9 15.3
5 17.0 16.9 17.0 16.7 17.0
PO4 1 3.1 (9.8) 3.0 (9.6) 3.1 (9.9) 3.1 (9.6) 3.1 (9.8)
2 2.6 (9.3) 2.5 (9.0) 2.6 (9.4) 2.6 (9.2) 2.5 (9.2)
3 4.0 (9.8) 4.0 (9.6) 4.0 (9.9) 3.9 (9.8) 4.0 (9.8)
4 4.3 (10.3) 4.3 (10.3) 4.3 (10.4) 4.2 (10.3) 4.3 (10.4)
5 4.8 (11.5) 4.7 (11.5) 4.8 (11.5) 4.7 (11.5) 4.8 (11.5)
Gly 1 0.3 (3.5) 0.3 (3.4) 0.3 (3.5) 0.3 (3.4) 0.3 (3.5)
2 0.3 (3.4) 0.2 (3.2) 0.3 (3.4) 0.2 (3.3) 0.2 (3.3)
3 0 (3.5) 0 (3.5) 0 (3.6) 0 (3.4) 0 (3.5)
4 0 (3.8) 0 (3.8) 0 (3.8) 0 (3.7) 0 (3.8)
5 0 (4.3) 0 (4.3) 0 (4.2) 0 (4.2) 0 (4.3)
CO1 1 1.4 1.4 1.4 1.4 1.4
2 1.5 1.5 1.5 1.5 1.5
3 1.2 1.2 1.2 1.1 1.2
4 1.3 1.2 1.3 1.1 1.3
5 1.3 1.3 1.3 1.3 1.3
CO2 1 0.5 0.5 0.5 0.5 0.5
2 0.6 0.6 0.6 0.6 0.6
3 0.7 0.6 0.7 0.6 0.7
4 0.7 0.7 0.7 0.7 0.7
5 0.8 0.8 0.8 0.8 0.8
Table 5: Integrated value of water molecules around each lipid and for their constituting
chemical groups (Cho: choline, PO4: phosphate, Gly: glycerol, CO1 and CO2: carbonyl
groups at the sn-1 and sn-2 positions). The integration is performed up to the first peak and,
if applicable, to the second (the latter of which is given in brackets). Peak positions are the
same throughout the simulations, except for glycerol in ID3 to ID5, where the first peak is









POPE (313 K) structural properties
ID Charges/FF/ester ApL (nm2) KA (mN m−1) DHH (nm) DB (nm)
1CH0 Chiu/54a8/CH0 0.591(5) 437 2.48 3.92
CH0 RM/54a8/CH0 0.595(5) 361 2.52 3.89
Experiment a 0.566 – – 4.13
Table 6: Area per lipid, lateral compressibility and bilayer thickness, according to the phos-
phate or Luzzati methods, derived from the electron density profiles for POPE bilayer. a
From [17].
POPE (313 K) Nr water molecules per group
ID Charges/FF/ester All Am PO4 Gly CO1 CO2
1CH0 Chiu/54a8/CH0 1.6 (5.7) 2.2 3.3 (10.6) 0 (3.4) 0.8 0.5
CH0 RM/54a8/CH0 2.1 (6.4) 2.5 4.2 (11.3) 0 (3.6) 0.6 0.6
Table 7: Number of water molecules per lipid hydrating the POPE bilayer and its different
polar moieties (Am: amine, PO4: phosphate, Gly: glycerol, CO1 and CO2: carbonyl groups at
the sn-1 and sn-2 positions). Integration was performed up to the first peak and when relevant
to the second one (value in bracket). Peak positions are the same for both simulations.
POPG (303 K) structural properties
ID Charges/FF/ester ApL (nm2) KA (mN m−1) DHH (nm) DB (nm)
CH0 RM/54a8/CH0 0.646(7) 198 3.76 3.98
Experiment a 0.661(13) – 3.74(7) –
Table 8: Area per lipid, lateral compressibility and bilayer thickness, according to the phos-
phate or Luzzati methods, derived from the electron density profiles. a From [11].
POPG (303 K) Nr water molecules per group
ID Charges/FF/ester All Etam PO4 Gly CO1 CO2
H0 RM/54a8/CH0 0.2 (3.7) 0.5 (7.8) 3.9 3.2 (6.2) 0.5 0.4
Table 9: Number of water molecules per lipid hydrating the POPG bilayer and its different
polar moieties (Etam: etamine, PO4: phosphate, Gly: glycerol, CO1 and CO2: carbonyl
groups at the sn-1 and sn-2 positions). Integration was performed up to the first peak, and
when relevant to the second one (value in bracket). Peak positions are the same for both
simulations.
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Comparison with the previous parameterization work
Poger et al. [16, 15] Present work
Lipid parameters
Choline partial charges Chiu [2] Reif [18]
Phosphate partial charges Chiu [2] Margreitter [8]
CH3p-OM C12 [kJmol−1nm12] 1.58E-5 [16] 1.10E-5 Present work
CH3p-CH3p C12 [kJmol−1nm12] 2.66E-5 [10] 6.48E-5 [18]
Simulations details
GROMACS version 3.2.1 2016.3 [1]
Long range electrostatics Reaction Field [21] PME [6]
Cut-off a Twin-range Single
Short range cut-off a 0.8 nm NA
Long range cut-off 1.4 nm 1.4 nm
System size (# of lipids) 128 512
Sampling time 120 ns 300 ns
# replicas 2 1
Table 10: Table of the changes occurred between simulations run in Poger et al. [16, 15]
and the present work, in terms of parameters used and simulation conditions. a Settings not









Figure 2: Time series of the area per lipid for a DPPC bilayer, for simulation ID 1 to 5 (see
Table 1 for details).
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Figure 3: Area per lipid (computed from the simulation box sides) of a DPPC bilayer, for the
five test simulation (ID 1 to 5 in Table 1) and the control ones (SI Table 1), computed for









Figure 4: Area per lipid (computed from the simulation box sides) for a DPPC bilayer, for
the control simulations as described in SI Table 1). Simulation ID1 (see Table 1) has been
included for comparison, as each control simulation (small, RF, ID0) differs from ID1 by only
one property (either the system size, long-range electrostatic treatment or the head group
partial charges).
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Figure 5: Area per lipid (a), electron density of CH2 tails and total (b), order parameter (c)
and distribution of the distance between water oxygen and the nearest lipid Choline atom for










Figure 6: Area per lipid (a), electron density of CH2 tails and total (b), order parameter (c)
and distribution of the distance between water oxygen and the nearest lipid Choline group
atom for a DMPC bilayer (d), obtained by 5 different sets of parameters (see legend in panel
(a,c) and Table 1).
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Figure 7: Area per lipid (a), electron density of CH2 tails and total (b), order parameter (c)
and distribution of the distance between water oxygen and the nearest lipid Choline group
atom for a DOPC bilayer (d), obtained by 5 different sets of parameters (see legend in panel









Figure 8: Area per lipid (a), electron density of CH2 tails and total (b), order parameter (c)
and distribution of the distance between water oxygen and the nearest lipid Choline group
atom for a POPC bilayer (d), obtained by 5 different sets of parameters (see legend in panel
(a,c) and Table 1).
18
Figure 9: Area per lipid (a), electron density of CH2 tails and total (b), order parameter (c)
and distribution of the distance between water oxygen and the nearest lipid Choline group
atom for a DPPC bilayer (d), obtained by 5 different sets of parameters (see legend in panel









Figure 10: Electron density profiles of the whole hydrated DLPC, DMPC, DOPC, DPPC and
POPC bilayers (Total) and of their individual components (Cho: choline, PO4: phosphate,
gly+carb: glycerol carbonyl groups, CH2: methylenes of the acyl chains, CH: CHdCH groups
in the oleoyl chains, CH3: terminal methyls of the acyl chains) for simulation ID1 (54A7 force
field, Chiu charges).
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Figure 11: Electron density profiles of the whole hydrated DLPC, DMPC, DOPC, DPPC and
POPC bilayers (Total) and of their individual components (Cho: choline, PO4: phosphate,
gly+carb: glycerol carbonyl groups, CH2: methylenes of the acyl chains, CH: CHdCH groups










Figure 12: Electron density profiles of the whole hydrated DLPC, DMPC, DOPC, DPPC and
POPC bilayers (Total) and of their individual components (Cho: choline, PO4: phosphate,
gly+carb: glycerol carbonyl groups, CH2: methylenes of the acyl chains, CH: CHdCH groups
in the oleoyl chains, CH3: terminal methyls of the acyl chains) for simulation ID4 (54A8_v2
force field, Reif-Margreitter charges).
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Figure 13: Electron density profiles of the whole hydrated DLPC, DMPC, DOPC, DPPC and
POPC bilayers (Total) and of their individual components (Cho: choline, PO4: phosphate,
gly+carb: glycerol carbonyl groups, CH2: methylenes of the acyl chains, CH: CHdCH groups
in the oleoyl chains, CH3: terminal methyls of the acyl chains) for simulation ID5 (54A8_v3









Figure 14: Deuterium order parameter SCD profiles of the sn-1 and sn-2 fatty acyl chains of
hydrated DLPC, DMPC, DOPC, DPPC and POPC bilayers calculated from simulations ID2
(54A8 force field, Chiu charges). The SCD values are averaged over all the lipid sn-1 and -2
acyl chains in the systems (proS hydrogen only). Experimental values: Douliez1995 from Ref.
[5], Petrache2000 from Ref. [12].
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Figure 15: Deuterium order parameter SCD profiles of the sn-1 and sn-2 fatty acyl chains
of hydrated DLPC, DMPC, DOPC, DPPC and POPC bilayers calculated from simulations
ID4 (54A8_v2 force field, Reif-Margreitter charges). The SCD values are averaged over all
the lipid sn-1 and -2 acyl chains in the systems (proS hydrogen only). Experimental values:









Figure 16: Deuterium order parameter SCD profiles of the sn-1 and sn-2 fatty acyl chains
of hydrated DLPC, DMPC, DOPC, DPPC and POPC bilayers calculated from simulations
ID5 (54A8_v3 force field, Reif-Margreitter charges). The SCD values are averaged over all
the lipid sn-1 and -2 acyl chains in the systems (proS hydrogen only). Experimental values:
Douliez1995 from Ref. [5], Petrache2000 from Ref. [12].
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Figure 17: Distribution of the distance between the water oxygen and the nearest lipid head-
group atom in given moieties for simulations of a DLPC bilayer. Cho: choline, PO4: phos-









Figure 18: Distribution of the distance between the water oxygen and the nearest lipid head-
group atom in given moieties for simulations of a DMPC bilayer. Cho: choline, PO4: phos-
phate, Gly: glycerol, CO1 and CO2: carbonyl groups at the sn-1 and sn-2 positions.
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Figure 19: Distribution of the distance between the water oxygen and the nearest lipid head-
group atom in given moieties for simulations of a DOPC bilayer. Cho: choline, PO4: phos-









Figure 20: Distribution of the distance between the water oxygen and the nearest lipid head-
group atom in given moieties for simulations of a POPC bilayer. Cho: choline, PO4: phos-
phate, Gly: glycerol, CO1 and CO2: carbonyl groups at the sn-1 and sn-2 positions.
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Figure 21: Values of SASA for Choline, Phosphate and Glycerol moieties for all the five



























































































Figure 24: Lateral diffusion coefficient for DPPC in the control simulations as per SI Table 1.
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Figure 25: Snapshot after 400 ns simulation of a DPPC patch at 303 K with the 54a8_v1
parameter set. In the circle a detail of the ordered lipid tails which have already transitioned









Figure 26: Properties of POPE bilayer simulated with the 54A8 force field, Chiu charges and
CH0 esters. Top: electron density profiles (Total: whole bilayer, am: amine, PO4: phosphate,
gly+carb: glycerol carbonyl groups, CH2: methylenes of acyl chains, CH: CHdCH groups of
oleoyl chains, CH3: terminal methyls); middle: deuterium order parameter SCD of the sn-1
and sn-2 fatty acyl chains (proS hydrogen only); bottom: distribution of the distance between
the water oxygen and the nearest lipid headgroup atom - insets: integral of the distribution
(am: amine, PO4: phosphate, gly: glycerol, CO1 and CO2: carbonyl groups at the sn-1 and
sn-2 positions).
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Figure 27: Properties of POPE bilayer simulated with the 54A8 force field, RM charges and
CH0 esters. Top: electron density profiles (Total whole bilayer, am amide, PO4 phosphate,
gly+carb glycerol carbonyl groups, CH2 methylenes of acyl chains, CH CHdCH groups of
oleoyl chains, CH3 terminal methyls); middle: deuterium order parameter SCD of the sn-1
and sn-2 fatty acyl chains (proS hydrogen only); bottom: distribution of the distance between
the water oxygen and the nearest lipid headgroup atom - insets: integral of the distribution










Figure 28: Properties of POPG bilayer simulated with the 54A8 force field, RM charges and
CH0 esters. Top left: area per lipid and experimental value (dashed line); top right: electron
density profiles (Total: whole bilayer, etam: etamine, PO4: phosphate, gly+carb: glycerol
carbonyl groups, CH2: methylenes of acyl chains, CH: CHdCH groups of oleoyl chains, CH3:
terminal methyls); bottom left: deuterium order parameter SCD of the sn-1 and sn-2 fatty acyl
chains (proS hydrogen only); bottom right: distribution of the distance between the water
oxygen and the nearest lipid headgroup atom - insets: integral of the distribution (etam:
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Figure 29: Four different orientations of the peptide 1LFC (bovine lactoferricin) used to
sample different initial conditions for the peptide-membrane simulations. OII, OIII and OIV
are obtained from OI with an anticlockwise rotation along the main axis (shown as x-axis
in OI) of respectively 90◦, 180◦, 270◦. The membrane plane is placed parallel to the main
axis of 1LFC; the residues displayed in the bottom are the ones facing the lipids. Backbone
red cartoon representation and whole peptide bonds representation coloured by residue type.
The insets shows a cartoon representation of the portion of LFC facing the membrane, with









Figure 30: Angle with respect to the z-axis formed by the β-sheet plane. The backbone
of amino acids 19 and 17 form hydrogen bonds with the backbone of amino acids 7 and 9
respectively. The vectors connecting the heavy atoms bonded to the O-H pairs forming them
are taken as reference to compute the orientation. Solid lines refer to parameter set Chiu/54a8
and dashed ones to set RM/54a8_v1.
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4.1. Additional material: effects of membrane undulation 203
4.1 Additional material: effects of membrane undulation
During the revision process of the paper which constitute this Chapter, it was brought
to our attention that membrane undulations are incompatible with the computation of
ApL performed from the sides of the simulation box. The more a membrane patch is
deviating from a flat geometry, the more approximate would be such method. Moreover,
as the electron density profile is computed as an average over all the x and y positions,
undulations of the membrane would result in a broader profile, with more uncertainty
on the exact positions of the electron density peaks.
A brief comment on this appears on Section 2.5.1 of the paper, granting that the
procedure chosen was suitable for the analysis of the simulations presented, and we
would like to provide additional evidence to strengthen the case. This analysis supports
as well the choice of using the box sides approach in Chapter 3 for simulation without or
with low electric field, switching to a computation which takes into account undulations
only for the highly curved membranes obtained with a high electric field.
The computation of ApL accounting for the membrane curvature is performed us-
ing a Fourier approach according to the work of Braun et al. [2011] and using the
software made available from the same publication. This allows to obtain the ratio
between the “true” area per lipid (i.e. computed taking into account the undulations
of the membrane) and the projected one (i.e. from the box sides approach). Figure
4.1 reports the ratio ApLund/ApLproj for each lipid and each parameter set: the values
span between 1.0020 and 1.0046, which translates into an ApL correction between 0.20
and 0.46%, or, in absolute value, 0.001-0.003 nm2. These discrepancies are lower than
the standard deviation for any of the area per lipid computed, showing that the more
accurate computation has no consequence for the purpose of evaluating the ApL and
comparing parameter sets. The parameter set showing less discrepancy is Chiu/54a7,
compatible with the fact that on average it produces smaller area per lipid: a more
packed bilayer results in less freedom for the lipids to undulate.
Regarding the electron density, to check the influence of the averaging procedure
over different locations of the patch, we computed the electron density for the phos-
phorus atoms on the full patch (256 lipid per leaflet), on a medium patch of roughly
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Figure 4.1: Ratio between area per lipid computed taking into account the undulations
of the membrane (according to the procedure devised in Braun et al. [2011]) and the
one computed from the projection on the plane parallel to the membrane. A value of
1 would be obtained for a perfectly flat membrane.
one forth in dimension (60 lipids per leaflet, see Figure 4.2(b) for a scheme), and finally
a small 12 lipids per leaflet patch. It must be noticed that the GROMACS software,
while computing the density perpendicular to the bilayer plane (presently along the z
axis), centres the patch analysed around its center of mass, at each time step. This
holds for GROMACS versions 5 onward, an version 2016.3 was used for all the analyses
presented.
The resulting densities from the three different patches described above are nor-
malised by the number of lipids present in each and compared. Figure 4.2(a) shows
that the profiles for the full and medium patches are almost identical, while the smaller
patch produces narrower peaks. Indeed, computing the full width at half maximum
(FWHM) of these peaks, the FWHM of the small patch peaks is 16% smaller than
the FWHM of the large patch peaks. However the distance between phosphorus peaks
differ between patches by around 0.1 Å only, showing that the undulations have an
effect mainly (or only) on the peaks broadness. As such, the hydrophobic thickness
(measured as the distance between the phosphorous peaks) is virtually unvaried, and
the difference imputable to the computing procedure is smaller than both the experi-
mental thickness error and the differences arising from the use of different parameter
sets. Further analysis must be done on the Luzzati thickness estimate, which depends
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DPPC bilayer - Chiu/54a7 parameter set
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Figure 4.2: (a) Electron density of the phosphorus atom computed on the full mem-
brane, a medium and a small patch. (b) van der Waals representation of the phos-
phorus atoms of the DPPC lipid bilayer (initial configuration) used for simulations.
The simulation box is highlighted in blue. The green plus red regions constitute the
medium patch mentioned in the analysis; the red one constitute the small patch.
on the broadness of the water profile. However, it must be noticed that also for this
measure, the range of experimental results is quite broad and thus, as for many prop-
erties assessed in the paper, likely to be larger than the differences which can derive
from the analysis procedure.
Another valid point raised in the discussion regards the use of the Berendsen baro-
stat. As this algorithm does not reproduce the correct isobaric ensemble (see 2.1), the
estimate of the lateral compressibility module is not accurate and should not be used to
validate the parameters. Its computation is still valid as a comparison with the results




n this work we sought to understand and characterise at the molecular level the
structures of a nanocapsule formed by antimicrobial peptides AMPs (named capzip)
in solution. This assembly could not be determined by conventional structural investi-
gations. In particular, we wanted to identify which amino acids or sub-structures play a
role in the assembly to a nanocapsule unit and in its antimicrobial function. Multiscale
simulations identified a network of β-sheets organised in a double layer as the preferred
geometry for the assembly. The presence of a second layer was proved necessary to form
a stable three dimensional object. This requirement allows to optimise the propensity
of the residues in the sequence for solvent exposure by burying hydrophobic residues
and exposing charged residues necessary to the antimicrobial activity.
To host both the hydrophilic and hydrophobic moieties present in AMPs, rigid α-
helical structures have been in the past widely employed as they can accommodate both
of them in a suitable way. However, the design of the peptide capzip explored the pos-
sibility of forming AMP structures without such fold. Our simulations have explained
how the assembly of capzip is compatible with an amphiphatic structure formed by
β-sheet peptides, once many copies are assembled together in a specific manner. The
resulting double layer capsule successfully buries Tryptophan residues, which are the
drivers of the stability and cohesion between the layers, and expose Arginine ones, which
contribute to the β-sheet pairing. To pinpoint the role of specific amino acids was one
of the aim of the work and it is particularly important in the context of designing new
AMPs, as indeed a possible future direction of this work is the exploration of different
amino acids composition for the molecule. This can hardly be done in a systematic
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manner both at the experimental level and in silico, even employing coarse-grained
simulations. Thus, ultra coarse-grained models could be employed in which capzip is
represented with three/four beads for each strand. This would provide an important
screening to understand which electrostatic and hydrophobic properties each segment
should have to tailor the assembly.
The simulations of pre-assembled structures gave insight into the driving forces to
assembly stability, particularly in comparing different coarse-grained force fields. One
question which remains open concerns details on the kinetics of the process.
The second question this work aimed to answer was how the antimicrobial activity
of the nanocapsule was performed, understanding which moieties actively perturbed
the membrane and how such perturbation could be quantified. We used model mem-
branes matching different experimental compositions, namely a bacterial membrane
composed by zwitterionic and anionic phospholipids, and a mammalian one composed
only by zwitterionic phospholipids. We assessed that capzip interacts favourably with
the bacterial membrane, but less favourably with the mammalian one. This property
is needed to selectively exploit the antimicrobial activity. The peptide decreases the
stability of the bacterial membrane and its ability to withstand external perturbation
like the one of an electric field. This observations illustrate how capzip can promote
poration of the bacterial membranes only.
The disruptive action is lead by charged Arginine insertion in the hydrophobic
membrane region, while we do not observe the hydrophobic residues (Tryptophan) to
penetrate deeply into it. This is in disagreement with the generally accepted picture
of antimicrobial peptide insertion into membranes, which proposes a two step process
formed by a charge binding event followed by hydrophobic insertion. However, this
mode of action was postulated for helical AMPs. Here we proved instead that for an
assembly of AMPs with high β-sheet content, the Arginine insertion is sufficient to
trigger poration without rearrangement of all the Tryptophan within the membrane
by applying an electric field close to physiological values. The assembly of capzip is
crucial in bringing many antimicrobial sequences within the same region of the mem-
brane, creating loci with high positive charge. Moreover, through the presence of many
Arginine residues, a chain of water molecules inserting into the hydrophobic membrane
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core triggers the formation of a pore, that leads to the disruption of the membrane.
This investigation necessarily explores specific, simplified membranes. The results
correlate with the experiments on Supported Lipid Bilayer of the same composition,
informing the mechanism that allow their disruption. However, they must be reconciled
with the complex structure of both bacterial and mammalian real membranes: the
bacterial model used is mimicking the inner membrane, and therefore the mechanism
of permeation and/or transportation of the peptide through the outer membrane (for
Gram-negative bacteria) or the peptidoglycan layer (for Gram-positive ones) remains
still to be elucidated. However, the bacterial cell wall is negatively charged, as in
the adopted model. Therefore we can assume that the mechanism of adsorption and
disruption observed in our simulations is in broad sense reproducing the physiological
situation.
On the contrary, the scarce interaction observed with the mammalian membrane
poses the question of which determinants are then favouring a good internalisation of
siRNA molecules in HeLa cells, as proven by experiments Castelletto et al. [2016]. The
resulting system (siRNA plus capzip assembly) is very different with respect to the
pure capzip assembly because of the negative charge contributed by siRNA molecules.
As such, it has not been investigated in this work. The modelling of this is within
the future outlook of this work, important for applications of capzip for delivery and
alternative therapies. Indeed, the capsule itself has the potential to transport a broad
variety of drugs, rather than siRNA only, but the characteristics of the capzip-drug
assembly must be specifically modelled for each case to understand the interaction of the
nanocapsule carrier with bacterial and mammalian membranes. These considerations
make an exciting ground for boosting the application of capzip assembly not only as an
antimicrobial agent but also as a delivery agent, fully exploiting the multi-functional
behaviour it was designed for.
Finally, this work brought two contributions to methodological aspects of simula-
tions techniques: they emerged as a valuable by-product of the in silico exploration
chosen, in the effort of developing and applying the best and more updated techniques
to our system.
First, connected with the exploration of capzip assembly, we performed a systematic
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analysis of the performances of different coarse-grained force fields (SIRAH, MARTINI,
Polar MARTINI) in simulating the assembly of the capzip. In particular we proved
that the SIRAH force field returns an energetic profile closer to the atomistic one,
while the MARTINI models proposed a remarkably different balance between the elec-
trostatic and short range energetic components. These conclusions could be a result of
the model underlying the respective parametrisations, as SIRAH groups fewer atoms
than MARTINI in one bead, however, to our knowledge, this is the first comparison
which presents a quantitative analysis of it. This is important for the choice of the
coarse-grained model, in particular when simulating systems with a high net charge,
as the relative weight of the Coulomb interactions versus short range ones may vary
considerably.
Finally, we carefully analysed and questioned the parametrisation of lipids in the
GROMOS force field, proposing a more up to date version of parameters for phop-
sholipids and phosphocholine in general (called version 54A8 v1, available at http:
//fraternalilab.kcl.ac.uk/wordpress/biomembrane-simulations/). This novel
parametrisation has a significant impact on the simulations of proteins-lipids interac-
tion, as proved by test simulations of the AMP Lfcin. We think that this parameters
are a first step toward reconciling the description of the two components, to model their
mutual influence at best. This work places itself in the workflow of continuous improve-
ments of MD simulations parameters, which is constantly prompted by three factors:
better experimental results available, the development of new strategies of parametri-
sation, and the evolution of computers, which allows the simulations of larger systems
and longer time scales, verifying or questioning what already achieved exploring re-
duced systems or shorter times. The past successes of MD simulations already show
the potential of this techniques which nevertheless must be continuously improved to
tackle more complex systems. As such, we are keen in testing more extensively the
new parameters and to repeat selected simulations of capzip on model membranes to
understand the type of interactions that they propose.
Overall, this work elucidate some principles and rules in the assembly and antimicro-
bial mechanism of actions of a synthetic molecule by use of computational techniques:
these processes are inaccessible to experiments, proving that Molecular Simulations are
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an irreplaceable tool to access their atomistic details.
Appendices
A.1 Additional publications
The following pages present the manuscript: Kepiro, I. E., Marzuoli, I., Hammond, K.,
et al. Engineering chirally blind protein pseudo-capsids into nanoprecise antibacterial
persisters, submitted and in second revision for ACS Nano. Chapter 3 includes part of
the results presented in the paper, elaborating them further.
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ABSTRACT: the spread of bacterial strains persistent to antibiotic treatments stimulates the search 
for an alternative means of antimicrobial interventions. Here we report a virus-like pseudo-capsid 
engineered to self-assemble from re-purposed effector domains of a host defence protein to exhibit a 
broad spectrum of antibacterial activities in vitro and in vivo. Using a combination of nanoscale and 
single-cell imaging we demonstrate that such pseudo-capsids inflict instantaneous and all-out damage 
to bacterial cells by penetrating and disrupting their membranes. Unlike conventional antibiotics, these 
agents are effective against phenotypic bacterial variants, while clearing superbugs in vivo without 
toxicity. The monomeric subunits of the designed pseudo-capsids can be in either epimeric form, L or 
D, providing a versatile platform for engineering structurally diverse and functionally persistent 
antimicrobial capsids. 
Antimicrobial resistance is a natural process that helps bacteria adapt to new environments (1). The 
process is relentless and represents a major health threat given our dependence on antimicrobial 
treatments (2). With conventional antibiotics losing their effectivity at an alarming rate, alternative 
antimicrobial interventions attract an ever-increasing interest (3). Most compounds that are prescribed 
to patients today act by binding to individual intracellular targets in bacterial cells. A single genetic 
event is sufficient for bacteria to acquire potent counter measures. The time these take to manifest can 
fall within just a few years after a given antibiotic is introduced to the market (3). As a consequence, 
bacteria can develop into “superbugs” – strains that no longer respond to antibiotic treatments. The 
spread of these pathogens necessitates the development of novel antimicrobials that can rapidly attack 
a bacterial cell as a whole. This strategy may provide agents capable of killing growing, persister and 
dormant cells – this feat is inaccessible to conventional antibiotics (4). New agents should be able to 
differentiate between host and bacterial cells as the attack is likely to involve cell membranes. Strictly 
speaking, the innate immune systems of multicellular organisms do not use antibiotics. Instead, they 
















peptides or relatively small domains in globular proteins that recognise pathogen associated molecular 
patterns on the surfaces of microbial cells (5). These effector molecules are diverse in structure and 
origin, but share common physicochemical properties. Most of them are cationic and fold into 
amphipathic conformations upon binding to anionic microbial membranes (6). In membranes, these 
conformations assemble into higher-order oligomers that overcome a threshold of peptide 
concentration, beyond which antimicrobial effects become apparent. Reaching this concentration 
appears to be a limiting step in the ability of the oligomers to permeate membranes (7), and is more 
characteristic of host defence peptides, e.g. human defensins and cathelicidins (8), than of effector 
domains of multifunctional proteins, e.g. lactoferrins, that recognise pathogen surfaces without the 
need to self-oligomerize (9). Nonetheless, in free, isolated forms, these domains can oligomerize to 
induce bacteriostatic effects (10). This presents a considerable opportunity for antimicrobial 
engineering. Multiple copies of an isolated effector domain can be arranged to fold into a discrete and 
autonomous assembly. The domain copies of the assembly are ready to be deployed at the site of 
contact with microbial membranes, where they instantaneously deliver concentrations that 
significantly exceed those necessary to rupture microbial membranes. An ultimate benefit of this 
design is rapid and all-out damage to a microbial cell without the need for the transition from 
unstructured peptide monomers to membrane-active oligomers – a strategy that may be less subject to 
acquired resistance. However, the success of this approach relies on the ability of the effector 
molecules to pre-concentrate in a distinct nanoscale structure that can bind to microbial membranes. 
More specifically, most bacterial cells do not exceed 0.2 to 1 µm in width. Therefore, a discrete 
assembly of effector domains ranging from tens to hundreds of nanometres in diameter would be 
sufficient to inflict irreparable damage to a bacterial cell. To be discrete at these size ranges the 
assembly is best confined to a platonic, symmetrical structure. The nature of the symmetry is of less 
importance as long as the assembly is locked into a three-dimensional form that can bind to microbial 
membranes. In this regard, viral capsids inspire a straightforward solution. These are self-assembled 
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nanoscale shells that can be commensalistic to multicellular hosts. Viruses do not kill bacteria on 
contact, but can provide suitable architectural templates for the capsid-like assembly of effector 
molecules. Resulting assemblies need not be strictly monodisperse because their designed function 
allows for a level of structural polymorphism that is typical of aberrant and pseudo-capsids (11-13). 
Furthermore, the assigned function imposes no a priori constraints on the chirality of the effector 
domains. Polypeptide chains of reversed chirality or all-D peptides are much more stable to 
proteolysis, fold in a similar manner to that of all-L peptides and are likely to be non-immunogenic 
(14-17). Antimicrobial D epimers are as effective as their L counterparts, which is consistent with that 
host defence peptides act by binding to the lipid components of bacterial membranes rather than dock 
to a specific protein (17, 18). Herein we demonstrate the application of the outlined principles for the 
design of antimicrobial pseudo-capsids or Ψ-capsids. 
RESULTS 
Pseudo-capsid design 
Our approach adapts a short host defence motif from a multifunctional protein lactoferrin – a major 
component of the innate immune system (9, 10). The antimicrobial properties of this protein are 
attributed to its N-terminal domain. The domain has a broad spectrum of targets including porins, 
DNA, intracellular metabolites, and can stimulate the immune system by neutralising endotoxin (19-
21). The host defence motif of the domain is a hexapeptide RRWQWR, which has strong propensity 
for antiparallel β-sheet conformations (22).  
To render this motif self-complementary, the C-terminal arginine of the peptide was replaced with a 
glutamate. This modification facilitates inter-strand Coulombic interactions with the N-terminal 
arginine of the opposite β-strand. The core of the motif is also homologous to a characteristic motif of 
tryptophan zippers, WTW, which folds with cross-strand tryptophan rings packed tightly against one 
another (23). To capitalise on this analogy, the glutamine in the peptide was replaced with a threonyl 
















bilayer with two cationic exteriors. In viruses, capsid proteins interface orthogonally with each other 
to network into penta- and hexagonal assembly units. Each of these units adopts a three-fold rotational 
symmetry which ensures their propagation into a closed symmetry, shell (24). To emulate the three-
fold symmetry of native shell-like subunits, the resulting motif RRWTWE was converted into a triskel 
conjugate (Figs 1A and S1 in Supporting Information), with both L- and D-forms of this conjugate 
chemically synthesised (Fig S2).  
 
Figure 1. Pseudo-capsid design. (A) A molecular model of the triskel RRWTWE conjugate. (B) A snapshot 
of molecular dynamics simulations showing a pentagonal assembly unit formed by designed triskelions. (C) 
Two β-sheet arms (green and yellow) forming a bilayer interface via cross-strand packed tryptophans (grey). 
(D) A schematic representation of the designed triskelion as a monomer subunit in a truncated icosahedron 
shown as a 5-fold Schlegel orthographic projection. (E) 5-fold symmetry orthographic projections of two 
truncated icosahedra (black and red) forming a double-walled assembly. Note: for clarity only one of each of 
the pentagonal (green) and hexagonal (orange) units is highlighted in D and E. (F) A single-walled triskelion 
assembly templated on a truncated icosahedron. (G) A double-walled triskelion assembly templated on a 
truncated icosahedron. Outer and inner shells in (F) and (G) are shown in green and yellow, respectively. 
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Each arm of this triskelion pairs into an antiparallel β-sheet with another arm of another triskelion. 
Each folded pair of two arms interfaces with another folded pair of two other conjugates (Fig 1B, C). 
The monomer has a tri-lateral symmetry which enables it to assemble into penta- and hexagonal units 
forming β-sheet bilayer networks (Fig 1B). Because β-strands are stabilised by inter-strand interactions 
it is physically impossible for the bilayers to have free, “sticky” edges. These have to close on one 
another. Triskelion structures have an intrinsic non-zero curvature (25-27). In propagating β-sheet 
networks, the curvature translates into a trans-sheet asymmetry prompting the spontaneous closure of 
increasingly curved sheets into a minimum energy structure – shell (27, 28). This mode of assembly 
is analogous to that of viral shells which follows an icosahedral symmetry, with a truncated 
icosahedron being one of the most common architectures (29, 30). This polygon architecture offers an 
ideal template for the assembly of triskelions: it has only three-fold vertices, each of which can host 
an individual triskelion (Fig 1D, E). Therefore, the cooperative assembly of triskelions within the 
template should create an equilibrated β-sheet shell. The monolayer configuration of this structure is 
not stable as the hydrophobic side chains of the tryptophanyl residues are oriented inwards towards 
the water-filled core of the shell (Fig 1F). A β-sheet bilayer or a double-wall shell, in which cationic 
arginyl residues furnish its exterior and interior surfaces, is deemed more stable (Fig 1C, G) (31). In 
support of this conjecture, coarse grain molecular dynamics (MD) simulations (32) showed that single-
wall icosahedra assembled from the triskelion collapsed within the first 600 ns of simulations 
following an equilibration phase (Fig S3A). Under the same simulation conditions, double-walled 
shells retained their initial configuration over 1 μs of coarse grain simulations, evolving into more 
compact shapes, for both L- and D-forms, which was also confirmed by 100 ns atomistic simulations 
(33) (Figs S3B, S4 and Movie S1). The results of the simulations indicate that triskelions can assemble 
cooperatively in the template reaching an equilibrated and stable structure.  
















Consistent with the simulations, Circular Dichroism (CD) spectra for both forms of the triskelion were 
characteristic of antiparallel β-sheet and β-turn conformations (Fig S5A). Fourier transform infrared 
(FT-IR) spectra revealed bands for the de-convoluted amide regions at 1650-1670 cm-1 for β-turn 
structures and at 1630 cm-1 and 1545 cm-1 for β-sheets (Fig S5B).  
 
Figure 2. Pseudo-capsid assembly. (A) TEM images of assembled D-Ψ-capsids. Scale bars are 50 nm. (B) 
Higher resolution TEM images of individual collapsed capsids. Scale bars are 50 nm. (C) Topography images 
of D-Ψ-capsids obtained on a mica substrate by in liquid AFM. Colour (height) and scale bars are 60 nm and 
200 nm, respectively. (D) 3D representation of D-Ψ-capsids. Colour (height) bar is 65 nm. (E) Size distributions 
and dominating sizes of D-Ψ-capsids by AFM and TEM. (F) Average sizes of dominating populations of Ψ-
capsids. Assembly conditions: 100 µM peptide, pH 7.4, 10 mM MOPS, 20˚C, overnight. 
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The results suggest that inter- and intra-molecular hydrogen bonds in β-sheets and β-turns, 
respectively, support the cooperative folding of the triskelions into higher-order structures. Indeed, 
transmission electron microscopy (TEM) and atomic force microscopy (AFM), performed in solution, 
revealed uniformly spherical capsid-like shells (Fig 2A-D), some of which appeared to collapse into a 
double-walled or double-layered morphology (Fig 2B). The diameters of the shells were consistent by 
width (TEM) and height (AFM) measurements showing narrow step-size distributions, e.g. 10-20 nm, 
20-40 nm (Fig 2E, F). This suggests that the triskelions may adopt an integer step size in assembly, 
generating shells that are polymorphic in size, but not in shape. This property is akin to that of viral 
capsids and synthetic virus-like assemblies that can adapt to repack into smaller and larger shells (34-
36). This is also in marked contrast to mutant viral capsids and polymorphic virus-like particles whose 
variations in morphology feature filamentous and aberrant structures with irregular serrations (12, 13). 
Taken together the findings indicate that the designed triskelions propagate with the formation of 
thermodynamically stable Ψ-capsids exhibiting a degree of structural plasticity that helps 
accommodate size variations without compromising on morphological uniformity. Since the 
triskelions occupy the vertices of pentagonal and hexagonal faces in the truncated icosahedron, rather 
than tightly pack in the faces, the overall architecture of Ψ-capsids remains independent of size 
allowing for wide size variations. This property renders the assembly adaptable to morphological 
changes imposed by hierarchically complex and dynamic environments such as microbial membranes.  
To test their behaviour in membranes in sufficient detail, Ψ-capsids were introduced into reconstituted 
phospholipid bilayers that were assembled on mica substrates as described elsewhere (37). The 
resulting supported lipid bilayers (SLBs) provide suitable models for bacterial membranes, are flat (to 
within ~0.1 nm) in their unperturbed state (Fig 3A, B), and allow for the accurate depth measurements 
of surface changes in solution and in real time by AFM (38). As gauged by these measurements, Ψ-


















Figure 3. Pseudo-capsids porating phospholipid bilayers. (A) In liquid AFM topography of SLBs treated 
with D/Ψ-capsids. The images are taken at 4-min intervals. Individual Ψ-capsids are numbered (1-6) to highlight 
conversions into pores. Scale bars are 100 nm for the first image and 200 nm for the others. The height (colour) 
bar is 10 nm. (B) Cross-sectional analyses of Ψ-capsids numbered as in (A) for each given time point. (C) 
Topography of a Ψ-capsid converting into a pore in 15 min, with the height profiles of the corresponding 
conversion area. Images are taken at 5-min intervals. Scale and height (colour) bars are 50 nm and 10 nm, 
respectively. (D) A plot combining height profiles of three Ψ-capsids from (A) to show conversions as a function 
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of time. (E) A snapshot of coarse-grain MD simulations of a Ψ-capsid landing on a phospholipid bilayer at 2 µs 
and simulated for additional 8 µs. Key: outer and inner shells are in green and yellow, respectively; golden 
beads denote phosphate groups linked to two types of polar groups (blue and magenta); aliphatic lipid tails are 
in cyan. (F) A 72-ns snapshot from 100-ns atomistic simulations of a rudimentary pore showing a triskelion arm 
stretching across the bilayer interface. Key: for clarity, only phosphate groups (golden beads) are shown for the 
bilayer.  
The conversion of individual shells into pores at their precise landing positions was complete within a 
few minutes of treatment: Ψ-capsids gradually sank in the lipid bilayers at the depths of a folded 
triskelion arm, ~1.8 nm (0.3 nm translation per β-strand residues) (Fig 3A-D). Coarse grain simulations 
of the capsids in the lipid bilayers (39) run over 10 µs revealed that the sinking effect occurred at the 
expense of pressing and displacing lipids deep into the bilayer interface (Fig 3E, Movie S2). In accord 
with this, atomistic simulations of a rudimentary pore showed that triskelion arms oriented towards 
the bilayer interface (Figs 3F, S6 and Movie S3). Such localised responses are consistent with a 
mechanism where triskelions re-assemble in the bilayer and that forming pores do not expand and 
remain confined within the diameters of Ψ-capsids. This is important for three reasons. First of all, the 
assemblies exhibit a larger structural plasticity than crystalline materials or viruses do, which allows 
them to rapidly re-arrange into peptide-lipid oligomers at the sites of contact with phospholipid 
membranes. Secondly, these oligomers maintain the size of the resulting pores close to that of the 
landed capsids thereby supporting precise and site-specific membrane disruption. Thirdly, this 
behaviour suggests that Ψ-capsids may support differential responses in cell environments favouring 
attack on microbial membranes. To gain a better insight into this, the biological properties of Ψ-capsids 
were assessed using a range of in vitro and in vivo assays.    
Biological properties of pseudo-capsids 
Irrespective of chirality, Ψ-capsids were found to be antimicrobial and non-hemolytic (Table S1). The 
















agents including conventional antibiotics (Table S1). However, the principal advantage of Ψ-capsids 
over antimicrobial compounds lies in their ability to exert rapid and all-out damage to a bacterial cell, 
which makes them equally effective against susceptible and tolerant cells. In liquid AFM experiments 
showed that the capsids can indeed disrupt membranes within minutes. MIC experiments cannot 
directly relate to the AFM results as these are optical density measurements that do not take into 
account changes at the cellular level. Therefore, we sought complementary evidence from three series 
of experiments using planktonic and sessile bacterial culture of two of the most common pathogens – 
E. coli and S. aureus. In the first series, the antimicrobial activity of Ψ-capsids was assessed as a 
measure of total cell counts following capsid treatments (27). Negligible cell counts were observed for 
cultures treated with the capsids in comparison to the samples of untreated cells in which appreciable 
bacterial growth was observed (Fig S7). These findings provide end-point results of treated cell 
populations obtained over the same timescale as MIC measurements. To elucidate the antimicrobial 
kinetics of Ψ-capsids within the first hours and with a single-cell resolution, the second series of 
experiments was conducted. In these experiments thousands of individual E. coli cells were screened 
using a high throughput microfluidic device comprising thousands of growth channels (40). Each 
channel serves as a trap for an individual cell where the cell can grow through one of its distal poles, 
whereas the diameter of the channel matches that of the cell thereby arresting its movement (41). The 
replicative age of this trapped, mother, cell increases by one generation at each cell division allowing 
to follow phenotypic cell inheritance for an infinite number of generations. Such a “mother machine” 
then enables the single-cell monitoring of antimicrobial kinetics in situ and is able to reflect the 
responses of different cell phenotypes to antimicrobial agents (42). With this in mind, Ψ-capsids were 
introduced into E. coli cells trapped in the channels of the device (Fig 4A). After three hours of 
treatment under a constant flow the microfluidic environment was replaced by flowing the culture 
medium over 21 hours to restore normal conditions for bacterial growth. Subsequent analyses revealed 
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that Ψ-capsids killed all encountered cells (Fig 4). By contrast, persister cells and viable but not-
culturable (VBNC) cells were found after ampicillin treatments (Fig 4A, B).  
 
Figure 4. Single-cell antimicrobial kinetics of pseudo-capsids. (A) Three panels of representative optical 
micrographs of E. coli cells (i) killed by D/-capsids; (ii) survived and regrown after ampicillin treatments 
(persister cells); (iii) survived but not re-grown after ampicillin treatments (VBNC cells). In each panel, image 
bars show (from left to right) cells after 3-hour treatments with capsids or ampicillin, during subsequent washing 
with the growth medium over 21 hours, and after washing. The last micrographs in the panels are fluorescence 
images of 24-hour samples stained with propidium iodide (PI) – a live-dead stain penetrating dead bacteria with 
compromised membranes. (B) Cell fractions treated with D/-capsids and ampicillin. The data and error bars 
















microfluidic channels in four independent biological replicates. The distribution of fractions of susceptible cells 
to ampicillin was significantly lower than that to D/-capsids (p <0.0001). The distributions of fractions of 
persister and VBNC cells to ampicillin were significantly higher than those to D/-capsids (p <0.0001). (C) 
Electron micrographs of microtomed E. coli cells treated with D/-capsids. The scale bar is 200 nm.  
These tolerant phenotypes represent common sub-populations in clonal bacterial cultures that persist 
antibiotic treatments even at high doses (43). Persister cells resume growth after the drug is removed 
from their environment, whereas the regrowth of VBNC cells often requires specific conditions (44, 
45). Both phenotypes contribute to infection relapses prompting repetitive treatments and can be linked 
to dormancy (46). With Ψ-capsids effectively reducing these phenotypes to susceptible cells, changes 
in cell morphology may shed light on the mechanism of action at the single cell level. Indeed, the 
capsid-treated cells appeared shrunk and somewhat denser when compared to unaffected cells 
suggesting that the capsids accumulated in the membranes. This is consistent with the AFM findings 
(Fig 3), though the cells in the mother machine did not disintegrate and seemed intact (Fig 4B). 
Therefore, cells treated with capsids were microtomed and imaged by TEM. Complete membrane 
destruction was evident (Figs S8). Intriguingly, however, many cells appeared as empty and half-
empty carcases with displaced and bulging membranes that tended to open up at distal poles (Figs 4C, 
S8). This effect is not normally observed for bacteria damaged by host defence peptides or membrane-
active antibiotics, which porate bacterial membranes indiscriminately, causing cells to shrink and leak 
(37) or, as polymyxins, aggregate with lipopolysaccharides into membrane-destabilising blebs across 
the whole bacterial surface (47). The emphasis on distal poles is reminiscent of bacteriophages that 
preferentially target the poles of bacterial cells (48). Although, like polymyxins, Ψ-capsids favor 
anionic lipids, morphologically they are more of phage mimetics that may be attracted to outward 
membrane curvature or cell poles serving as DNA mobilisation sites before cell division (48, 49). The 
third series of experiments provided further insight into this. The attack of Ψ-capsids on E. coli cells 
was monitored by structured illumination microscopy (SIM), which was custom designed to image 
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biomolecular and cellular processes in situ (50-52). The capsids rapidly adhered to the cell surfaces, 
with adsorption at the distal poles being also apparent (Figs 5A and S9A). Within a doubling time (20 
min), the capsids proved to come into direct contact with the cells accumulating in their membranes 
and cytoplasm (Fig 5B, C). The affected cells then underwent sharp rupture accompanied by a burst 
of fluorescence intensity (Figs 5C, S9A-C and Movie S4). This effect was more profound in cocci cells 
(S. aureus). Although the distal poles of these cells are less defined, the transition from the initial 
contact with Ψ-capsids to the disintegration of their only membrane was somewhat sharper when 
compared to that for E. coli (Figs 5C, S9B and Movie S5).  
Figure 5. Time-kill kinetics of pseudo-capsids. Structured illumination micrographs of E. coli cells (A) 
immediately after the addition of L/-capsids and (B) during the treatment highlighting individual capsids in 
contact with cells. The capsids are labelled with carboxyfluorescein (green). Cell membranes are stained with 
FM4-64FX (red). Scale bars are 5 μm and 500 nm for (A) and (B), respectively. (C) SIM images recorded at 5-
min intervals for E. coli (upper) and S. aureus (lower) incubated with the capsids. Scale bars are 1 μm.  (D) 
















with -capsids and host defence peptides. Vancomycin and phosphate buffered saline (PBS) were used as 
positive and negative controls, respectively. Inoculations were done straight after the initiation of infection (first 
2 hrs) without subsequent treatments. (E) Survival of MRSA-infected G. mellonella larvae treated with 
vancomycin, L/-capsids and PBS, administered at 18 and 36 hrs after the initiation of infection. Survival rates 
for Ψ-capsids were significantly higher when compared to PBS control (Mantel-Cox test, p < 0.001). Grey 
arrows indicate inoculation time points. 
Strikingly, the time of cell disruption closely matched that needed for the conversion of the capsids 
into membrane-disrupting pores as gauged by AFM (Fig 3). Collectively, these findings suggest that 
Ψ-capsids need not disintegrate in the membranes, which they may effectively traverse reaching the 
protoplasm. Such a mode of action infers that the capsids may be able to circulate over prolonged 
periods of time in cellular environments that are challenged by sustained and active bacterial growth. 
To verify this in a biologically relevant model, Ψ-capsids were administered into G. mellonella larvae 
infected with a methicillin-resistant S. aureus (MRSA) strain susceptible to vancomycin (53, 54). Over 
the first 48 hours the treatments were as effective as those by high doses of vancomycin (Fig 5D). The 
survival rate of up to 80% proved to be steady for another 24 hours for larvae treated with D/Ψ-capsids, 
whereas a 10% drop was observed for larvae treated with the L-form (Fig 5D). The resulting rate of 
70% did not change over the total of 120 hours of treatment for L/Ψ-capsids. In comparison, for the 
D-form it dropped to 50% on day 4, suggesting a depletion of the capsids in the larvae. The exact 
reason for this is unclear, though the decrease is likely to link to that D/Ψ-capsids were more active 
during the first 72 hours, possibly at the expense of more capsids being engaged with bacteria (Fig 
5D). The observed survival rates proved to be superior over those reported for membrane-active 
antibiotics and bacteriocins implying that the capsids may indeed be equally effective in killing 
bacterial cells from the outside and inside (54-56). These experiments also demonstrated the 
importance of pre-assembling effector monomers into capsids, which was re-emphasised by the failure 
of stand-alone host-defence peptides to exert sustained antimicrobial effects under the same conditions. 
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Specifically, the administration of human (LL37), insect (cecropin B) and animal (magainin 2) 
antimicrobial peptides into the infected larvae did not improve survival rates relative to those of mock 
injections with PBS (Fig 5D). Furthermore, the capsids maintained high rates of bacterial clearance 
even when administered at significantly delayed injection times: the larvae treated with capsids at 18 
and 36 hours exhibited a 50% survival up to day 4 post-infection (Fig 5E), which is twice the time 
achieved by bacteriophage therapies (56). Finally, multiple injections of the capsids into uninfected 
larvae did not lead to appreciable cytotoxic effects (Fig S10). 
DISCUSSION 
The obtained results prompt several conclusions. First of all, we have demonstrated that a discrete 
virus-like shell assembled from moderately antimicrobial effector molecules delivers instantaneous 
and irreparable damage to a bacterial cell. The damage results from a direct impact that the assembly 
has on the cell upon contact and ensues via multiple avenues starting with the rapid conversion of the 
assembled shells into membrane-disrupting pores. Remarkably, pore formation is spatially confined to 
the landing position of a shell, which ensures the rapid and highly localized influx of high antimicrobial 
doses at the site of contact. Such an impact is different from that of organic or inorganic nanoparticles 
that are able to rupture membranes indiscriminately by a purely physical means, are unable to 
disintegrate and are prone to agglomeration. In contrast, the shells are cooperative ensembles of 
monomeric units that are capable of re-assembly in bacterial membranes and subsequent integration 
into the protoplasm. Thus, secondly, these ensembles yield equilibrated nanoscale systems whose 
construction is symmetry driven. This is a prerequisite for the structures of this type if they are to 
remain autonomously operational within the nanoscale size range (24, 57, 58). In this regard, the 
polygonal architecture of viral capsids proved to be a suitable framework for templating the assembly 
of monomeric units, which can be of virtually any chirality and topology. An efficient strategy for the 
design is then to re-purpose host defence effector molecules into structurally and functionally tunable 
















resemble membrane-active antibiotics or host-defence peptides, but their efficacy is no longer subject 
to the lag phase of reaching a critical threshold concentration on bacterial surfaces. Once assembled 
into a geometrically locked pseudo-capsid the motifs acquire a dual capacity of pre-concentrated and 
stimuli responsive antimicrobial doses. Their responsiveness builds upon their structural plasticity, 
which allows them to accommodate changes in dynamic environments without being restricted to a 
particular size (27, 59). Subsequently, requirements for nanoscale order are looser than those for viral 
subunits that tune their assembly to the size of encapsidated genomes. Similar to other protein 
paracrystals, which often exhibit periodic nanoscale patterns (e.g. striations or rings) (60, 61), the 
designed pseudo-capsids display fine surface structure (Fig 2A-D). Although this did not feature 
readily recognizable patterns, the assemblies appeared to adopt a size integer while being 
monomorphic in shape without competing morphologies such as filaments (62). Combined these 
physicochemical properties give rise to a highly effective antimicrobial system that, unlike antibiotics, 
is not frustrated by antibiotic tolerant phenotypes such as persister or VBNC cells, or by superbugs, 
killing all. This outcome is also notable in that the design may provide a useful tool to aid in a better 
understanding of how different bacteria phenotypes can be distinguished and selectively targeted (63). 
A question remains as to how universal the ability of such pseudo-capsids is in overcoming different 
resistance mechanisms including cell surface fortifications, efflux pump blockages or peptide 
antagonists that block access to cell membranes (64-67). As it has been long postulated (68) and re-
emphasized most recently (69), host defence polypeptides are evolutionarily conserved molecules, 
against which a widespread resistance has yet to emerge and cannot be developed easily. Resistance 
mechanisms against them exist but are not deemed systemic and are readily counteracted by relatively 
marginal alternations in peptide structure (69, 70). In this light, the pseudo-capsids demonstrated here 
may constitute a step change in the evolution of host defence effector molecules shifting the host-
pathogen arms race in favor of more sustainable and adaptable antimicrobial treatments, serving an 
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Materials and Methods 
Peptide synthesis and purification: L- and D-triskelions – (RRWTWE)-βA-K(RRWTWE)-
K(RRWTWE)-am – were assembled on a Liberty microwave peptide synthesizer (CEM) using 
standard Fmoc/tBu solid-phase protocols with HBTU/DIPEA as coupling reagents on a Rink amide 
MBHA resin. Fmoc-K(Mtt)-OH was used to enable orthogonal conjugation via a tri-functional 
dendritic hub – βAKK-am. Carboxyfluorescein-labelled triskelions were made on resin by coupling 
carboxyfluorescein to the N-terminus of βA-RRWTWE-βAKK, with fully protected side chains, 
on the resin. The remaining two arms were then assembled on resin following Mtt removal. 
Magainin 2 and cecropin B were synthesized as peptide amides on a Rink amide MBHA resin and 
LL37 was assembled as a peptide acid on a Fmoc-S(tBu)-Wang resin. After post-synthesis cleavage 
and deprotection (95% TFA, 2.5% TIS, 2.5% water) all peptides were purified by semi-preparative 
reversed-phase high-performance liquid chromatography (RP-HPLC). Peptide identities were 
confirmed by analytical RP-HPLC and MALDI-ToF.  
MS [M + H]+: cecropin B – m/z 3834.6 (calc.), 3836.0 (found); LL37 – m/z 4493.2 (calc.), 4495.8 
(found); magainin 2 – m/z 2465.9 (calc.), 2467.0 (found); L-triskelion – m/z 3090.5 (calc.), 3092.3 
(found); D-triskelion – m/z 3090.5 (calc.), 3092.8 (found);  carboxyfluorescein-L-triskelion – m/z 
3518.9 (calc.), 3519.7 (found).  
Analytical and semi-preparative RP-HPLC was performed on a JASCO HPLC system (PU-980; 
Tokyo, Japan), using a Vydac C18 analytical and semi-preparative (both 5 µm) columns. Both 
analytical and semi-preparative runs used a 10-70% B gradient over 30 min at 1 mL/min and 4.5 
mL/min, respectively, with detection at 280 and 214 nm (buffer A, 5% and buffer B, 95% aqueous 
CH3CN, 0.1% TFA). 
 
 
Ψ-capsid assembly: triskelions were assembled overnight at the concentrations stated in the text 
(100-400 µM) in filtered (0.22 μm), 10 mM MOPS, phosphate or PBS buffers, pH 7.4, at room 
temperature.  
Circular dichroism spectroscopy: CD spectra were recorded on a JASCO J-810 
spectropolarimeter fitted with a Peltier temperature controller. The measurements were taken in 
ellipticities in mdeg and converted to molar ellipticities ([θ], deg cm2 dmol-1 res-1) by normalizing 
for the concentration of peptide bonds. The data was collected with a 1 nm step, 1 sec collection 
time per step, and is presented as the average of 4 scans.  
Fourier transform infra-red spectroscopy: FT-IR spectra were recorded using a Tensor-27 series 
FTIR spectrometer equipped with a BioATR II unit (Bruker Optics), as the sampling platform, and 
a photovoltaic mercury cadmium telluride (MCT) detector and a Bruker Optics workstation 
equipped with OPUS software. Low-volume (20 µL) capsid samples (100 µM) were placed in a 
circular sampling area of radius 2 mm with a path length of 6 µm. FTIR spectra was recorded with 
resolution 4 cm-1, scanner velocity 20 kHz, 256 scans, phase resolution 32 and zero filling factor 
4. Spectra deconvolutions were performed by Gaussian peak fitting using the proprietary software.  
Molecular dynamics simulations: MD simulations were performed using the GROMACS 2016 
software with the GROMOS96 53A6 force field (atomistic) and the MARTINI force field (coarse 
grain) (32, 33).  A SPC water model was used for atomistic simulations and standard MARTINI 
water for coarse grain simulations (33). In all simulations chloride and sodium ions were added up 
to a 150 mM concentration. Additional ions were placed if required for charge neutralization. The 
initial Ψ-capsid configuration was constructed geometrically using the editconf tool from 
GROMACS. The DLPC/DLPG (3:1) membrane was constructed with the PACKMOL software 
with dimensions of 12 × 12 nm (atomistic) or 30 × 30 nm (coarse grain) (39). Periodic boundary 
conditions were imposed, setting the minimal distances between the protein and the box boundaries 
to 3 nm. All simulations are run in the NPT ensemble maintaining the temperature at 303K with 
the velocity rescale thermostat, and the pressure at 1 bar using the Parrinello-Rahman barostat, with 
either an isotropic or semi-isotropic coupling; simulations without and with membranes, 
respectively. For atomistic simulations of the Ψ-capsid in solution, multiple restrained equilibration 
runs (65 ns overall) precede the 100 ns production, which were run in three replicates. Similarly, 
for coarse grain simulations a 10 ns equilibration precedes the 1 μs production, which were run in 
three replicates. For simulations including membranes, the lipid patches were equilibrated for 500 
ns (1 μs for coarse grain) before placing the peptide close in contact with the lipid surface 
(atomistic) or at the minimal distance of 1 nm (coarse grain). Production was then carried out for 
















field of 130 mV/nm in the direction perpendicular to the membrane, with the higher potential region 
on the side of the bilayer where the peptide rests. 
Transmission electron microscopy: micrographs of the Ψ-capsids were recorded using a JEOL 
1010 transmission electron microscope equipped with an Orius SC1000 (Gatan Inc.) CCD camera, 
operated at 80 keV. Droplets of capsid solution were placed on glow discharged Cu finder grids 
coated with carbon film (mesh 200), stained with uranyl acetate (aq. 2%, w/v) for a few seconds 
and buffer excess was removed by blotting paper. Micrographs of E. coli were recorded using FEI 
Tecnai T12 transmission electron microscope equipped with a Morada G2 (Olympus Inc.) camera, 
operated at 80 keV. Samples were fixed with glutaraldehyde (aq. 5%, w/v), treated with a post-
fixation agent osmium tetroxide (1%, w/v, 100 mM PIPES, pH 7.2) and stained with uranyl acetate 
(aq. 2%, w/v). The resulting samples were embedded in a Spurr resin, and were left to solidify at 
60 ºC, over 24 hrs. The resin was then microtomed to ultrathin sections that were placed on 
Formvar carbon coated grids (mesh 200), post-stained using lead citrate (aq. 5%, w/v) and imaged. 
Preparation of unilamellar phospholipid vesicles for AFM imaging: 1,2-dilauroyl-sn-glycero-
3-phosphocholine (DLPC) with 1,2-dilauroyl-sn-glycero-3-phospho-(1’-rac-glycerol) (DLPG) 
lipids used for vesicle construction were from Avanti Polar Lipids (Alabaster, USA). DLPC were 
used as mammalian model membranes, and DLPC/DLPG (3:1, molar ratios) were used as bacterial 
model membranes. The lipids were weighted up, dissolved in chloroform-methanol (2:1, vol/vol), 
dried under a nitrogen stream and then under vacuum to form a thin film. The film was hydrated in 
10 mM phosphate buffer (pH 7.2) with shaking (1 h, 220 rpm) and bath sonicated for 30 min. The 
obtained suspension was extruded using a hand-held extruder (Avanti Polar lipids) (twenty nine 
times, polycarbonate filter, 0.05 µm) to give a clear solution of small unilamellar vesicles, whose 
sizes (50 nm) were confirmed by photon correlation spectroscopy. 
In-liquid atomic force microscopy on supported lipid bilayers: supported lipid bilayers were 
formed using a vesicle fusion method as described elsewhere (38). Freshly prepared vesicles (1.5 
µL, 3 mg/mL) were added to cleaved mica a pre-hydrated with buffer (70 µL, 120 mM NaCl, 20 
mM MOPS, 20 mM MgCl2). Following adsorption and incubation for 45 min, the samples were 
washed to remove unfused vesicles and resulting SLBs were checked to confirm they were defect 
free. Peptides were then introduced into a 100-µL fluid cell (Bruker AXS, USA) where they were 
diluted to the final concentrations of 0.1-0.8 µM. All imaging was performed using Peak Force 
TappingTM mode on a Multimode 8 AFM system (Bruker AXS, USA) using MSNL-E cantilevers 
(Bruker AFM probes, USA). Images were taken at PeakForce frequency of 2 kHz, PeakForce 
amplitude of 10 nm and PeakForce set-point of 10-30 mV (<100 pN). Images were processed using 
 
 
Nanoscope analysis software (Bruker AXS, USA) or Gwyddion (http://gwyddion.net) for first 
order line-by-line background subtraction (flattening) and first-order plane fitting. 
Photon correlation spectroscopy. Prepared phospholipid vesicles for AFM imaging were re-
suspended to a final concentration of 1 mg/mL and were analysed on a Zetasizer Nano (ZEN3600; 
Malvern Instruments). Dynamic light scattering batch measurements were carried out in a low 
volume disposable cuvette at 25 °C. Hydrodynamic radii were obtained through the fitting of 
autocorrelation data using the manufacturer’s Dispersion Technology Software (version 5.10). 
Minimum inhibitory concentrations assay: minimum inhibitory concentrations were determined 
by broth microdilution on P. aeruginosa, E. coli, S. aureus, M. luteus, B. subtilis, S. typhimurium 
and K. pneumoniae according to the Clinical and Laboratory Standards Institute. Typically, 100 μL 
of 0.5–1 × 106 CFU per ml of each bacterium in Mueller Hinton media broth (Oxoid) were 
incubated in 96-well microtiter plates with 100 μL of serial two-fold dilutions of the capsids (from 
100 to 0 μM) at 37 °C on a 3D orbital shaker. The absorbance was measured after capsid addition 
at 600 nm using a SpectraMax i3x Multi-Mode Microplate Reader (Molecular Devices). MICs 
were defined as the lowest peptide concentration that inhibited visible bacterial growth after 24 h 
at 37 °C. All tests were done at least in triplicate and results are summarized in Table S1. The 
values that are given without standard deviations are those for which no variations were found 
within triplicates.  
Hemolysis assay: hemolysis was determined using human erythrocytes sourced commercially 
from Cambridge Bioscience Ltd. and used within two days. 10% (vol/vol) suspensions of human 
erythrocytes were incubated with the capsids. The cells were rinsed four times in 10 mM phosphate 
buffer saline (PBS, Gibco™), pH 7.2, by repeated centrifugation and re-suspension (3 min at 3000 
× g). The cells were then incubated at room temperature for 1 h in either deionized water (fully 
hemolysed control), PBS, or with capsid in PBS. After centrifugation at 10,000 × g for 5 min, the 
supernatant was separated from the pellet, and the absorbance was measured at 550 nm using a 
SpectraMax i3x Multi-Mode Microplate Reader (Molecular Devices). Absorbance of the 
suspension treated with deionized water defined complete hemolysis. All tests were done in 
triplicate and results are shown in Table S1. The values given correspond to concentrations needed 
to kill a half of the sample population (50% lysis of erythrocytes) and are expressed as median 
lethal concentrations, LC50.  
Bacterial culture for single-cell antimicrobial kinetics measurements: lysogeny broth (LB) (10 
g/L tryptone, 5 g/L yeast extract, and 0.5 g/L NaCl, Formedium) and LB agar plates (LB with 15 
g/L agar) were used for planktonic and plate bacteria growth, respectively. E. coli BW25113 was 
















were incubated at 37 °C, over 17 hours in fresh LB medium (100 mL) with shaking (200 rpm). The 
prepared culture was span down (10 min, 3000 g and 20 ºC). The supernatant was filtered twice 
(Medical Millex-GS Filter, 0.22 µm, Millipore Corp.) and used to re-suspend the bacteria pellet to 
an OD595 of 50. The resulting highly concentrated bacterial suspension was used in high throughput 
single-cell kinetic measurements, together with M9 minimal medium (7 g/L Na2HPO4, 3 g/L 
KH2PO4, 1 g/L NH4Cl, 0.5 g/L NaCl, 1 mM thiamine hydrochloride) (Sigma Aldrich), ampicillin 
(Sigma Aldrich) and propidium iodide (PI) (Thermo Fisher Scientific), as described below. 
High throughput single-cell kinetic measurements: antimicrobial efficacy with a single-cell 
resolution was measured using a multi-channel microfluidics device as reported elsewhere (40, 41). 
The device used was a polydimethylsiloxane (PDMS, Dow Corning) replica of the original mold 
kindly provided by Suckjoon Jun (40). The device is an array of dead-end microfluidic channels 
1.5 µm in diameter and a 25 µm in length. Each channel can host 1-4 bacterial cells in a single file. 
The channels are connected to a main microchamber (25x100 µm) that is continuously supplied 
with antimicrobial agents, fresh LB or propidium iodide (see below). The device was permanently 
attached to a glass coverslip and functionalized with a solution of bovine serum albumin (50 
mg/mL). 2 µl of the highly concentrated bacterial suspension, prepared as described above, was 
injected in the device and individual bacteria were allowed to diffuse into the lateral channels for 
30 min. The device was then completed with fluorinated ethylene propylene inlet and outlet tubing 
(1/32"×0.008") connected to a flow-rate measuring system (Flow Unit S, Fluigent, France) with 
the applied pressure controlled by a computerized pressure-based flow control system (MFCS-4C, 
Fluigent). The completed device was mounted on an inverted microscope (IX73 Olympus, Tokyo, 
Japan) equipped with a 60×, 1.2 N.A. objective (UPLSAPO60XW, Olympus) and a sCMOS 
camera (Zyla 4.2, Andor, Belfast, UK) used to acquire bright-field images (exposure time 0.03s) 
of thousand channels per hour for the duration of each experiment (24 hrs). After acquiring the first 
set of images, the microfluidic environment was changed by flowing M9:LB (9:1 v:v) containing 
antimicrobial agents (D/-capsids or ampicillin) at 25×MIC at 100 µL/h over three hours and then 
by LB for a further 21 hrs. At 24 h PI (30 µM) was delivered into the microfluidic device for 10 
min to identify dead cells with compromised cell membranes. The device allowed to track each 
bacterial cell and its progeny throughout the assay, with the images obtained in each channel loaded 
to ImageJ. 
Time-lapse structured illumination microscopy of E. coli and S. Aureus:  bacteria (E. coli 
ATCC 15597 and S. aureus ATCC 6538) were inoculated into Mueller Hinton broth, grown 
overnight at 37 °C, 150 rpm, re-inoculated and grown to OD600 of 0.5-0.8. The cells were then 
pelleted by centrifugation (4000 rpm, 10 mins), and after removing the supernatant, were re-
 
 
suspended in 1 mL PBS (10 mM) and transferred to an Eppendorf tube. FM4-64 (1 mg/mL, 5 μL) 
was added to each tube followed by rotation on a rotating disk for 5 mins. The cells were then 
centrifuged (7000 rpm, 3 mins), the supernatant was removed, and the cell pellet was re-suspended 
in PBS (1 mL). Bacteria was then diluted to OD600 of 0.16 and 0.08 for E. coli and S. aureus, 
respectively. 100 μL of each suspension was added to different wells of a chambered microscope 
coverslip (Ibidi μ-Slide 8 Well) and left for 30 min to allow cells to settle onto the substrate. 
Immediately prior to each imaging experiment a 100-μL solution of Ψ-capsids assembled from 
caroxyfluorescein-labelled and unlabelled triskelions at 1:100 molar ratios were added to the well 
to a final concentration of 50 μM (total peptide). For control datasets, 100 μL of PBS was added 
prior to imaging. Time lapse imaging was performed at 5-min intervals using a custom-built 
structured illumination microscope (50). Briefly, sinusoidal excitation patterns were generated by 
projecting a spatially filtered image of a spatial light modulator (SLM), configured to display a 
series of binary phase gratings, into the focal plane of the microscope objective lens (UPLSAPO 
60x/1.3, Olympus). Sample images were acquired using a scientific CMOS camera (ORCA-
Flash4.0, Hamamatsu Photonics), with the global exposure period of the camera’s rolling shutter 
synchronised to the pattern displayed on the SLM. At each time point FM4-64 and 
carboxyfluorescein-labelled capsids were imaged sequentially, using excitation at 561 nm with a 
655 nm long pass emission filter and excitation at 488 nm with a 525/50 bandpass emission filter 
respectively. Images were reconstructed as described elsewhere (51) and lateral drift and chromatic 
offsets in the reconstructed images were corrected using ImageJ. The FM4-64 colour channel was 
then corrected for photobleaching using an exponential fit to the image intensity within a suitable 
region of interest. Manual background subtraction and colour balancing was performed to optimise 
image contrast. 
In vivo MRSA clearance assay: Galleria mellonella larvae assay was performed as described 
elsewhere (53, 54). Wax moth larvae were purchased in bulk from Livefood UK, stored at 4°C 
upon arrival and kept at 37°C during the course of the assay. Ψ-capsid samples were prepared from 
stock solutions in Milli-Q water to working concentrations in sterile phosphate buffered saline 
(PBS). Typically, a single bacterial colony was picked to inoculate 5 mL of tryptic soy broth (TSB), 
and the resulting culture was left to grow overnight (~16 hours) at 37°C with shaking (200 rpm). 
The culture was then diluted (100x) into a fresh TSB (5 mL) and incubated over 4 hours at 37°C 
with shaking (200 rpm). After centrifugation (2500g) for 10 min, pellets were obtained and re-
suspended in sterile PBS to an OD595 of 0.2, giving ~10
8 CFU/mL.) The re-suspended culture (10 
µL aliquots; ~1.2 × 106 CFU) was administered to larvae (seven groups; n=10 in each group) behind 
the rear thoracic segments using a Tridak Stepper Pipette Dispenser (Dymax, UK). The infected 
















magainin 2 (12.5 μM), cecropin B (12.5 μM), LL37 (12.5 μM), vancomycin (40 μM) or PBS at 
stated time points after inoculation. The toxicity of Ψ-capsid was assessed using two groups of 
larvae (n=10 in each group). These were mock-infected with PBS and treated with 10 μL of L or 
D/Ψ-capsid (25 μM) at stated time points after inoculation. For the delayed treatment assay, three 
groups of infected larvae (~106 CFU) were treated with 10 μL of L/Ψ-capsid (12.5 μM), 
vancomycin (40 μM) or PBS at stated time points after inoculation. All experiments were carried 
out as blind studies, and the treatment identities were not revealed until each experiment was 
completed. Larvae were considered dead when they did not respond to touch to the head. Survival 
























Table, Figures and Movies 
 
 
Table S1. Biological activities of Ψ-capsids in comparison with other antimicrobial agents. 





Figure S1. Triskelion design. (a) N-terminal domain of lactoferrin (PDB entry 1LFC rendered by PyMol). 
The core sequence, RRWQWR, in the domain is highlighted in blue, and converted to a self-complementary 
β-strand, RRWTWE. (B) Three copies of RRWTWE are conjugated into a β-strand triskelion. Triskelions 
interact via β-strand arms. For clarity only two triskelions forming a β-sheet are shown and highlighted in 
different colours. (C) The chemical structure of the triskelal RRWTWE conjugate. Note: the schematics are 






ampicillin melittin polymyxin B cecropin B 
L-form D-form 
Minimum Inhibitory Concentration, μM 
E. coli  7.8 ± 2.7 6.6 ± 3.9 >25 2.3 ± 1.1 1.3 ± 0.3 <1 
S. aureus  8.3 ± 2.9 17.2 ± 8.1 <1 <1 25 50 
P. aeruginosa  9.4 ± 3.1 >25 >25 9.3 ± 3.1 1.5 25 
S. typhimurium 12.5 9.4 ± 5.4 8.3 ± 2.9 3.1 1.5 <1 
K. pneumoniae >25 8.2 ± 4.6 12.5 3.1 2.6 ± 0.7 1.5 
B. subtilis 2.3 ± 0.8 5.2 ± 1.5 25 3.1 3.1 >50 
M. luteus 1.2 ± 0.4 2.3 ± 0.8 1 ± 0.4 <1 2 ± 0.7 <1 
 LC50,a μM 
Human 
erythrocytes 

















Figure S2. Triskelion synthesis.  MALDI-ToF spectra (A) and RP-HPLC profiles (B) for purified L- and 
D-triskelions. (C) RP-HPLC (left) and MALDI-ToF (right) traces for the purified L-triskelion modified with 









Figure S3. Pseudo-capsid shells. (A) Final snapshot (1 μs) of a coarse grain MD simulations of a β-sheet 
single-walled shell templated on a truncated icosahedron (green, peptide backbone only). For comparison, 
a final configuration for double-walled shell is shown in grey (peptide backbone only). (B) Root mean 
square deviations (RMSD) of double-walled shells versus their initial configurations as a function of time. 
Initial, mid-time and final configurations are shown in insets. See also Movie S1. 
 
Figure S4. Double-walled pseudo-capsid shell. Final configurations of L- and D-forms of the triskelion 
assembly templated on a truncated isosahedron after 100 ns of atomistic simulations. Initial configurations 

















Figure S5. Pseudo-capsid folding. (A) CD spectra for L/Ψ-capsids (dashed line) and D/Ψ-capsids (solid 
line). (B) FT-IR spectra for L/Ψ-capsids (right) and D/Ψ-capsids (left), including raw spectra (black line), 
cumulative fit (dashed red line), deconvoluted amide spectra (other coloured lines). Folding conditions: 100 
µM peptide, pH 7.4, 10 mM MOPS, 20˚C. 
 
 
Figure S6. A rudimentary pore. Snapshots taken at 62 ns (left) and 72 ns (right) of 100-ns atomistic 
simulations of a rudimentary pore in phospholipid bilayers. Key: for clarity, only phosphate groups (golden 





Figure S7. Antimicrobial kinetics of Ψ-capsids. (A) Fluorescence micrographs of bacterial cells after 16-
hour incubations without (blank) and with Ψ-capsids. The scale bar is 20 µm. (B) Total cell counts for 
samples after 16-hour incubations without (blank), taken as 100%, and with Ψ-capsids. Total cell counts for 
samples treated with the capsids were significantly lower than those for un-treated cells (p <0.001). (C) 
Representative bacteria growth curves (E. coli) recorded for serial peptide dilutions (100 µM to 0 µM) as a 
function of time. Individual data points are collected at 30 min intervals. 
 
 
Figure S8. Single-cell antimicrobial kinetics of Ψ-capsids. Electron micrographs of microtomed E. coli 

















Figure S9. Time-kill kinetics of pseudo-capsids in vitro. (A) SIM images of E. coli cells immediately 
after the addition of L/-capsids and after 45 min of the treatment. The capsids are labelled with 
carboxyfluorescein (green). Cell membranes are stained with FM4-64FX (red). (B) A larger area of E. coli 
cells imaged at 45 min of the treatment. (C) Control SIM images recorded at 5-min intervals for S. aureus 
(upper) and E. coli (lower) without the capsids. Scale bars are 1 μm. 
 
 
Figure S10. Time-kill kinetics of pseudo-capsids in vivo. Survival of G. mellonella larvae treated with -
capsids.  Inoculations were done straight after the initiation of infection (first 2 hrs) with two subsequent 
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A.2 Supplementary material
Supplementary material can be found at https://github.com/imarzuoli/Thesis_
marzuoli and includes Supplementary Movies of:
• SI_M1_GROMOS_buckyball.mp4
GROMOS atomistic simulation of the buckyball bilayer - 100 ns;
• SI_M2_SIRAH_buckyball.mpg and SI_M3_PolarMARTINI_buckyball.mpg
SIRAH and Polar MARTINI coarse-grained simulations of the buckyball bilayer
and monolayer - 1 µs;
• SI_M4_GROMOS_capzip_bacterial_E130_poration.mp4
atomistic simulation of poration of a model bacterial model membrane under the
combined action of the pentagonal capzip subunit and an external electric field
of 130 mV/nm - 60 ns;
• SI_M5_MARTINI_capzip_bacterial.mp4 and SI_M6_MARTINI_capzip_mammalian.
mpg
standard MARTINI simulation of a buckyball bilayer approaching a bacterial and
mammalian model membrane - 10 µs;
• SI_M7_PolarMARTINI_capzip_bacterial_E40_poration.mpg
Polar MARTINI simulation of a buckyball bilayer porating a model bacterial
membrane under the effect of a 40 mV/nm external electric field - 200 ns.
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A.3 Software developed
The simulations and analysis of capzip systems prompted the development of tools to
facilitate the task. These are meant to be used in conjunction with standard analysis
tools provided by GROMACS [Berendsen et al., 1995; Abraham et al., 2015, 2018]
and MDAnalysis [Michaud-Agrawal et al., 2011; Gowers et al., 2016]. The scripts and
packages developed can be found at https://github.com/imarzuoli/MDtools, which
includes (among others):
• a python module to manipulate and prepare multi-branched peptide topology files
in the GROMACS format for GROMOS simulations (MD_mutate_and_manipulate.
py);
• python functions to perform the analysis of contacts as in Section 3.4 of Chapter
3 (contacts_analysis.py);
• functions to perform the hydration analysis as in Section 3.4 of Chapter 4 (an_
min_hist.py).
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Wassenaar, T. A., Ingólfsson, H. I., Böckmann, R. A., et al. (2015). Computational
Lipidomics with insane : A Versatile Tool for Generating Custom Membranes for
Molecular Simulations. Journal of Chemical Theory and Computation, 11(5):2144–
2155.
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